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1. INTRODUCTION 
                   “Is life worth living? It all depends on the liver.” 
                                                                                                  -William James                                                                                         
  In traditional system of medicine, the Siddha system of medicine has its own 
uniqueness to maintain the balance of the body and mind. It is a boon offered by the 
eminent powers called Siddhars; this system not only helps to cure the diseases but 
also protects the body mainly for longevity with complete freedom from illness and 
preventing ageing (Rejuvenation). 
As the number of people, preferring natural health remedies and herbal health 
remedies are increasing day by day and Indian medical systems are gaining popularity 
all over the world nowadays, this is the best time to introduce Siddha system to the 
World. 
Siddhars are the spiritual scientists, who established the Siddha science. 
Siddhars have more knowledge about the universe and its contents. 
 Agastiyar is considered as the foremost Siddhar and guru of Siddha cult. 
There are also 18
 
prime Siddhars who are the followers of the primordial guru. One of 
the concepts of Siddha is focused to “Attamasiddhi”, which are the eight supernatural 
powers. Those who attained or achieved the supernatural powers are known as 
Siddhars
 [1]
. 
The main goal of Siddha system of medicine is to satisfy the people with 
healthy and hygienic life. “Pancha bootham” (Five primordial elements)   and 
“Tridhosam” (Three humors) forms the basis of Siddha. All the physiological 
function in the body is arbitrated by “Tridhosam” (‘Vatham’, ‘Pitham’ and 
‘Kabam’)[2].                    
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Siddha system has an enormous pharmacopoeia containing herbs, metals, 
minerals, animals and its derivatives are the core sources of Siddha medicine. It is 
classified into 64 varieties, which consists of 32 types of internal medicines and 32 
types of external medicines. Under each classification thousands of formulae are 
mentioned by the Siddhars.  
The drugs used in Siddha medicine are classified on the basis of five 
properties: ‘Suvai’ (Taste), ‘Gunam’ (Character), ‘Veeryam’ (Potency), ‘Pirivu’ 
(Class) and ‘Mahimai’ (Action) [3].     
The importance of health science and its cure are mentioned in the Classical 
Tamil sangam literature “THIRUKKURAL”. Saint Thiruvalluvar defines medicine as,  
“உற்றான் அளவும் பிணியளவும் காலமும் 
கற்றான் கருதிச் செயல்” 
The learned physician should ascertain the condition of his patient; the nature 
of his disease, and the seasonal changes and then proceed with his treatment.
 [4] 
Siddha system is primarily based on 96 principles (Thathuvas) that offers 
better solution to 4448 diseases supposed to be affecting mankind and everything 
have been portrayed in the literatures. Among the traditional system of medicine, 
Siddha system has enormous number of liver tonics and liver protective agents of 
herbals and mineral origin for the benefit of mankind. 
Liver is the largest organ in a human body, situated in the right side of upper 
abdominal cavity. It plays an important role in Carbohydrate, Protein, Lipid, 
Bilirubin, Bile acid, Vitamin and Mineral, Hormone, Drug, Alcohol, and Cholesterol 
metabolism. The liver plays an astonishing array of vital functions in the maintenance, 
performance and regulating homeostasis of the body. The bile secreted by the liver 
plays an important role in digestion. 
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Liver synthesizes all the coagulation factors and requires vitamin K to activate 
some factors. Prothrombin time depends on factors I, II, V, VII and X, and it gets 
prolonged when the plasma concentration of anyone of these falls below 30 % of 
normal. 
Prothrombin time (normal value 12 seconds) is prolonged in: 
 Severe liver damage as in acute hepatitis e.g. viral hepatitis  
 Prolonged biliary obstruction which reduces vitamin K absorption. 
Therefore, maintenance of a healthy liver is essential for the overall well being 
of an individual
 [5]
. 
 Environmental pollutions, fast foods, drugs, alcohol and sedentary lifestyles 
are the causes of Liver diseases. As a result it depresses the immune systems, constant 
fatigue, obesity, sluggish digestive system are the main cause of health problems. 
Alcohol and many pharmaceutical drugs can affect the metabolism of the liver, and if 
this continues for long periods of time, health will be endangered. The most common 
diseases of liver includes Hepatitis, Alcohol related liver diseases, Liver tumor and 
Rey’s syndrome [6]. 
In recent years, people widely suffered from liver diseases. One of the major 
causes of liver diseases is Jaundice which affects humans in all ages. In Siddha 
system of medicine, “Jaundice” is correlated with “Pitha Kamaalai” or “Manjal 
Kamaalai”. As per the text Manjal Kamaalai is of 13 types [7]. 
Jaundice is a general condition that results from abnormal metabolism in 
retention of bilirubin. Jaundice causes a yellow discoloration of the skin, mucous 
membranes and sclera. The three principle types of Jaundice are pre hepatic, hepatic 
and post hepatic. Many of the liver diseases are accompanied by Jaundice caused by 
increased levels of bilirubin in the system
 [8]
. 
Liver disease is one of the major causes of morbidity and mortality in public 
affecting humans of all ages.  
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 According to WHO, about 46% of global diseases and 59% of the mortality is 
because of chronic diseases and almost 35 million people in the world die of Chronic 
Liver diseases.  Liver disease rates are steadily increasing over the years
 [9]
.  
According to the latest WHO data published in may 2014 Liver Disease deaths 
in India reached 216,865 or 2.44% of total deaths. The age adjusted Death Rate is 
21.96 per 100,000 of population
 [10]
. 
This report gives an alarm, to decrease the morbidity and mortality rate caused 
by hepatic complications; one of the most common problems in the world is hepatic 
diseases. If it is persists for long time the morbidity and mortality will be increased. 
So we have to make the most of the existing formulations or evaluating new 
treatments. 
           The Liver is quantitatively the most important site of drug metabolism. 
However many drugs are known to cause hepatic injury. Conventional and synthetic 
drugs used in the treatment of liver diseases are sometimes inadequate and can have 
serious adverse effect. 
Steroids, vaccines and anti-viral drugs, have been used as therapies for liver 
diseases, they have potential adverse effect. Current medical treatment for liver 
diseases is ineffective, and therefore efforts are being made to seek new effective 
medications 
[11]
. 
In latest research, Poly-herbal combination treatment is an alternative 
medication in market and active transporters by herbal phytochemical fractions may 
affect therapeutic outcomes of co-administered allopathic medicines due to changes in 
their pharmacokinetic profiles.  
Combination of different plant extracts as polyherbal medication is a new 
approach in treatment of liver disease, for example Liv 52 Himalaya drug co. 
product), Livergen (Standard Pharmaceuticals), Tefroliv (TTK Pharma Pvt. Ltd), etc 
are generally used in India for hepatotoxicity treatment. Polyherbal formulation is 
used widely by different pharmaceuticals companies for treatment of liver toxicity
 [12]
. 
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           Due to known side effects of approved pharmaceuticals, patients often turned 
to alternative medicine which is considered natural and healthy
 [13]
. 
Many herbal preparations support or promote the process of healing or 
regeneration of liver cells with fewer side effects. The majority of plants are used for 
liver disorders
 [14]
. 
Poly herbal formulations reported to have hepatoprotective activities that are 
available in Indian market which comprise about 100 Indian medicinal plants.
 [15] 
Some of the most valuable plants used for the treatment of liver problems are 
Phyllanthus amarus, Silybum marianum, Glycyrrhiza glabra, Curcuma longa, 
Picrorhiza kurroa
 [16]
. 
Siddhars have achieved supreme knowledge in herbal medicines and 
enlightened spiritually as well. In short, herbs are a natural and primary therapeutic 
remedy for liver diseases.  
Though the liver has a marked regenerative capacity and a large functional 
reserve, hepatic failure may develop from severe acute and fulminant liver injury with 
massive necrosis of liver cells (acute hepatic failure) or from advanced chronic liver 
disease. Hence, herbal drugs have become popular and their use is widespread
 [17]
. 
“Modern medicine is a negation of health. It isn’t organized to serve human 
health, but only itself as an institution. It makes more people sick than its heals.” 
                                                                                                  -Ivan Illich. 
Modern medicines have a little to offer for alleviation of hepatic diseases, only 
the plant based preparations are employed for the treatment of liver disorders. Herbal 
medicines are the most cost effective form of traditional medicine.
 
In our traditional system of medicine Siddha system is a treasure which 
contains immense herbal formulations. 
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                             “Nature is the healer of disease.” 
                                                                                             -Hippocrates 
 A number of plants and formulations have been claimed to have 
hepatoprotective activity. Nearly 160 phytoconstituents from various plants have been 
claimed to possess liver protecting activity. In India, more than 87 plants are used, 33 
are patented as proprietary ingredient plant formulations. 
Now- a- days there are so many medicines have been used in the treatment of 
liver diseases, but there is a need for the drug which could be less toxic, cost effective 
and more potent. Among them, one of the polyherbal formulation mentioned in 
Siddha literature for hepatoprotective activity is “Siringipaerathi Chooranam” 
consists of Piper longum, Cuminum cyminum, Syzygium aromaticum, Bambusa 
arundinacea and Cinnamomum tamala which acts as a Hepatoprotective and Anti-
oxidant activities
[18]
. 
  Scientific validation is not available in the formulation.  Even though the 
shelf life period of Chooranam is limited, its potency is too high. So I have preferred 
to choose the “Chooranam” form of medicine that will definitely act as a 
“HEPATOPROTECTIVE” to safeguard the people from liver damage.  . 
 I hope the study effect of “Siringipaerathi Chooranam” for hepatoprotective 
activity will discover a choice of new drug for better health care of patient to deal 
with hepatic disorder. 
AIM AND OBJECTIVES 
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2. AIM AND OBJECTIVES 
Aim 
The present investigation was aimed to validate the safety and efficacy of the Siddha 
polyherbal formulation ‘SIRINGIPAERATHI CHOORANAM’ for its Hepatoprotective 
activity against CCL4 and Paracetamol induced hepatotoxicity and Anti-oxidant 
activity in In-vivo and In-vitro models. 
Objectives 
The objectives of this work were done through the following steps. 
 Collection of relevant literature from classical Siddha texts as well as 
Modern sciences that supported this study. 
 Description of pharmacognostic features of the plant in this formulation 
including the taxonomic identification, collection, purification of plants 
etc. 
 Preparation of the drug according to the procedure described in Siddha 
literature. 
 Standardisation of the trial drug by means of physico-chemical analysis, 
phyto chemical analysis. 
 Revealing the Anions and Cations present in the drugs through proximate 
Chemical analysis. 
 Elucidation of the chemical structure, microscopical structure of the drugs 
by means of instrumental analysis. 
 Interpreting the results of acute and repeated dose 28-day oral toxicity of 
SIRINGIPAERATHI CHOORANAM according to OECD guidelines 423 
and 407. 
 Detailing the study of pharmacological activities like CCL4, Paracetamol 
induced hepatotoxicity and Anti-oxidant activity of the trial drug 
SIRINGIPAERATHI CHOORANAM in In-vivo and In-vitro models. 
 
 
REVIEW OF LITERATURE 
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3. REVIEW OF LITERATURE 
DRUG NAME: “SIRINGIPAERATHI CHOORANAM” 
SIDDHA LITERATURE: SARABENDRA VAIDHIYA MURAIGAL 
“துதிசெய்யிஞ்ெி மேற்ம ோலைச் ெவீிக் ச ோண்டு 
துண்டுதுண் டோய்நறுக் ி நிழைினிலு ைர்த்தி 
பதினோறு பைம்பசுவின் சநய்யி ைிஞ்ெி 
பக்குவேோய் வறுத்திடித்து ேிளகு நன் ோய் 
விதித்திடுவி ரோ சனலட பனிசரண் சடட்டோம் 
மவண்டியதிப் பிைிநில திப் பிைியின் மூைம் 
அதினோன்கு  ோசெலடமேற் ச ோடியின் மவைி 
யோகும்வ ரோ சனலட பத்துந் தோமன”. 
   
 
“பத்சதல்ைோ மைைேிை வங் ப் பட்லட 
ப ர்மூங் ி லுப்மபோடு ைவங் ப் பத்திரி 
யுத்தேேோம் ெந்தனம்வி ைோேிச் ெம்மவர் 
உயர்ெோதிக்  ோசயழில்ெ ீர ங் ி ரோம்மப 
யித்தலனயும் வல க்ச ோருப ைந்தோன் கூட்டீ 
யிடித்துவடி  ட்டியிஞ்ெி முதல்தூட் ச ல்ைோம் 
புத்தநற்ெ ீனியுேிரண்டு போங் ோய்ச் மெர்த்து 
சபோருந்தவுந்தோ மன ைந்து  ச ோண்டி  டோமய”. 
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“ச ோண்டிருவ ரோ சனலட யிரண்டு மபோதும் 
குணேோன மதனில்நித்த முண்மட வந்தோல் 
பண்டிருந்த சுரம்ேோர்பில் வைி ி ரோணி 
ப ரோம்பற் பித்தங் ோ ேோலை வோந்தி 
துண்டரிக் ப் பீனிெமும் வோெி யோகும் 
மதோல யிடப் போ ர்பதப் பூலெ யோமை 
எண்டிலெயுங்  ீர்த்திசபற்  தருே மூர்த்தி 
சயங் ள்ெர மபந்திரேோ ைியம்பும் வோம ”. 
-ெரமபந்திரர் லவத்திய முல  ள்[19]. 
 
THE FOLLOWING ARE THE INGREDIENTS QUOTED IN THIS SONG 
Inji    - Zingiber officinalis 
Milagu    - Piper nigrum 
Thippili   - Piper longum 
Thipili moolam - Piper longum 
Lavanga pathiri - Cinnamomum tamala 
Elam    - Elettaria cardamomum 
Kodiveli ver  - Plumbago zeylanica 
Lavanga pattai - Cinnamomum zeylanicum 
Moongil uppu  - Bambusa arundinaceae 
Sandhana thool - Santalum album 
Vilamichu-ver  - Plectranthus vettiveroides 
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Sathikkai   - Myristica fragrans 
Seeragam   - Cuminum cyminum 
Kirambu   - Syzygium aromaticum 
Sugar    - Saccharum officinarum 
Nei                         - Ghee 
 
3.1. BOTANICAL ASPECT OF DRUGS 
 GINGER  
Botanical name  : Zingiber officinale 
Family   :  Zingiberaceae 
Part used  : Rhizome 
Scientific classification 
Kingdom  :  Plantae 
Class          :  Monochlamydeae 
Order      :  Zingiberales 
Family   :   Zingiberaceae 
Genus     :  Zingiber 
Species    :  officinale 
Occurrence and distribution 
Inji is the rhizome of Zingiber officinale (Family: Zingiberaceae), widely 
cultivated in India, rhizomes dug in January- February, buds and roots removed, 
soaked overnight in water, decorticated and sometimes treaded with lime and dried. 
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Description 
Macroscopic: 
Drug occurs as entire rhizome or in pieces, rhizome laterally compressed 
bearing flattish ovate, oblique branches on upper side, each having a depressed scar at 
its apex, pieces 5 to 15 cm. Long, 1.5 to 6.5 cm. Wide (usually 3 to 4 cm.) and 1 to 
1.5 cm .thick, fracture short with projecting fibres, transversely cut surface shows a 
wide central stele having numerous greyish cut ends of fibres and yellow secreting 
cells; odour characteristic; taste pungent. 
Microscopic: 
Rhizome – Shows a few layered, irregularly arranged, tangentially elongated, 
brown cells of outer cork and 6 to 12 rows of thin-walled. Colourless, radically 
arranged cells of inner cork. secondary cortex consisting of hexagonal to polygonal, 
isodiametric, thin-walled, parenchymatous cells containing numerous circular to oval 
starch grains with characteristic striations and hilum at one end measuring 5 to 25 µm 
in dia., idioblasts containing large yellowish to brownish globules of oleo-resin; walls 
of oil cells suberised; numerous ckised,conjoint,collateral, cortical fibro-vascular 
bundles scattered throughout cortical zone, greater number occurring in inner cortical 
region, larger bundles consists of 2 to 7 vessels, small cells of sieve tube; pericycle 
single layered enclosing central stele; larger bundles found scattered throughout stele, 
composed of xylem, phloem, parenchyma and sheath of sclerenchyma. 
Constituents 
               Volatile oil containing cineole, zingiberol, zingiberene, bisabolene and 
phellandrene, gingerdione,dihydrogingerol,dexahydrocurcumin and desmethyk 
hexahydrocurcumin, dehydrigingerdione.
 
Medicinal Uses: 
 It is used to treat cold, cough, regurgitation, diseases due to heat, derangement 
of 3 humours, diarrhoea due to indigestion, pain in the joints & it increases 
appetite. 
 Ginger is a rejuvenating herb, promotes eye sight, kapham diseases[20]. 
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PEPPER 
Botanical name  : Piper nigrum 
Family   :  Piperaceae 
Part used  : Dried fruits 
Scientific classification 
Kingdom : Plantae 
Phylum : Magnoliophyta 
Class  : Magnoliopsida 
Order  : Piperales 
Family  : Piperaceae 
Genus  : Piper 
Species : nigrum                                  
Etymology 
The word "Pepper" is derived from the Dravidian word for long pepper, 
pippali. Ancient Greek and Latin turned pippali into the Latin piper, referring both 
black pepper and long pepper. "Pepper" was used in a figurative sense to mean 
"spirit" or "energy" at least as far back as the 1840s, in the early 20
th
 century, this was 
shortened to pep
[21]
 . 
Distribution  
It is cultivated in moist parts of India cultivated from Konkan southwards, 
especially in North Konkan Kerala and also in Assam. 
Description 
Macroscopic Character 
Fruits greyish-black to black, hard wrinkled, 0.4 to 0.5 cm. in diameter, 
aromatic, pungent in taste. 
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Microscopic Characters 
Fruit consists of a thick pericarp enclosing a small embryo, pericarp consists 
of epicarp mesocarp and endocarp, epicarp composed of single layered tubular cells 
forming epidermis, mesocarp composed of band of tangentially elongated 
parenchymatous cells and tangentially elongated oil cells present in outer region and a 
few fibro vascular bundles, a single row of oil cells in the inner region of  mesocarp, 
endocarp composed of a row of beaker shaped stone cells testa single layered, yellow 
coloured, thick walled sclerenchymatous cells, perisperm contains parenchymatous 
cells having a few oil globules and angular polyhedral cells, packed with starch grains 
measuring 5.5 to 11.0 in diamter, having 2 or 3 components and a few minute 
aleurone grains
[20a]
. 
 
Constituents 
Piperine, piperettine, piperolein A,B, ascorbic acid, carotene, ß-alanine 
piperidine, serine, threonine, piperyline, arginine, serine, glutamic acid, cystine 
Properties and uses 
The fruit is pungent, hot, bitter, anthelmintic, alterative, useful in kapham, 
vadham, asthma, pains, urinary discharges, night blindness, increase biliousness, 
brings on sleep and epileptic fits. The fruit has a sharp, pungent, slightly bitter taste, 
carminative, aphrodisiac, purgative, alexipharmic. 
It is also useful in inflammation, pain in the muscles, diseases of liver and 
spleen, eructations, leucoderma, lumbago, chronic fever, facilitates menstruation.  
It is employed in cholera, weakness following fevers, vertigo, coma.  
It’s action as a stimulant is more evident on the mucous membranes of the 
rectum and urinary organs. Externally it is an effective rubefacient
[22]
. 
 
LONG PEPPER 
Botanical name  : Piper longum 
Family   :  Piperaceae 
Parts used  : Dried spikes 
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Scientific Classification 
Kingdom : Plantae 
Division : Magnoliophyta 
Class  : Magnolipsida 
Order  : Piperales 
Family  : Piperaceae 
Genus  : Piper 
Species : longum 
Distribution 
It is cultivated in hotter parts of India from Central Himalayas to Assam upto 
hills of West Bengal and evergreen forests of Western Ghats as wild and also in North 
East and many parts of the South. 
Description 
Macroscopic Characters 
 Fruit greenish-black to lack, cylindrical, 2.5 to 5 cm. long and 0.4 to 1 cm. 
thick, consisting of minute sessile fruits, arranged around an axis, surface rough and 
composite, broken surface shows a central axis and 6 to 12 fruitlets arranged around 
an axis, taste pungent producing numbness on the tongue, odour aromatic. 
Microscopic Characters 
Catkin shows 6 to 12 fruits, each having an outer epidermal layer of irregular 
cells filled with deep brown content and covered externally with a thick cuticle, 
mesocarp consists of larger cells, irregular in shape and thin walled.  
Outer layer of this zone composed of thin walled cells and colourless, most of 
the endocarp cells filled with starch grains, round to oval measuring 3 to 8 in 
diameter
[22a]
.  
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Constituents 
Piperine, piplartine, alkaloid, starch, resin, gum, fat, triaconane, 
dihydrostigmasterol, reducing sugars, glycosides 
 Medicinal uses 
 The root and fruits are used in palsy, gout, lumbago. The fruit has a bitter, hot, 
sharp taste; carminative, tonic to the liver, stomachic, emmenagogue, 
abortifacient, aphrodisiac, haematinic.  
 Long pepper in the form of powder is suspended in warm water and given to 
women after parturition to check haemorrhagic fever.  
 Pellitorine, piplartine, piperine exert medicinal uses.  The fruits as well roots 
are attributed with numerous medicinal uses and may be used for respiratory 
diseases and as an emmenagogue, abortifacient
[23]
. 
 
INDIAN CINNAMON 
Botanical name  : Cinnamomum tamala 
Family   :  Lauraceae   
Part used  : Dried Leaves 
Scientific Classification: 
Kingdom  :  Plantae 
Class          :  Magnoliopsida   
Order      :  Laurales   
Family   :   Lauraceae   
Genus   : Cinnamomum 
Species  : tamala 
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Distribution 
Dried mature leaves, a small evergreen tree up to 7.5 m. high and occurs in 
tropical, sub-tropical Himalaya between 900 to 2300 m; often raised from seeds sown 
in nursery; leaves collected in dry weather from about ten year old plants during 
October to March. 
Description 
Macroscopic: 
Leaves-12.5 to 20 cm. long, 5 to 7.5 cm. Wide at the centre, 3 converging 
nerves from base to apex, young leaves pink ; petiole 7.5 to 13 mm. Long ; margin 
entire, apex acute or acuminate , both surfaces smooth ; stomata paracytic; odour 
aromatic; taste slightly sweet, mucilaginous and aromatic. 
Microscopic:  
Petiole and midrib – Transverse sections of petiole and midrib show 
epidermis externally covered with cuticle , uniseriate, multicellular trsichomes present 
with 1 to 3 cells; oil cells present as single or groups ; isolated large  stone cells, much  
lignified and showing striations, are found scattered; most of the parenchymatous 
cells of cortex show reddish-brown contents; pericycle represented by a few layers of 
sclerenchymatous cells; stele more or less planoconvex as in the midrib of leaf; xylem 
on upper and phloem on lower side consisting of usual elements, present. 
Constituents 
β – Caryophyllene,linalool,caryophyllene oxide, d – β-phellandrene, eugenol, 
α and β pinene, p-cymene, 3,4`,5,7 –tetrahydroxy flavones, 3,3`,4`,5,7 – O – 
pentahydroxy flavones, kaempferol – 3-O-glucopyranoside,kaempferol -3-O-
sophoroside,quercetin 3-O-rutinoside. 
Medicinal Uses 
 It cures cough ,asthma ,vomiting ,mouth ulcer 
 Lavanga oil cures body pain, tooth ache and headache[20b]. 
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CARDAMOM 
Botanical name  : Elettaria cardamomum 
Family   :  Zingiberaceae 
Part used  : Seeds 
Scientific Classification: 
Kingdom  :  Plantae 
Class          :  Monochlamydeae 
Order      :  Zingiberales 
Family   :   Zingiberaceae 
Genus   :  Elettaria 
Species  :  cardamomum 
Occurrence and distribution 
 It is a native of the evergreen forest of south India, growing wild in the 
Western Ghats. 
Description  
A tall herbaceous perennial, with branching subterranean roots, stock, from 
which arise a number of upright leafy shoot. It is 5-18 ft. height and bearing alternate, 
elliptical or lanceolate sheathing leaves. Flowers are borne in panicles and arising 
from the base of vegetative shoots. 
 Fruits are trilocular capsules, fusiform to ovoid in shape and pale green in 
yellow in colour, its containing 15-20 seeds. Cardamom seeds have pleasant aroma 
and pungent taste. 
Constituents: 
The seeds contain Volatile oil, Cineol, Terpineol, Terpinene, Limonene and 
Sabinene. 
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Medicinal Uses 
 Powdered form of seeds of cardamom, dried ginger, cloves, cumin seeds cure 
stomach ache, ulcer. 
 Roast seeds of cardamom, omam and cumin seeds then they are powdered and 
given to cure indigestion
[24]
. 
LEAD WORT 
 Synonyms  
    Plumbago viscosa   
Common names 
     Ceylon lead word, Doctor bush, Plumbago 
Etymology  
The generic name Plumbago is derived from the Latin plumbum, lead.  
The specific epithet zeylanica is from the Latinized name for Sri Lanka 
(Ceylon). 
Botanical name  : Plumbago zeylanica 
Family   :  Plumbaginaceae 
Part used  : Root 
 
Scientific Classification: 
Kingdom  :  Plantae 
Class          :  Magnoliopsida 
Order      :  Plumbaginales 
Family   :   Plumbaginaceae 
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Genus   :  Plumbago L. 
Species  :  zeylanica 
Distribution 
It is a perennial herb distributed widely in India, much cultivated widely in the 
peninsular regions, probably in Bengal, Malay, Peninsula, Ceylon, tropics of the 
world. 
Description 
Macroscopic Characters 
Mostly perennial shrubs of about 60-120 cm in height. Leaves alternate, ovate, 
acute, glabrous, entire, short stalk, flowers white, bracteates, glandular and elongated 
spikes, 10-30 cm long. Seeds oblong shaped. Roots 30 cm or more in length, 6 mm or 
more in diameter as also as short stout pieces, including root stocks reddish to deep 
brown, bark thin and brown, internal structure striated, odour, disagreeable, taste, 
acrid
[25]
.  
Microscopic Characters
 
Transverse section of root shows outer most tissue of cork consisting of 5 -7 
rows, secondary cortex consists of 2-3 rows of thin walled rectangular, light brown 
cells, starch grains. Secondary cortex followed by a wide zone of cortex is composed 
of large polygonal parenchymatous cells varying in size and shape, containing starch 
grains and some cells with yellow contents, fibres scattered singly or in groups 
consisting of usual elements and phloem fibres, similar to cortical zone, phloem fibres 
usually in groups of 2-5 or more but occasionally occurring singly, lignified with 
pointed ends and narrow lumen, cambium indistinct, xylem light yellow to whitish 
radically arranged, 1-6, seriate, radically elongated, starch grains, stone cells absent. 
Constituents 
Plumbagin, citranone, elliptone, ß-sitosterol-glucoside, bakuchiol, phenols, 
isoaffinetin, saponaretin, flavanoids, psorealen, iso-orientin. 
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Medicinal uses 
 The root increases the digestive power, promotes the appetite and useful in 
dyspepsia, piles, anasarca, skin diseases. 
 The active principle “Plumbagin” stimulates the contraction of the heart, 
intestine and the uterus. It stimulates the secretion of sweat, urine and bile
[26]
. 
CINNAMON BARK 
Botanical name  : Cinnamomum zeylanicum 
Family   :  Lauraceae 
Part used  : Bark 
Scientific Classification: 
Kingdom  :  Plantae 
Class          :  Magnoliopsida 
Order      :  Laurales 
Family   :   Lauraceae 
Genus   :  Cinnamomum 
Species  :  verum 
Distribution 
Dried inner stem bark, a moderate sized evergreen tree usually attaining a 
height of  6 to 7.5m; cultivated in the Western Ghats and adjoining hills; bark 
collected during April-July and October-December. 
Description 
Macroscopic:  
Bark pieces about 0.5mm. thick, brittle, occurs as single or double, closely 
packed compound quills, up to a metre or more in length and up to about 1cm.in 
diameter,inner surface darker in colour, striated with longitudinally elongated . 
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Microscopic:  
Transverse section of bark (devoid of cork and cortex)  shows except at certain 
places pericyclic sclerenchyma, 3 or 4 rows of isodiametric cells, sometimes 
tangentially elongated.Inner and radial walls often being thicker than the Outer 
containing axially elongated secreting cells containing volatile oil or mucilage; 
phloem fibres with very thick walls, upto 30 µm in diameter, isolated or in short 
tangential rows; cortical parenchyma and medullary rays containing small starch 
grains.  
Constituents 
Cinnacassiol A,B and C, trans-cinnamic acid,cinnamaldehyde and eugenol. 
 
Medicinal Uses: 
 Powder  cures vomiting, indigestion, stomach pain, diarrhoea. 
 Bark powder 650 gm cures dysentery[20c]. 
THORNY BAMBOO 
Synonyms 
Bambusa bambos Druce 
Botanical name  : Bambusa arundinaceae 
Family   :  Poales  
Scientific Classification: 
Kingdom  :  Plantae 
Class          :  Monocotyledanae 
Order      :  Poales 
Family   :   Poaceae 
Genus   :  Bambusa 
Species  : arundinaceae  
REVIEW OF LITERATURE 
 
 
HEPATOPROTECTIVE ACTIVITY OF SIRINGIPAERATHI CHOORANAM 22 
 
Etymology 
The etymology of the word BAMBOO comes from the wrong pronunciation 
of the Indian word MAMBU, which is the local name of a native species of the plant. 
Carl Linnaeus in his best known "Species plantarum" mentioned the "Arundo 
Bambos", and this name, then modified in BAMBUSA, has been officially adopted as 
identification of the family
[21a]
.  
Distribution
 
It is distributed throughout the world especially in Western ghats, Eastern 
Ghats, all over foot hills, Western plains in India. 
Description 
Shrubs or trees are usually large, stem sheaths are broad, the blade often 
triangular. Petiolate leaves. Spikelets -1 flowered usually arranged in a large leafy 
panicle or in paniculate spikes.Stamens 6 free, ovary oblong or ovoid with a hairy tip; 
styles short or long; stigma 2-3, grain oblong or linear oblong furrowed on one side; 
pericarp thin adherent to the seed
[27]
. 
 
Constituents 
Protein, carbohydrates, aminoacids, minerals like potassium, calcium, 
manganese, zinc, copper, iron, thiamine, niacin, vitamins A,B, B6.  
Medicinal Uses 
 The stem and leaves are acrid, sour, bitter, cooling, laxative and burning 
sensations, blood coagulopathies, biliousness, leucoderma, inflammations, 
strangury and piles.  
 In North Lakhimpur forest division of Assam, very soft shoots of the plant are 
reported to be used for birth control
[28]
.  
SANDAL WOOD 
Botanical name  : Santalam album 
Family   :  Santalaceae 
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Parts used: Heart Wood and oil  
Scientific Classification: 
Kingdom  :  Plantae 
Class          :  Magnoliosida 
Order      :  Santalales  
Family   :   Santalaceae 
Genus   :  Santalum 
Species  :  album 
Distribution 
It is commonly found in comparatively dry regions of peninsular India from 
Vindhya mountains southwards, especially in Mysore & Tamilnadu, ascending to an 
altitude of    1200 m . It has also been found in dry districts of  Gujarat, Konkan, 
Deccan, and Rajasthan, parts of  Uttar Pradesh, Madhya Pradesh and Orissa. 
Description 
A small medium sized, ever green semi parasiti tree, with slender branches, 
sometimes reaching up to 18 m in height &2.4 m in girth. Bark reddish or grey or 
nearly black, rough with deep vertical cracks  on old trees; leaves glabrous ,thin, 
elliptic-ovate or ovate-lanceolate,1.5-8 cm.x1.6-3.2 cm., some times larger; flowers 
straw – coloured, brownish purple, reddish purple or violet, unscented, in terminal 
,axillary paniculate cymes; drupe globose or 3 cm diam.,purple-black, with hard, 
ribbed endocarp; seeds globose or ovoid. 
Chemical Constituents 
Sandalwood oil contains α & β santalol, α and β-santalenes, santenol, 
teresantalol, nor-tricycloekasantalal, exo-norbicycloekasantalal, isovaleraldehyde, 
santanone, teresantalicacid, trans-β-santalol, epi-cis-β-santalol, β-santalol, epi-β-
santalane, cis-lanceol, cis-nuciferol, tropan alkaloidssantalbicacid, palmitcacid. 
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Principles constituents of sandal wood:  
Santalols (up to 90%), fusanol santene, Santalic acid, terestanol, borneol, 
santalone. 
 
Medicinal Uses 
 It is used to treat derangement of 3 humors, internal heat, leucorrhoea, 
thirst, itching. It strengthens the body
[29]
. 
 
WHITE CUS CUS GRASS 
Botanical name  : Plectranthus vettiveroides 
 
Family   :  Lamiaceae 
Parts used  : Root 
Scientific Classification: 
Kingdom  : Plantae 
Class          : Magnoliosida 
Order      : Lamiales 
Family   :  Lamiaceae 
Genus   : Plectranthus 
Species  : vettiveroides 
Parts used: Aril part of root 
Occurrence and Distribution: 
Found wild in dry and Barren hills of sub tropical Himalayas including 
Kumaon and Nepal ascending to 2700m, in the Deccan, Peninsula, Gujarat and Bihar; 
cultivated in Baroda and Maharashtra. 
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Description 
A perennial plant, branched, aromatic herb, about 30 to 62 cm height with 
thick root . Stem stout, villous or hispid . Flowers born in racemes, stout; Upper calyx, 
lip rounded – ovate, corolla pale blue; fruits nut lets. 
Chemical Constituents:                                         
 Allylroyleanone, barbatusin, 3β-hydroxy-3-deoxy-barbatusin, coleons E 
and F, cyclobutatusin, plectrin, plectrinonA, plectrinon B, brbatusol. 
  20-deoxocarnosol,coleonol D, coleonol E, coleonone, coleosol, α-copaene 
deoxycoleonol,β-bisabolene, bornylacetate, camphene. 
  β-cymene, 3-decanone, β-clemene, cariocal, 6α-hydroxycarnosol. 
 Medicinal uses  
 Aril: Spasmolytic, root: hypertensive,spasmolytic and given to children in 
constipation: decoction as tonic and in the treatment of worms, parts to 
allay. Burning festering boils: mixed with mustard oil, grounded root 
externally applied to eczema and skin disease. 
 Forskolin,isolated from roots, is a bronchodilatator, cardiac tonic in the 
treatment of congestive heart failure, glaucomotherapy, anti-hypertensive, 
remedy for metastatic  condition and thrombosis
[30]
. 
NUTMEG TREE 
Botanical name  : Myristica fragrans 
Family   :  Myristicaceae   
Part used  :  Mace (aril) and nutmeg(seeds) 
Scientific Classification: 
Kingdom  : Plantae    
Class          : Magnoliopsida    
Order      : Magnoliales   
Family   :  Myristicaceae   
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Genus   : Myristica  
Species  : fragrans  
Occurrence and Distribution: 
A native of Moluccas, cultivated in many tropical countries. Grown in kerela , 
Karnataka, The Niligiris and West Bengal. 
Description: 
A dioecious are occasionally monoecious, evergreen, aromatically, usually 9 
to 12 m height and often attaining a height of 20m or more. Blackgreyish-black, 
longitudionally fissured in old trees. 
Leaves coriaceous,elliptic or oblong – lanceolate , upper Surface deep green 
and lower greyish, turning red greyish when ripe; veins on lower surface; petiole 0.61 
to 1.27cm long. flowers greemy yellow, fruits globose or broadly pyiriform , 6 to 9cm 
long ,seed arillate albuminous, broadly ovoid.flowers appear before the rainy season 
and fruits appear later. 
Macroscopic: 
Aril –Aril of M.fragans is commonly known as mace,which constitutes the 
outermost third integument of the seed, covering the basal part of it by scarlet or pale 
yellow ribbon- like robes, laciniated, recticulate; lobes 3 or 4 cm  long and 2 or 3 mm 
wide and  about 1 mm thickness, strongly aromatic with a pleasant  aromatic taste . 
Seed – Ovoid, 2.2 to 3.2 cm length and 1.5 to 2.5 cm breadth ; the kernel is 
greyish brown externally and is marked with numerous minute dark reddish- brown 
points and lines; it is also reticulately marked with small furrows. The outer region is 
a thin layer of perisperm which grows inwards to the endosperm at the position of the 
external furrows.  
Kernal of seeds ( endosperm) rather soft bud firm , whitish and strongly 
aromatic with a warm slightly bitter taste. 
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Microscopic: 
Aril –TS of the lobe of the aril shows epidermis consisting a single row of 
highly thick walled ,rectangular cells. The parenchyma cells are polygonal without 
intercellular spaces.  
They contain carbohydrate  reserve food material as irregular granules. The oil 
cells ate which are scattered among the parenchyma are mostly rounded in shape.  
Seed – TS of the seed shows testa , perisperm , endosperm. Testa comprises of 
epidermis with large cells, several rows of thin- walled tangentially elongated cells 
filled with brown coloured material and occasional groups of sclerenchymatous 
fibers. 
Chemical Constituents: 
             β-pinine,α-terpinene,terine,methyleugenol,myristicin,elemicin,trimyristin, 
dihydrodisoeugenol. 
Medicinal uses 
 Mace is beneficial in Asthma; combination with aromatics found useful in 
chronic bowel  complaints. 
 When roasted both nutmeg and mace are efficacious in diarrhoea, flatulence, 
colic and dyspepsia
[30a]
. 
CUMIN SEED 
 
Botanical name  : Cuminum cyminum 
Family   :  Apiaceae 
Part used  :  Seeds 
Scientific Classification: 
Kingdom  :  Plantae 
Class          :  Asterids 
REVIEW OF LITERATURE 
 
 
HEPATOPROTECTIVE ACTIVITY OF SIRINGIPAERATHI CHOORANAM 28 
 
Order      :  Apiales 
Family   :   Apiaceae 
Genus   :  Cuminum 
Species  :  cyminum 
Distribution 
Extensively cultivated as a cold-season crop on the plains and as summer crop 
on the hills in Northern India,Himalayas, Punjab,Baluchistan,Kashmir,Kumarun, 
Garhwal and Chamb.The plant also imported from Persia and Asia minor. 
Description 
A slender,annual, glabrous herb, leaves twice or thrice 3-partite,ultimate 
segments filifrom,Flowers in compound umbels bracteole, bracts linear rigid. Calyx 
teeth small,subulate,unequal shaped. Fruit cylindric shape, tip narrowed, seeds 
somewhat dorsally compressed. 
Macroscopic Characters 
Fruit, a cremocarp, often separated in to mericarps, brown with light coloured 
ridges, ellipsoidal, elongated ,about 4 to 6 mm, high and 2 mm,wide. 
Constituents 
Cuminaldehyde, Cuminin,1,3 - β - menthadien -7-al, 1,4- β - menthadien -7-al,  
β-cymene,terpinene,β-pinene,7-1(O-β-D-galalacturonide)-4,5dihydroxy,glycosides 
luteolin and apigenin. 
 
Medicinal uses 
 Seeragam,Chukku, Elam and Nellimulli powder 1 part sugar ½ part mixed 
with and used for reduce pitham 
 Cumin seeds soaked in karisalai leaf juice then make it dried powder mixed 
with sugar and chukka powder used for the treatment of jaundice and vatha 
disease
[22b]
. 
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CLOVES 
Botanical name  : Syzygium aromaticum 
Family   :  Myrtaceae 
Parts used  :  Dried flower buds 
Scientific Classification: 
Kingdom  :  Plantae 
Class          :  Dicotyledons 
Order      :  Myrtales 
Family   :   Myrtaceae 
Genus   :  Syzygium 
Species  :  aromaticum 
Occurrence and distribution 
A tree cultivated in many parts of the world and extent in south India, Tamil 
Nadu and Kerala. 
 
Description  
A pyramidal or conical evergreen tree usually up to 12 meter in height with 
single main stem bearing obliquely oriented branches leaves simple, lanceolate, gland 
– dotted, fragrant. Flower buds greenish to pink, clustered at the ends of the branches, 
buds are measuring 10 to 17.5mm in length. Colour- Dark brown to black, four side 
hypanthium readily exuding oil when pressed; fruits fleshly, dark pink drupes seeds 
oblong, grooved on one side. Odour is strongly aromatic; taste is pungent. Aromatic 
followed by slight tingling of the tongue. 
 
Chemical constituents: 
Caryophylleneoxide, Eugenol, Acetophenone, Benzylsalicylate, Palustrol. 
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Medicinal uses 
 Cloves (unopened flower buds): To relieve Flatulence, Gastric irritability, 
dyspepsia and to increase the flow of saliva. 
 A wineglassful of hot water to which are added 5 grams of bruised cloves and 
20 grams of bicarbonate of soda is taken before meals for indigestion
[31]
. 
 
SUGARCANE 
Botanical name  : Saccharum officinarum-Sarkkarai 
Family   :  Poaceae 
Part used  :  Root, Sugar, Juice 
Scientific Classification: 
Kingdom  :  Plantae 
Class          :  Monocotyledons 
Order      :  Poales 
Family   :   Poaceae 
Genus   :  Saccharum 
Species  :  officinarum 
Occurrence and distribution 
Sugar cane is indigenous to tropical south and Southeast Asia. 
Description of the plant 
It is a tropical, perennial grass that forms lateral shoots at the base to produce 
multiple stems, typically three or four meters high and about 5 cm diameter and once 
harvested the stalk will regrow allowing the plant to live for between 8 to 12 years.  
The leaves of grow from the nodes of the stem, arranged in two rows on either side of 
the stem. The leaves are tubular and blades like, thicker in the centres than at the 
margins and encircle than the stem.  
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Medicinal uses 
 It purifies the air present in chronic ill patients’ room. 
 Sugar syrup can be used as preservative and also it cures Sinusitis and 
Rhinitis
[32]
. 
3.2. GUNAPADAM ASPECT OF DRUGS 
INJI (GINGER) 
Metonymy 
Allam ,Aartharagam, Aathiragam, Ilaakkottai, Narumaruppu madhil 
Vernacular names: 
Tamil            :     Aartterakam, Allam, Narumaruppu matil 
English        :    Ginger 
Tel            :    Allamu, Allam 
Mal            :    Inchi 
Kan           :    Alla, Hasishunti 
Sansk            :    Ardraka,Katybhadra,Srngavera 
Hin           :    Adarakha 
Parts used :  Rhizome 
Properties and action 
Suvai (Taste)   :    Kaarppu (Pungent) 
Thanmai (Potency)   :    Veppam (Hot potency) 
Pirivu (Bio-Transformation) :    Kaarppu (Pungent) 
Seigai (Actions) :   Stimulant, Stomachic, Carminative, Digestive 
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General Character 
“இஞ்ெிக்  ிழங்குக்  ிருேல்யம் ஓக் ோளம் 
வஞ்ெிக்குஞ் ென்னிசுரம் வன்மபதி-விஞ்சு ின்  
சூலையறும் வோதம்மபோந் தூண்டோத தபீனேோம் 
மவலையறுங்  ண்ணோய்-விளம்பு”.  
 
“இஞ்ெியின் குணமே சதன் ி யல்புட னுலரக்க்க் ம ளரீ் 
அஞ்ெிடுஞ் ென்னிசயல்ைோ ே ன் ிடும் பித்த மதோடம் 
சநஞ்ெினி ைிருேற் ம ோலழ சந ிழ்ந்திடும்  பங் ள் தன்லன 
ேிஞ்ெினி வருமேோ  சவன்று விளம்பிடும் மதவ நூமை”. 
 
“ேணிைோக் ம ோட்லடசயோன்று ேோத்திரமே  ற்பசேன்ப 
சதண்ணிக்ல  யோ ி யிருக்குமே- ண்ணுக்கு 
நன்முல யோஞ் ெதீளத்லத நோடோே  மையடிக்குந் 
தின்முல லே நீய ிந்து தின்”. 
 - குணபோடம் மூைில  வகுப்பு. 
 
Medicinal Uses: 
 It is used to treat cold, cough, regurgitation, diseases due to heat, derangement 
of 3 humours, diarrhoea due to indigestion, pain in the joints & it increases 
appetite. 
 Ginger is a rejuvenating herb, promotes eye sight, kapham diseases[32a]. 
 
 
 
REVIEW OF LITERATURE 
 
 
HEPATOPROTECTIVE ACTIVITY OF SIRINGIPAERATHI CHOORANAM 33 
 
MILAGU (PEPPER) 
Scientific name: Piper nigrum - Milagu 
Other names: 
Malayali,Masam, Sarumabandam, Kayam, Kalinai, Miriyal. 
Vernacular names: 
Tamil            :     Milagu 
English        :    Black pepper 
Tel            :    Miriyalu 
Mal            :    Kurumilagu 
Kan           :    Menasu 
Sansk            :    Maricha 
Hin           :    Kali-mirch 
Parts used:  Dried fruit 
Properties and action 
Suvai (Taste)                 :    Kaippu(Bitter), Kaarppu(Pungent) 
Thanmai (Potency)                  :    Veppam (Hot potency) 
Pirivu (Bio-Transformation)  :    Kaarppu (Pungent) 
Seigai (Actions)                       :    Carminative, Stimulant, Anti-vadha, Antidote. 
General characters 
“ெதீசுரம் போண்டு ெிமைத்ேங்   ிரோணிகுன்ேம் 
வோதம் அருெிபித்தம் ேோமூைம்- ஓதுென்னி 
யோெேபஸ் ேோரம் அடன்மே ம்  ோெேிலவ 
நோெங்   ிேிள  ினோல்”. 
 - அ த்தியர் குணவோ டம்[33] 
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Indications: 
It cures Anaemia, gastric ulcer, giddiness, diarrhoea, dysentery, vomiting, anal 
fissure and Cataract. 
Therapeutic uses: 
 Dried unripe fruits are prescribed in cholera, dyspepsia, flatulence and various 
gastric ailments. 
 Powder of black pepper used as tooth powder [34]. 
THIPPILI (LONG PEPPER) 
Scientific name: Piper longum – Thippili 
Other names: 
Pippli, Kaman, Sowndi, Kanam, Saram, Koli, Ambu, Aathimarunthu, Kanai. 
 
Vernacular names: 
Tamil            :     Thippili 
English        :    Long pepper 
Tel            :    Pippilu 
Mal            :    Thippili 
Kan           :    Hippili 
Sansk            :    Pippali 
Hin           :    Pipar 
Parts used   : Dried fruit and Roots 
Properties and action 
Suvai (Taste)                        :    Kaarppu (Pungent) 
Thanmai (Potency)                :    Veppam (Hot potency) 
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Pirivu (Bio-Transformation) :    Inippu (Sweet) 
Seigai (Actions)                      :    Carminative, Stimulant, Expectorant,Antiseptic, 
Febrifuge. 
General character 
“ ட்டி சயதிர்நின்று  டுமநோசயல் ைோம்பணியும் 
திட்டி விலனய லும் மத சேத்த-புட்டியோம் 
ேோேனுக்கு ேோேசனன ேற் வர்க்கு ேற் வனோங் 
 ோேசேனுந் திப்பிைிக்கும் ல ”. 
- மதரன் சவண்போ[35] 
 
Indications: 
It relief kapham related diseases and strength the body.  
Therapeutic uses 
 Long pepper powder with honey and betel leaf juice cures fever. 
 Powdered form of long pepper seeds with ghee for aphrodisiac activity[32b].         
LAVANGAPPATTIRI (INDIAN CINNAMON)  
Scientific name: Cinnamomum tamala –Lavangappattiri 
Other names   :   Thamalappattiri 
Vernacular names: 
Tamil            :     Lavarikappattri 
English        :    Indian cinnamon 
Tel            :    Akupatri 
Mal            :    Karuvapatta patram  
Kan           :    Tamalpatra,Dalchini ele  
Sansk            :    Tvaka patra,Varanga,Coca 
Hin           :    Tejpatra 
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Properties and action 
Suvai (Taste)                         :    Kaarppu (Pungent) 
Thanmai (Potency)                 :    Veppam (Hot potency) 
Pirivu (Bio-Transformation) :    Karppu (Pungent) 
Seigai (Actions)                      :    Appetiser, Carminative, Diaphoretic
 
General Character  
“மே சுரம் ெதீசுரம் சவட்லடசுவோ ெங் ோெம் 
தோ பித்தம்  வோந்திெர் வோெியமநோய்- மே த்தின் 
 ட்டிசயோடு தோதுநட்டங் ல ப்பருெி மபோக் ிவிடும்  
இட்டஇை வங் த் திலை”. 
       -அ த்தியர் குணவோ டம்[33a]. 
Medicinal Uses 
 It cures cough ,asthma ,vomiting ,mouth ulcer 
 Lavangam oil cures body pain, tooth ache and headache[20d]. 
                           
 ELAM (CARDAMOM) 
Scientific name: Elettaria cardamomum - Elam 
Other names: 
Onchi, Gorangum, Thudi. 
Vernacular names: 
Tamil            :     Elam 
English        :    Cardamom  
Tel            :    Elakulu 
Mal            :    Elattari 
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Kan           :    Elakki 
Sansk            :    Ela  
Hin           :    Elachi 
Parts used :    Seeds 
Properties and action 
Suvai (Taste)                         :    Kaarppu (Pungent) 
Thanmai (Potency)                 :    Veppam (Hot potency) 
Pirivu (Bio-Transformation) :    Karppu (Pungent) 
Seigai (Actions)                      :    Carminative, Stomachic, Expectorant, Tonic. 
General characters 
“சதோண்லட வோய் வுள் தோலுகு தங் ளில் 
    மதோன்றும் மநோயதி ெோரம்பன் மே த்தோல் 
உண்லட மபோல்எழுங்  ட்டி  ிரிச்ெோரம் 
   உழலை வோந்தி ெிைந்தி விஷஞ்சுரம் 
பண்லட சவக்ல  விதோ மநோய்  ோெமும் 
    போழுஞ் மெோேப் பிணிவிந்து நட்டமும் 
அண்லட யீலளவன் பித்தம் இலவக்ச ல்ைோம் 
    ஆை ேோங் ேழ் ஏை ேருந்தமத”. 
- பதார்த்த குண சிந்தாமணி[36] 
Indications: 
It cures cough, diarrhoea, haemorrhoids, dyspepsia, vomiting, anal fissure. 
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Therapeutic uses: 
 Powdered form of seeds of cardamom, dried ginger, cloves, cumin seeds cure 
stomach ache, ulcer. 
 Roast seeds of cardamom, omam and cumin seeds then they are powdered and 
given to cure indigestion
[37]
. 
KODIVELI-VER (LEAD WORT) 
 Synonyms  
    Plumbago viscosa   
 Common names 
     Ceylon lead wort, Doctor bush, Plumbago . 
Vernacular names 
Tamil            :     Chittiri, Chittira 
English        :    Leadwort 
Tel            :    Chitramulamu 
Mar            :    Chitramul 
Ben           :    Chita 
Sansk            :    Anala, Dahana, Pithi, Vahnisajnaka, Agni, Agnika, Jyothi. 
Hin           :    Cheetha 
Properties and action 
Suvai (Taste)                         :    Kaarppu (Pungent) 
Thanmai (Potency)                  :    Veppam (Hot potency) 
Pirivu (Bio-Transformation) :    Karppu (Pungent) 
Seigai (Actions)                      :    Anti-periodic, Diaphoretic. 
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Medicinal Uses: 
 The root and root bark are bitter, hot, dry, stomachic, carminative, 
anthelmintic, alterative, cure intestinal troubles, dysentery, leucoderma, 
inflammation, piles, bronchitis, itching, diseases of liver, consumption, ascites, 
good in anaemia. 
 The root has a sharp bitter taste, laxative, expectorant, stomachic, tonic, 
abortifacient, alexipharmic, good appetizer, useful in laryngitis, rheumatism, 
diseases of spleen, leucoderma, ring-worm, scabies.  
 It acts as a powerful sudorific.  
 The use of plumbago as a rubefacient, vesicant, local ecbolic, sudorific has a 
rational basis . The root appears to possess abortifacient and vesicant. 
properties. The drug is known to cause abortion and in Malaya even eating the 
leaves is said to cause abortion 
[23a].
 
                                               LAVANGAPATTAI (CINNAMON BARK)          
Scientific name: Cinnamomum zeylanicum-Lavangapattai 
Other Names:  
                           Karuvapattai   
Vernacular Names: 
Tamil            :     Karuvapattai,Lavarikappatai 
English        :    Cinnamon bark 
Tel            :    Lavangapatta,Dalchini chekka 
Mal            :    Karuvapatta,Illavarngathely 
Kan           :    Dalchini Chakke 
Sansk            :    Tvak,Darusita 
Hin           :    Dalchini 
Parts Used       :    Bark 
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Properties and action 
Suvai (Taste)                :    Inippu(Sweet) ,Karppu (Pungent) 
Thanmai (Potency)                 :    Thatpum (Cold Potency) 
Pirivu (Bio-Transformation) :    Inippu(Sweet) 
Seigai (Actions)                      :    Aphrodisiac, Carminative, Stimulant 
Indications: 
 It cures peptic ulcer, asthma, indigestion. 
 It cures flatulence ,dyspepsia, diarrhoea, dysentery, fever, nausea and 
vomiting. 
Therapeutic Uses: 
 Powder cures vomiting, indigestion, stomach pain, diarrhoea. 
 Bark powder 650 gm cures dysentery[20e]. 
MOONGILUPPU (THORNY BAMBOO)  
Synonyms 
  Bambusa bambos Druce 
Common names   
           Golden bamboo, Buddha’s belly bamboo, Thorny Bamboo, Bans, Bamboo 
Vernacular Names: 
Tamil            :     Moongil, Mulla Veduru  
English        :    Thorny Bamboo 
Mal            :    Mula, Mola 
Kan           :    Biduru, Gatte 
Mar            :    Kate Bamboo 
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Properties and Action  
Suvai (Taste)                         :    Astringent 
Thanmai (Potency)                 :    Veppam (Hot Potency) 
Pirivu (Bio-Transformation) :    Karppu(Pungent) 
Seigai (Actions)                      :    Stimulant, Tonic, Anthelmintic, Emmenagogue
 
 Medicinal Uses 
 The stem and leaves are acrid, sour, bitter, cooling, laxative and burning 
sensations, blood coagulopathies, biliousness, leucoderma, inflammations, 
strangury and piles.  
 In North Lakhimpur forest division of Assam, very soft shoots of the plant are 
reported to be used for birth control
[28a]
 . 
SANTHANATHOOL (SANDAL WOOD) 
 Scientific name: Santalum album-Chandanam 
Vernacular Names: 
Tamil            :    Chandanam 
English        :    Sandalwood 
Tel            :    Gandeapu-chkka 
Mal            :    Chandana 
Kan           :    Gadnhad chehke 
Sansk            :    Shri-gandha chandanam 
Hin           :    Chandan 
Parts used :    Wood, oil 
Properties and Action  
Suvai (Taste)                         :    Bitter, Mild Astringent 
Thanmai (Potency)                 :    Thatpum(Cold Potency) 
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Pirivu (Bio-Transformation)  :    Inippu(Sweet) 
Seigai (Actions)                      :    Alterative, Diuretic, Diaphoretic, Stimulant,                           
Astringent,Coolant. 
General Character 
“ம ோதில் ெந்தனஞ் ெமீதோஷ்ணங் ச ோண்டிருக்கும் 
வோதபித்தம் ஐயம் ேனப்பிரலே-ஓதுசுரம் 
மே ம் தனித்தோ ம் சவப்பு செோ ி யும்மபோக்கும் 
ஆ ந் தனக்குறுதி யோம்” 
.       - அ த்தியர் குணவோ டம்[33b] 
Medicinal Uses: 
 Decoction of sandal wood powder used to treat in Fever, Tachycardia and 
decreases the pulse rate. 
 Also used to treat in various skin Diseases, Diarrhorea[32c]. 
VILAMICHU-VER (WHITE CUS CUS GRASS) 
Scientific name: Plectranthus vettiveroides-Vilamichu-ver   
Vernacular Names: 
Tamil             :     Vilamichu-ver 
English         :     White cus cus grass 
Mal             :      Iruveli 
Sansk             :      Hroeberam 
Properties and Action  
Suvai (Taste)                          :    kaippu (Bitter)  
Thanmai (Potency)                  :    Coolant  
Pirivu (Bio-Transformation)   :    Inippu (Sweet) 
Seigai (Actions)                      :    Refrigerent, Anti-pittha.  
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General character 
“மே ம் விழிசயரிச்ெல் வ ீிரத்த பித்தசேோடு 
தோ ேத மூர்ச்லெபித்தந் தன்ேயக் ம்-மெோ ஞ்  
ெிரமநோய் இலவமயகுஞ் செய்யவிைோ ேிச்சுக் 
ச ரிசுரமும் இல்லை யிலெ”. 
-குணபோடம் மூைில  வகுப்பு. 
Indications: 
 It cures diabetes, burning sensation in eyes, hypertension, giddiness, dropsy, 
and headache
[32d]
. 
                                                SATHIKKAI (NUTMEG TREE) 
 
Scientific name: Myristica fragrans  
Other names: 
 Kullakai, Jathikai 
Vernacular Names: 
Tamil            :     Jadikai 
English        :    Nutmeg tree 
Tel            :    Jajikai, Jadikai(seed), Apatri(aril). 
Mal            :    Jarikaya, Jatikka(seed), Jatipattri(aril) 
Kan           :    Jajikai, Jaikai(seed), Jaipatri(aril) 
Sansk            :    Jatiphala,Jatipatri 
Hin           :    Jaiphal, Javitri 
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Properties and Action  
Suvai (Taste)                         :   Thuvarpu (Astringent), Karppu (Pungent) 
Thanmai (Potency)                 :    Veppam (Hot Potency) 
Pirivu (Bio-Transformation) :    Karppu (Pungent) 
Seigai (Actions)                      :    Stimulant, Carminative, Aromatic, Tonic. 
General Character 
“தோது நட்டம் மபதி ெருவோெி யஞ்ெிர மநோய் 
ஓதுசுவோ ெங் ோெம் உட் ிரணி-மவமதோ 
டிைக் ோய் வரும்பிணிமபோம் ஏற் ேயல் பித்தங் 
.குைக் ோ யருந்துவர்க்குக் கூறு” 
- குணபோடம் மூைில  வகுப்பு. 
Therapeutic Uses 
 The powder made from nutmeg (0.4gm),dry ginger( 0.4gm) and caraway 
(0.7gm) is a good carminative. 
 The oil of nutmeg and mace is used in sprains , paralysis , Rheumatism[32e]. 
 
SEERAGAM (CUMIN SEED) 
Scientific name:Cuminum cyminum-Seeragam 
Other Names  
                 Asai, Chiri, Upakumbapeesam, Narcheeri, Thutthasambalam, Piraththi-vika, Pitha 
nasini,  Bosanakudori, Meththiyam. 
Vernacular names 
Tam     :    Asai,Nar cirakam,pittanacini,pocanakutari 
Eng                :    Cumin Seed, Cumin 
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Hindi                :    Jira, Safed jira 
Kan     :    Jirage, Bilejirege 
Mal       :    Jeerakam 
Mar      :    Pandhare jire 
Sansk      :    Sveta jiraka, Ajaji, Jiraka, Ajajika 
Tel                       :    Jilakaraka, Tella jilakara 
Parts used :  Seeds 
 
Properties and Action  
Suvai (Taste)                         :    karppu, sweet  
Thanmai (Potency)                 :    Coolant  
Pirivu (Bio-Transformation) :    Inippu(Sweet) 
Seigai (Actions)                      :    Astringent, Stimulant, Stomachic, Carminative 
 
General character 
“வோந்தி யருெிகுன்ேம் வோய்மநோய்ப்பி லீ ேிலரப் 
மபற்திருேல்  ல்ைலடப்பி ைோஞ்ெனமும்- மெர்ந்த ம்ேல் 
ஆெனகு டோரிமயனும் அந்தக்  ிர ணியும் 
மபோெனகு டோரியுண்ணப் மபோம்”. 
- அ த்தியர்  குணவோ டம்[33e] 
“பித்தசேனு ேந்திரிலயப் பின்னப் படுத்தியவன் 
ெத்துருலவய் யுந்துரந்து ெோதித்து- ேத்தசேனும் 
ரோெலனயு ேீசவன்று  நண்லபப் பைப்படுத்திப் 
மபோெனகு டோரிசெயும் மபோர்”.  
- மதரன் சவண்போ[35a] 
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 Medicinal uses 
 Seeragam added with palm jaggery powder used for strengthens the body 
 1 gm Seeragam heated with 90 ml of gingely oil used for oil bath to reduce 
giddiness,  head ache, vomiting and eye disease
[38]
. 
KIRAMBU (CLOVES) 
Scientific name: Syzygium aromaticum - Kirambu 
Other names: 
Anjugam, Urkadam, Sosam, Thirali ,Varangam 
Vernacular names: 
Tam     :    Kirambu  
Eng                :    Cloves, Clove tree  
Hindi                :    Long  
Kan     :    Lavanga  
Mal       :    karampu 
Sansk      :    Lavangam  
Tel                       :    Lavangalu  
Parts used: Dried flower buds 
Properties and action 
Suvai (Taste)                         :    Kaarppu (Pungent) 
Thanmai (Potency)                 :    Veppam (Hot potency) 
Pirivu (Bio-Transformation) :    Kaarppu (Pungent) 
Seigai (Actions)                      :   Carminative, Stimulant, Antispasmodic, Expectorant.         
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General characters 
“பித்த ேயக் ம் மபதிசயோடு வோந்தியும்மபோம் 
சுத்தவிரத் தக் டுப்புந் மதோன்றுமேோ - சேத்த 
இைவங் ங் ச ோண்டவருக் ம ற் சு ேோகும் 
ேைேங்ம   ட்டுசேன வோழ்த்து”. 
-அ த்தியர் குணவோ டம்[33c] 
Indications: 
It cures diarrhoea, vomiting, dysentery, Asthma, cough, flatulence. 
Therapeutic uses 
 Cloves (unopened flower buds): To relieve Flatulence, Gastric irritability, 
dyspepsia and to increase the flow of saliva. 
 A wineglassful of hot water to which are added 5 grams of bruised cloves and 
20 grams of bicarbonate of soda is taken before meals for indigestion
[39]
. 
 
KARUMBU (SUGARCANE) 
Scientific name: Saccharum officinarum-Karumubu 
Other names: 
                      Punarpoosam, Ikku, Vaei 
Vernacular Names 
Tam     :    Karumubu 
Eng                :    Sugar cane 
Hindi                :   Ukh-Ganna 
Kan     :    Khabbu 
Mal       :    Karinpu 
Sansk      :    Ikshu 
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Parts used   : Juice, Sugar, Root 
Properties and action 
Suvai (Taste)                          :    Inippu (Sweet) 
Thanmai (Potency)             :    Thatpam (Clod potency) 
Pirivu (Bio-Transformation) :   Inippu (Sweet) 
Seigai (Actions)                     :   Anti septic, Demulcent 
General characters 
“அருந்து ேருந்திற்  னுபோன ேோ ப் 
சபோருந்துேடல் வோந்திபித்தம் மபோக்கும் அருந்தருெி 
நீக்கு ேதி பத்லத நீற்று ே ிழ்ச்ெியுண் 
டோக்கு நறுஞ் ெர்க் லர”. 
                                       - அ த்தியர் குணவோ டம் [33d] 
Indications: 
 It can be use the as adjuvant for several medicine 
 It cures vomiting. 
Therapeutic uses 
 It cures chronic healing ulcer. 
 Sugar along with honey wax can be used to treat Acne. 
 Sugar can be used as an antidote for toxicity of Copper, Arsenic and 
Mercury
[39a]
. 
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GHEE 
Butter is cleaned and heated in a vessel. When it melts either the leaves of Moringa 
olifera are the bettle leaves are added and filtered immediately, since it is difficult to 
filter after cooling. 
If Ghee is preserved in good vessel, it won’t spoil upto 3 months. Cow’s  ghee is 
slightly yellowish in colour. Ghee should be consumed with food. Food without ghee 
is considered to be forbidden. It is good to consume the melted ghee and diluted butter 
milk. The following lines stress these points : 
“ சநய்யில்ைோ உண்டி போழ்” 
“சநய்லய  உருக் ியும் மேோலரப் சபருக் ியும்” 
Among all the ghees, cow’s  is the best. If this is not available mixed ghee may be 
consumed.  
Properties of mixed ghee: 
 This will improve sperm production. 
 It also stimulate appetite and controls pitha dhosa and pitha  fever. In addition, 
it gives strength to the body. 
Constituents: 
Saturated, Transaturated, Monounsaturated, Polyunsaturated fats, Cholesterol, 
VitaminA, and VitaminE. 
Medicinal Uses: 
 Cow’s ghee cures morbid thirst, vomiting, emaciation increased pitha, vatha 
diseases, gonorrhoea, hiccough, cough, abdominal pain, gastritis, intestinal 
disorders, fatigue, haemorrhoids and dryness, hypermotility of gut, weakness 
of bones.  
 Ghee is good for eyes.  
 It increases body weight and gives a golden complexion. 
  It also cures the diseases of the eye, eyebrow ,forehead and head[40]. 
 
REVIEW OF LITERATURE 
 
 
HEPATOPROTECTIVE ACTIVITY OF SIRINGIPAERATHI CHOORANAM 50 
 
3.3 PHARMACEUTICAL REVIEW 
CHOORANAM 
Definition 
Chooranam are fine dry powders of drugs. The term “Chooranam” may be applied to 
the powders of a single drug or a mixture of two or more drugs, which are powdered 
separately prior to their being mixed to homogeneity. 
Method of preparation 
Equipment required 
1. The drug enumerated in the recipe in clean and dried state. 
2. A mortar and pestle. 
3. A fine sieve or fine cloth of close mesh. 
Process of preparation 
The drugs which are to be used in the preparations should be taken from 
recently collected material. Drugs which are aged by prolonged storage or changed in 
colour, taste and scent and those that are insects infected or attacked by fungi should 
be positively rejected. 
However, drugs like Emboli fruits, Senna, Long pepper, Jaggery and cow’s 
ghee are preferred from fairly aged stock, provided they are not infested with pests, 
deteriorated or spoiled or developed rancidity. 
            In general, the aromatic drugs are slightly fried in order to enhance their aroma 
and milling properties. Any extraneous material, organic or inorganic, should be 
removed from the drugs by close inspection. 
           The Chooranam should be as fine as to be called amorphous and should be 
never damp. The fineness of the sieve should be 100 mesh or still finer. 
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Purification of the prepared Chooranam 
“தோசனன்  சூரணத்தின் சுத்திக்ம ளு 
தப்போமத ெரக்ச ல்ைோஞ் சூரணித்து 
நோசனன்  வோவின் போைோற் பிலெந்து 
நைேோன ெட்டியிமை போலைவிட்டு 
வோசனன்  சுத்தெைம் போதிவிட்டு 
வளேோ  மேற்ெலீை ம ோடு  ட்டிப் 
போசனன்  சூரணத்லதப் பிட்டுமபோல் லவது 
பத ோமத சவந்சதடுக்க்ச் ெித்தியமே!”   
- அ த்தியர் லவத்திய இரத்தினச்சுருக் ம் 
The prepared Chooranam is mixed with the milk in half quantity milk and half 
quantity water is taken. The mouth of the pot is covered with a thin cloth material. 
Above this cloth the mixed Chooranam is placed. The pot is placed over the stove and 
heated.  
“ஆேப்போ ரவியுைர்த்திப் சபோடிதோன் செய்து 
அப்பமன ெேனோய்ச் ெர்க் லரலயச்மெர்த்து 
நோேப்போ ச ோண்டு வர மதோஷம் மபோச்சு 
நன் ோக்ச் சுத்தி செய்யோச் சூரணந்தோன் 
தோேப்போ மரோ த்லத சவல்ைோ தப்போ 
தளேோன வியதி சயல்ைோம் போரிக்கும் போர் 
மவேப்போ சுத்தி செய்து ச ோண்டோயனோல் 
சவகுசுறுக் ோய் தரீுேோ வியோதி ம ளு” 
                            - அ த்தியர் லவத்தியஇரத்தினச்சுருக் ம்[41] 
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Then the Chooranam is placed in the sunlight and powdered. Equal amount of 
sugar is added and taken internally. All type of disease gets cured. If the drug is taken 
without purification the diseases does not cure. If taken after purification the disease 
cures easily.  
Storage  
The prepared Chooranam should be allowed to cool by spreading and mixing, 
prior to packing. They should be stored in tightly closed glass container, polythene or 
tin containers or cellophane bags and sealed. These bags should in turn be enclosed in 
card board boxes.  
The Chooranam, to facilitate easy handling and to assure exact dosage of 
administration, could be pressed into tablets with the addition of a suitable binder.  
These tablets could be packed in bottles or tubes made either of glass or 
packed in strip of metal foil or plastic sheets. The Chooranam is said to retain its 
potency for three months and then gradually deteriorate. 
 However, if properly packed and stored they keep good for a year
 [42]
. 
In industry the tablets are made, counted and packed by electronic devices. 
According to AYUSH guidelines shelf life of Chooranam is one year
 [43]
. 
 Table: 1 ANALYTICAL SPECIFICATIONS OF CURNA/CHOORNAM  
S.No TESTS 
1. 
 
2. 
3. 
4. 
5. 
6. 
7. 
 
8. 
 
Description 
Macroscopic, Microscopic 
Loss on drying at 1050 C 
Total – ash 
Acid – insoluble ash 
Water-soluble extractive 
Alcohol – soluble extractive 
Particle size (80-100 mesh for Churna; 40-60 
mesh  for churna) 
Identifications, TLC/HPTLC-with marker (wherever 
possible) 
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9. 
 
 
 
 
10. 
 
 
11. 
 
 
 
 
12. 
 
 
 
13 
Test for heavy/Toxic metals 
Lead 
Cadmium 
Mercury 
Arsenic 
Microbial contamination 
Total bacterial count 
Total fungal count 
Test for specific Pathogen 
E. coli 
Salmonella spp. 
S.aureus 
Pseudomonas aeruginosa 
Pesticide residue 
Organochlorine pesticides 
Organophosphorus pesticides 
Pyrethroids 
Test for Aflatoxins (B1,B2,G1,G2) 
 
 
DISEASE REVIEW 
3.4. SIDDHA ASPECT DISEASE REVIEW 
JAUNDICE (KAMALAI)  
This is one among those diseases which occur due to derangement of Pittha 
uyir thathu. Pithha disease, Manjal kamalai, Kamalai, and Manjal disease are the 
synonyms of this disease. In this disease, urine, eyes tongue and the body will get 
yellowish discolouration. 
Aetiology: 
Consuming more food which stimulates Pittha thathu, drinking unhygienic 
and impure water and seasonal changes cause this disease.  
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Yugi vaidhya chinthamani states that jaundice will occur when one consumes 
more Pittha- stimulating food and indulges in excessive sexual activity under 
conditions of severe anaemia. 
Apart from this, obstruction of bile flow will cause jaundice.  When there is 
obstruction in bile duct, the bile, instead of going to the intestine, returns and mixes 
with the blood.   
           Obstruction of bile flow will occur due to bile stone in the bile duct, worms, 
constriction in the inner walls of the bile duct and new growths. 
 Cancerous growth, abscess or tumours or lymph nodules which occur in 
neighbouring parts of the bile duct may also obstruct the bile flow in the bile duct. 
The occurrence of any inflammation in the small branches of the bile duct may 
also cause obstruction. 
Because of the toxicity of certain metallic substances like copper sulphate, 
lead, white arsenic and copper, inflammatory reaction will occur in the liver leading 
to the obstruction of bile flow. 
There may be certain defects in RBCs by birth. Apart from this, on account of 
malaria and snake poison, the RBCs will get destroyed. In this condition also, 
jaundice will occur. 
In cirrhosis of liver also causes this disease. Cirrhosis will occur in malaria 
and yellow fever and on account of certain toxic substances like alcohol and toddy 
and so in this condition also jaundice occur. When the blood Thathu increases in the 
body, jaundice will occur. 
Premonitory symptoms 
 In this disease, excessive salivation, nausea, bitterness of tongue, anorexia,            
indigestion, dryness of the body and shrinking in the skin as like that of a frog 
skin will occur.  
 Shrinking of skin like a frog. 
 After that, eyes, nail beds, face and skin and also urine become yellow in 
colour.  
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முற்கு ிகுணங் ள்: 
“பரு மவ உள்ளங் ோ லுள்ளங் ல  ள் 
ப ர்மு ங் ண் ணுடம்புேி  சவளுப்பு  ோணுங் 
 ரு மவ  ோல்ல   மளோய்ச்ெ ைோகுங் 
 னேோ  நடுக் ிமய இலளப்புண் டோக்குஞ் 
சுரு மவ ேைந்தோனும் வ ண்டு  ட்டுந் 
தூயமு  ேஞ்ெளிட நி ே தோகும் 
சவரு மவ வகீ் ேோய்க்  லளப்புண்டோகும் 
ேி க் ோது ேந்தந்தலை  னப்புண்டோகும்." 
          -யூ ிமுனி 
 Again, in this disease, palm, sole, face, eyes and the body will become pale; 
there would be severe fatigue in the extremities, shivering of the body, constipated 
and hardened faeces, and yellowish discolouration of face, oedema, lassitude.
[44]. 
Classification of the disease 
In Siddha literatures, it is classified in to 13 varieties. They are as follows; 
1. Vatha kamalai 
2. Pittha kamalai 
3. Kaba kamalai 
4. Vatha kaba kamalai 
5. Pittha kaba kamalai 
6. Thirithathu kamalai 
7. Perunkamalai 
8. Uthu kamalai 
9. Varattu kamalai 
10. Azhagu kamalai 
11. Sengamala kamalai 
12. Kumba kamalai 
13. Gunma kamalai 
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Curable and Incurable  
 Among the 13 varieties, jaundice due to Pittha factor, severe jaundice, 
jaundice due to Kaba factor, jaundice with swelling, jaundice with dryness, jaundice 
due to Vatha Kaba factor and jaundice due to Kaba Vatha factor are curable easily. 
The other varieties are not easily curable. 
 நோடி நலட:  
பண்போன பித்தத்தில் மெத்து ேநோடி 
 ண் ோது நயனேைம் நீரு ேஞ்ெள். 
    (ெத  நோடி) 
ெோறுேடோ பித்தேந்த வோதத்தி மை ில் 
தளஞ்செய்யும் போண்டு  ோேோலை தோனும் 
    (நோடி நூல்) 
பித்தஐயக்  ைப்போலும், பித்தவோதக்  ைப்போலும் 
ேஞ்ெள்மநோய் உற்பத்தியோகும் என்பதோம்[45] 
Treatment  
 Thanks to the variable intake of food and other deeds which stimulate Pittha 
thathu, Pittha increases in its strength, joins Kaba and becomes Pittha Kaba factor. 
This factor spoils the spreading vayu (Paravu kal- Vyanan) and prevents it from doing 
its normal work and thus it spoils the strength of blood.  
Because of this, liver gets affected and so the bile is not able to flow in its 
normal route as there is obstruction. 
 Hence the bile mixes with the blood and jaundice occurs. The Vatha factor 
gets affected and the disease occurs due to Pittha Vatha factor.  
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Apart from this, the other Vayu (gases) also get spoiled. Hence the duty of the 
doctor is to set right the altered Kabam and Pittha Vatham, in order to make the bile 
flow in its normal route and to increase the strength of blood by suitable treatment.  
The altered spreading Vayu (gas) and other Vayu (gases) should be brought to 
normal and made to do the normal regular work. Then medicines for the disease 
should be given. 
To induce vomiting and diarrhoea 
 Since vomiting is a symptom in this disease, it should not be induced though it 
is advocated in Siddha literatures. 
 To stimulate normal and easy bowel movements, the following substances 
which have laxative action can be given: 
 Anthemides flower (simai samanthi flower)   
 Buds of rose (roja) 
 Grapes (kodi munthirigai) 
 Bark, leaves and flower of purging cassia (sarakkonrai) 
 Phyllanthus amarus (kizhanelli) 
 Terminalia chebula (kadukkai) 
 Terminalia bellerica (thandrikkai) 
 Phyllanthus emblica (Indian gooseberry) 
 Picrorhiza kurroa (kadugurohini) 
 Root of Indian jalap (sivathai) 
 Flower of hygrophila paniculata (nirmulli flower) 
 Flower of neem (veppam pu) 
 Tinospera cardifolia (sinthil) 
 Tribulus terrestris (nerunjil) 
A decoction of the above substances may be made and given for jaundice for laxative 
purpose.
[44a] 
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LIVER DISEASES AND MEDICINAL PLANTS 
 Polyherbal formulations reputed to have hepatoprotective activity that is 
available in the Indian market which comprises about 100 medicinal plants
 [15b]
. 
Andrographis paniculata 
           For centuries Andrographis has been important herb in the Asian healing 
system of Ayurveda, Unani and Traditional Chinese medicine. Traditionally herb has 
been used to potentiate immune system response to inflammation and infections, and 
as an Anti-inflammatory ,Anti – pyretic and a hepatoprotective. Andrographolide ,the 
active constituents isolated from the plant Andrographis paniculata showed a 
significant dose . 
Phyllanthus amaris 
           Phyllanthus amaris has been researched for its effects on hepatitis and reported 
that 22 of 37 cases of Hepatitis B lost their “Carrier” status after using the herb for a 
month
 [46]
. 
Boerhavia diffusa 
              An alcoholic extract of whole plant Boerhavia diffusa given orally exhibited 
hepatoprotective activity against experimentally induced CCL4 hepatotoxicity in rats 
and mice
[47]
.  
Swertia chirata 
            Mukherjee et al.,(1997) reported that simulataneous treatment with S.chirata 
(in different doses,vix.,20,50, and 100 mg/kg body wt daily) and CCL4 caused 
improvement at both biochemical and histopathological parameters compared to that 
of CCL4 treatment alone but it was most effective when S.chirata  was administered 
in a moderate dose (50 mg/kg body wt)
 [48]
. 
Terminalia belerica 
           Compound I isolated from fraction TB5 of Terminalia belerica identified as 
3,4,5-trihydroxy benzoic acid(gallic acid) and was evaluated for its hepatoprotective 
activity against CCL4-induced physiological and biochemical alterations in the liver.  
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Administration of compound led to significant reversal of majority of the 
altered parameters confirming the presence of hepatoprotective activity
 [49]
. 
Cichorium intybus 
           Cichorium intybus is a popular Ayurvedic medicine for the treatment of liver 
diseases. It is commonly known as kasni and is part of polyherbal formulations used 
in the treatment of liver diseases. In mice, liver protection was observed at various 
doses of Cichorium intybus but optimimum protection was seen with a dose of 
75mg/kg given 30 minutes after CCL4 intoxication. Kalantari and Rastmanesh (1985) 
in his preclinical studies showed that an alcoholic extract of Cichorium intybus was 
found  to be effective against chlorpromazine-induced hepatic damage in adult albino 
rats. A bitter glucoside,Cichorin(C32H34O19) has been reported to be the active 
constituent of the herb. 
Glychyrrhiza glabra 
           Glychyrrhiza glabra,commonly known as licorice contains triterpene saponin, 
known as glycyrrhizin, which has potential hepatoprotective activity. It belongs to a 
group of compounds known as sulfated polysaccharides.  
               Experimental hepatitis and cirrhosis studies on rats found that it can promote 
the regeneration of liver cells and at the same time inhibit fibrosis.  
Glycyrrhizin can alleviate histological disorder due to inflammation and restore the 
liver structure and function from the damage due to CCL4. 
              The effects including: lowering the SGPT, reducing the degeneration and 
necrosis and recovering the glycogen and RNA of liver cells. 
             Effects of glycyrrhizin has been studied on free radical generation and lipid 
peroxidation in primary cultured rat hepatocytes.  
              Favourable results have been reported in children suffering from 
cytomegalovirus after treating with glycyrrhizin. 
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Curcuma longa 
             Curcuma longa turmeric has been found to protect animal livers from a 
variety of hepatotoxic substances, including CCL4, galactosamine,pentobarbital,1-
chloro-2,4-dinitrobenzene, 7.4-hydroxy-nonenal and paracetamol .
[50]
  
Other Medicines for Jaundice (Siddha Aspect) 
 The medicinal Malakkudara oil in a dose of one teaspoonful with a small  
quantity of milk can   be given at  bedtime. The next day morning faeces will be 
passed out easily. 
Malalakudara wax (Mezhugu) of the size of a fever nut (kazhal kay-caelpinia 
bounduc) can be given at bet time.  Easy motion will occur in the morning. 
Sweet diarrhoea wax (Thithippu bedhi mezhugu) or sweet diarrhoea leghiyam  
(Thithippu bedhi leghiyam) of the size of  Indian gooseberry can be taken at bedtime.  
Easy to motion will occur in the morning. It may be given in suitable doses in the 
morning and evening. 
If the motion is not passed properly by the above methods, 2 sanjivi tablets 
with hot water can be given for children. Motion will be passed easily. 
For adults, one among the following may be given in a dose of 2 tablets with 
hot water in the morning alone. Faeces will be passed easily. The medicines are 
Vajjirakandi tablet, Attabairava tablets, Suka viresana tablet, Jivarathina tablet, 
Virechana bhupathy and Lavangathy tablet.  
 When Sanjivi tablet along with leaf juice of Euphorbia Nivula (Ilaikkalli) is 
given, vomiting and diarrhoea will be induced. Vomiting for two or three times will 
occur.  Diarrohoea will also occur.  Along with vomit or faeces, the bile fluid will also 
come out. 
The unripened fruit of Randia dumetorum (Marukkarai kay) in its tender 
reddish form may be taken.  It may be soaked in lime juice and leaf juice of 
Euphorbia Nivula(Ilaikkalli) for two days in each.  Then it can be taken out and dried.  
This can be ground and made into powder. ½ in 1 pinch can be given in the morning 
alone.  Diarrhoea and vomiting will occur. 
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Tinospera cardifolia (Sinthil), Eclipta alba (Karisalai), Phyllanthus 
amarus(Kizha nelli), Sivanar neem, Indigofera aspalathoides  (Sivanar vembu), 
Terminalia chebula (Kadukkay),Puncture vine(Tribulas terrestris – nerunjil), flower  
of purging  cassia (Cassia  fistula- Sarakkonrai) or its leaf or bark. 
Any one  of the above can be ground in raw greenish form  and made into a 
green paste (Karkam).  This can be given for jaundice. 
This may be considered as a preventive and curative medicine for jaundice.  
With salt-free diet, goat’s milk and rice may be eaten.  The next day salt may be 
included in the diet
[51]
. 
Tablet of Eclipta alba ( Karisalai matthirai) 
 Eclipta alba - one hand full 
 Black cumin 
 Long pepper  
 Pepper (Piper nigrum) 
 Garlic (Allium sativam) 
Each ¼ palam (8.5 gm), Grind them all in the mortar and make tablets in the 
size of Solanum torvum (Sundai), dry them in shade and put them in a wide-mouthed 
bottle; pour good quality gingili oil and close it with a lid and put it in sunlight.  One 
tablet each may be taken in the morning and evening.  Jaundice along with oedema 
will get cured. Tamarind and salt should be avoided
 [52]
. 
Ghee of Phyllanthus amarus (Kizha nelli ney) 
 Juice of Phyllanthus amarus 1.35 liter (one measure) 
 Cow’s ghee1.35 liter (one measure) 
 Cubeb (Valmilagu) 
 Nutmeg (Myristica fragrances) (Jathikkay) 
 Cardamom (Eletaria cardamom) (Elam) 
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Each 17.5 gm (1/2 palam) is taken. All of them may be ground in a mortar 
with milk. Then this may be heated and processed for oil (Thylam) and filtered. 16 ml 
(the standard volume of a small spoon (Uchikarandi) may be consumed in the 
morning and evening. Jaundice will be cured. Salt-free diet is essential.
 
Ghee of Eclipta alba (Karisalai ney) 
 Juice of Eclipta 1.35 litre (one measure),  
 Cow’s ghee 1.35 litre (one measure), 
 Thirikaduku (dry ginger, pepper, long pepper) 35 gm (one palam), 
 Hyoscyamus niger (Kurosani omam) 8.5 gm (1/4 palam),  
 Cubeb (Valmilagu) 17.5 gm (½ palam) 
  May be taken and the ghee may be prepared as described mix the above two 
and take in doses of ¼ to ½ teaspoon two or three times a day with cow’s milk or its 
buttermilk or goat’s milk or its buttermilk.   
It can be given with honey also or it can be taken separately.  It can be used as 
an adjuvant for any other Calx or Chenduram.  It will give an excellent cure for 
spleen and liver enlargement also.  
Jaundice powder (another process) 
 Charred turmeric – one part 
 Cubeb – fried, pounded and powdered – one part 
 Cumin seeds – fried, pounded and powdered – one part 
 Cane sugar powder – 4 parts 
 Calx of gypsum – 1 part 
Mix all the above five and make a single powder of them.   
Jaundice will be cured when this powder is taken in doses of 10 to 15 Kundri 
two to three times a day when with cow’s milk or goat’s milk or honey or in orange 
juice. It can also used as adjuvant to any other calyx or Chenduram or any other 
medicines prescribed for jaundice.  By this, anaemia, oedema and liver diseases will 
get cured
 [53]
. 
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Decoction of tender leaves of Thespesia  populnea for jaundice (Puvarasu 
kozhundhu ilai  kudinir) 
Put the iron pot on a stove. 8 gm of pepper may be put into the pot and fried. 
Make a powder of it keeping it in the pot itself. Then pour ½ measures of tender 
coconut water into the pot over the pepper. Let it be boiled in the pot. One handful of 
tender leaves of Thespesia populnea may be taken and squeezed to get juice.  
The juice may be poured into the pot when it starts boiling and the squeezed 
leaves may also be put in to the pot itself. Within a few minutes, the water portion in 
the pot will be reduced to 1/8 of a measure.  
Take the pot away from the stove and make it cool. Filter the decoction. The 
decoction is to be consumed when it is slightly hot. If it is prepared and consumed for 
three times, jaundice will get cured immediately.  
Saltiest and pungent diet should not be taken at the time of drinking this 
decoction for the whole day. Sweet substances are also to be reduced. Before 
consuming this medicine, the required food can be eaten
 [54]
. 
The procedure for consuming this medicine   
If the first dose of medicine is taken at 6pm of the day. 
            The second dose is to be taken at 6 am of the next day. 
            The third dose is to be taken at 6pm on the second day. For the whole day, 
salt-free rice porridge alone should be taken.  
The next day morning a little of cow’s butter may be put on the head and after 
half an hour, bath should be taken in cold water.   
Then the needed food can be taken. Those who suffer from this disease for a 
longer duration can consume 3 doses of this medicine with a break of one day. For 
children, dosage should be adjusted suitably according to their age, body type and 
strength
 [55]
. 
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Powder of East Indian rose (Nandiyavattai) for jaundice: 
Pericarp of the root of multiple-layered East Indian rose, pericarp of the root 
of Indian jalap which is cooked in milk, the outer part of Terminalia chebula – equal 
quantities of these 3 things may be dried and pounded in a stone mortar and the 
powder may be filtered by a muslin cloth. If this powder in a three finger pinch is 
consumed with hot water, jaundice, predominant Pittha condition, and oedema can be 
cured. 
Coconut medicine for jaundice: 
A well – ripened coconut may be taken, its eyes may be opened and the 
coconut water may be poured into a vessel. The root of Boerhavia  diffusa 
(Mukkirattai) may be rubbed with coconut water and a paste  is made.  
This paste must be inserted into the coconut through the opened eyes and then 
the eyes may be closed properly and a strong mud-sealing may be made over it and 
dried. This may be buried under the ground and kept for 3 days under the earth.  
It may be taken out on the fourth day and the sealing may be removed. The 
coconut may be broken and the medicine inside the coconut may be divided into 3 
equal parts. One part per day along with buffalo curd may be consumed. Fat free diet 
is essential. 
Two medicines for jaundice: 
The whole plant of Solanum nigrum (Manathakkali) or the whole plant of 
Phyllanthus amarus (Kizhanelli) may be macerated on a stone slab with water. A lime 
sized paste of it may be consumed with cow’s buttermilk or curds. 
Green paste of Eclipta alba (Kaiyanthakarai karkam) 
Tender leaves of Eclipta alba, tender leaves of Coldenia procumbens 
(Seruppadai), turmeric and pepper- equal quantities of the above 4 substances may be 
taken  and macerated on a stone slab. 
 A lime- sized paste may be consumed along with goat’s urine. Jaundice and 
oedematous jaundice will be cured. 
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Medicine of Acacia concinna (Sikaikkay) for jaundice: 
Four numbers of fresh fruit of Soapnut (Acacia conenua) may be collected and 
the seeds inside the fruit may be removed.  
The seedless fruits may be macerated with water very well and it may be 
consumed mixing it with half a litre of cow’s milk. If diarrhoea occurs, then it is 
good. This medicine may be consumed for 3 days. 
Rice with cow’s milk may be taken. Salt and tamarind should be avoided. 
Jaundice of any type will be cured. 
Ghee of Alternanthera sessilis (Ponnangani) for  jaundice: 
The root of Alternanthera sessilis may be collected and macerated on a stone 
slab. It is taken in lime fruit size and be soaked into 4 liters of cow’s milk and is 
allowed to mix with it. The next day, the butter from it may be taken out and 
consumed. Jaundice will be cured. 
Cissus quadrangularis (Pirandai) medicine for jaundice: 
Tender leaves of Cissus quandrangularis, Pepper, Acorus calamus, dry ginger 
equal quantities of these ingredients may be taken and macerated on a stone slab.  An 
areca nut sized ball of this paste may be covered in rice bran and consumed. 
Eye drops for jaundice: 
Leaves of Caesalpinia bouduc, garlic and Acorus calamus- these three may be 
squeezed and put in a cloth. 
 The drops of it may be squeezed out from the cloth and dropped into both the 
eyes. As it is a pungent drug, only a small drop alone is to be poured into the eyes.  
If there is swelling in the eyes, tender leaves of Cynodon dactylon (Arugu) 
may be macerated with cow’s milk and the paste may be given for 6 days. Jaundice 
will be cured. 
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Medicine of turmeric, etc. and calx for jaundice (Aridradhi churnam parpam): 
Turmeric (Manjal), pericarp of Tchebula (Kadukkay thol), pericarp of 
Terminalia belerica (Thandrikay thol) and pericarp of Indian gooseberry (Nelli 
mullai), Pircorzhiazha kurroa (Kadugurohini), rock salt (Induppu) equal quatities  of 
the above substances may be taken, dried and pounded in a stone mortar. One 
Verukadi (cat’s foot print) quantity mixed with water may be consumed.  Jaundice 
will be cured. 
Leaves of Pavonia zeylanica (Chitramutti), bark of Cassia fistula (Konrai), 
Syzygium cumini (Naval), coriander leaves, purified iron powder, leaves of Indigofera 
tinctoria(Avuri) – equal quantities of the above substances may be taken and Calx of 
the above may be prepared.   
The Calx may be put in a mortar and ground with lime juice. The paste in the 
size of the Solanum torvum( Sundaikkay) may be consumed. Jaundice will be cured .. 
Leaves of castor plant for jaundice (Amanakkilai marundhu) 
Tender leaves of castor plant Aamanakku kozhundhu), tender leaves of 
Trianthema protulacasturm (Saranai kozhundhu), dry ginger and white onion- equal 
quantities of the above things may be taken and macerated on a stone slab. The paste 
may be mixed with buffalo curd and consumed.  Jaundice will be cured. 
Medicine of iron filings for jaundice (Arappodi marunthu) 
Iron filings may be put soaked in the bark juice of Terminalia arjuna 
(maruthu) and allowed to absorb the juice.  Then the iron filings may be taken out and 
dried in the sun. Then it is powdered. 
 Take 40 Terminalia chebula fruits. Remove the seeds. Fry the epicarp portion 
in a vessel and make it charred, and then it is powdered.  
Equal quantities of this powder along with the iron powder may be consumed. 
Ascitis, anaemia and jaundice will be cured. 
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Phyllanthus distichus (Arunelli) for jaundice: 
Phyllanthus distiches in the size of the fruit of Alexandrian laurel (punnai kay) 
may be taken and macerated on a stone slab. This may be given along with ¼ of a 
measure of sour buttermilk for 3 days in the morning. Jaundice will be cured. Rice 
with goat’s milk can be taken. Salt should be avoided. 
Excreta milk of buffalo for jaundice (Erumai sani pal) 
The excreta milk of buffalo and buffalo curd may be mixed together. Cumin 
seeds and onion in equal quantities may be macerated and added to the above. 
 The mixture may be again mixed with cow’s milk and given in 6 to 7 equal 
doses. Jaundice will be cured. 
Decoction for jaundice: 
Flower of Madhuca longifolia (Iluppai), Tinospera cordifolia (Sinthil), neem 
petioles, petioles of Adathoda vasica, clearing nut, Vettiver ziznaioides- take equal 
quantities of the above and prepare a decoction.  The decoction may be taken along 
with sugar, ghee and honey. Jaundice will get cured. 
70 gm of Sivanatha powder along with cold water or honey or with the three 
fruit (three myrobalans-kadu, tanri and nelli) decoction may be consumed. Jaundice 
will get cured. 
White variety of Indian jalap (Vellai sivathai), dry ginger (Chukku), root of 
Burleria prionities (Semmulli ver) make a powder of these and mix together and take 
with milk and sugar. 
The whole plant of Phyllanthus amarus (Kizhanelli) 50 gm and dry ginger 
(Chukku) 10gm may be macereated and given or a decoction made out of them may 
be given. 
 Phyllanthus amarus (Kizhanelli), Terminalia chebula (Kadukkay- gall- nut)-a 
decoction may be prepared of the above and consumed along with sugar. Jaundice 
will get cured. 
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Root of Alternanthes sessilis (Ponnankani), root of Indigofera tinctoria 
(Avuri), Terminalia chebula (Kadukkay-gall- nut), tender leaves of white pumpkin 
(Venpusani kozundhu) any of the above may be macerated with goat’s butter milk and 
given for jaundice. Jaundice will get cured.  
Glycyrrhizha glabra (Athimathuram), sugar taken from Tinospera cordifolia 
(Sinthil sarakkarai), clearing nut (Thetran kottai), sandal (Chandhanam), all the 
above may be macerated with cold water and given for jaundice. Jaundice will get 
cured. 
Pericarp of the dry fruit of Indian gooseberry (Nelli thol), dry ginger (Chukku), 
pepper (Milagu), long pepper (Thippili), turmeric (Manjal) take equal  quantities of 
the above and make a Chooranam or powder.  To the above powder, iron Chenduram 
may be added and consumed. It can be taken along with honey, ghee or sugar.
 
Make a green paste from the whole plant of Phyllanthus amarus (Kizhanelli) 
and take the paste in the size of the area nut. Add 300 mg of conch shell Calx to this 
and consume it in the morning alone as single dose with butter milk.  
Take it for 3 or 5 days like this. Avoid salt. Jaundice will get cured. 
 Purified gypsum may be macerated with cow’s urine and consumed. Jaundice 
with oedema will get cured. 
Powder of Eclipta alba (Karisalai churanam): 
 Powder of dry leaves of Eclipta alba (Karisalai) 35 gm 
 Powder of epicarp of Terminalia chebula (Kadukkay) 15gm 
 Powder of pepper (Milagu) 10 gm 
 Powder of the root of Lowsonia alba - henna plant (Maruthonri) 10 gm 
Mix the all the above and grind it in the mortar to make it a fine powder. Take 
2gm of the above, add 200mg of rusted iron Chenduram and take 2 times a day with 
buttermilk. Within 5 to 10 days, jaundice will get cured. 
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Diet for jaundice: 
Salt should be restricted according to the strength of the patient. Porridge 
without salt and tamarind is good. Twice boiled rice can be given. As stated in 
aetiology, when the bile flow is obstructed in the bile duct, fat will not be digested as 
bile is not available for digestion.  
 Ghee, butter, oil and all other fatty substances should be avoided until the 
disease is cured completely. 
Tender vegetables which are not fried with mustard and gingelly oil, green, 
fruits, butter milk and goat’s milk can be taken in. Ginger paste can be added to diet 
to induce appetite. To the diet, cane juice, lime juice and ginger can be added.  
Smoking, tobacco chewing, and alcohol–like substances should be fully 
avoided. Rest is essential until the disease is completely cured
[56]
. 
3.5.Disease Modern Aspect 
Liver Diseases 
Liver diseases are a broad term re-counting any number of diseases affecting 
the liver. Many are escorted by jaundice caused by increased levels of bilirubin in the 
system. Liver disease may be classified as:- 
1. Hepatitis, inflammation of the liver, instigated mainly by various viruses but 
also by some poisons, autoimmunity or hereditary conditions. 
2. Cirrhosis is the foundation of fibrous tissue in the liver, replacing dead liver 
cells. The death of the liver cells can be affected by viral hepatitis, alcoholism or 
contact with other liver-toxic chemicals. 
3. Haemochromatosis, a hereditary disease causing the accretion of iron in the 
body, eventually leading to liver damage
[57]
. 
4. Cancer of the liver (Primary hepatocellular carcinoma or Cholangio 
carcinoma and metastatic cancers, usually from other Parts of the gastrointestinal 
tract). 
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5. Wilson's disease, a hereditary disease which reasons the body to retain 
copper. 
6. Primary sclerosing cholangitis, an inflammatory disease of the bile duct, 
likely autoimmune in nature. 
7. Primary billiary cirrohisis, autoimmune disease of slight bile ducts. 
8. Budd-Chiari syndrome, complication of the hepatic vein. 
9. Gilbert's syndrome, a genetic syndrome of bilirubin metabolism, found in 
about 5% of the population. 
10. Glycogen storage disease type II, the build-up of glycogen causes liberal 
muscle weakness (Myopathy) throughout the body and touches various body tissues, 
particularly the heart, skeletal muscles, liver and nervous system. 
Liver diseases are mainly caused by 
1. Infections 
2. Autoimmune disorder 
3. Chemical agents (certain Antibiotics, Peroxidised oil, Aflatoxin, 
Carbontetra chloride, Chlorinated hydrocarbon, Paracetamol etc. 
4. Excess consumption of alcohol. 
 
Hepatitis 
 It is the infection and damage of liver particularly involving the hepatocytes. 
It is usually due various infective and toxic substances. The condition can be 
selflimiting, healing on its own, or can progress to scarring of the liver. 
 A group of viruses known as the hepatitis viruses origin most cases of liver 
damage worldwide. 
 Hepatitis can also be due to toxins (notably alcohol), other infections or from 
autoimmune process
[58]
. 
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Infective Agents 
 These are mainly viruses like, Type A and Type B, Non – A, Non – B, Delta 
agent, virus of yellow fever, Epstin – Barr virus, cytomegalovirus, virus of Herpes 
simplex, Rubella, Marburg agent and others like Leptospira icterohaemorrhagiae 
canicola, Taxoplasma gondii, Borrelia recurrentis, etc.. 
Toxic Agents 
 Chlorpromazine and other Phenothiazine derivatives, Monoamine oxidise 
inhibitors (MAO-inhibitors),Erythromycin,Tetracycline,INH,Rifampicin,Methyldopa, 
Chlorpropamide, Phenylbu-tazone,Indomethacin, Paracetamol, Thiouracil, 
Acetaminophen, Halothen, Alcohol, Carbon tetrachloride, etc
[59]
. 
Table : 2 List of hepatotoxic therapeutic agents and chemicals 
 
Therapeutic agents Chemicals 
Allopurinol Methotrexate Alcohol 
Amiodarone Nicotinic acid Arsenic 
Azathioprine Nitrofurantoin Carbon tetrachloride 
Carbamazepine Paracetamol Chloroform 
Chlorpromazine Phenelzine Copper 
Chloroform Phenytoin  
Ciglitazone Pravastation  
Cimetidine Quinidine  
Dantrolene Rifampicin  
Erythromycin Salicylates  
Galactosamine Simvastatin  
Halothane Sodium valproate  
Iproniazid Sulphonamides  
Isoniazid Tetracyclines  
Ketoconazole Ethanol  
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Viral Hepatitis: 
Viral hepatitis is the cause of most cases of acute hepatitis. Types include 
Hepatitis A, Hepatitis B, Hepatitis C, Hepatitis B with D, Hepatitis E, Hepatitis F 
virus (existence unknown), and Hepatitis G or GBV-C. Hepatitis A or infectious 
jaundice is affected by a Picornavirus transmitted by the fecaloral route.  
It causes an acute form of hepatitis and does not have a chronic stage. 
Hepatitis B is caused by a Hepadnavirus, which can cause 500,000 to 1,200,000 
deaths per year worldwide due to the complications of chronic hepatitis, cirrhosis, and 
hepatocellular carcinoma. Hepatitis C (originally "non-A non-B hepatitis") is caused 
by a virus with an RNA genome that is a member of the Flaviviridae family.  
Hepatitis C may lead to a chronic form of hepatitis, culminating in cirrhosis. 
Hepatitis D is caused by hepatitis delta agent, which is alike to a viroid as it can only 
propagate in the presence of the Hepatitis B virus. Hepatitis E produces symptoms 
similar to hepatitis A. Several hepatitis F virus candidates emerged in the 1990s; none 
of these reports have been substantiated. Another potential viral cause of hepatitis, 
initially identified as hepatitis G virus
 [60]
, is probably spread by blood and sexual 
contact . 
There is very little evidence that this virus causes hepatitis, as it does not 
appear to replicate primarily in the liver
[61]
. It is now classified as GB virus C. In 
addition to the hepatitis viruses, other viruses can also cause hepatitis, including 
cytomegalovirus, Epstein-Barr virus, yellow fever, etc. Non viral infection like 
Toxoplasma, Leptospira and Q fever also causes hepatitis. 
Fatty Liver: 
Fatty liver, also known as fatty liver disease (FLD), Steatorrhoeic hepatosis, or 
Steatosis hepatitis, is a reversible condition where outsized vacuoles of triglyceride 
collect in liver cells via the process of Steatosis. Normal liver may cover as much as 
5% of its weight as fat. Lipiotic liver may contain as much as 50% of its weight as fat, 
most of being triglycerides. 
Severe fatty liver is sometimes accompanied by inflammation, a situation that 
is mentioned to as Steatohepatitis.  
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The progression to cirrhosis may be influenced by the amount of fat and 
degree of Steatohepatitis and by a variety of other informing factors. 
Cirrhosis: 
Cirrhosis can be defined as a chronic disease condition giving morphological 
alteration of the lobular structure characterized by destruction and regeneration of the 
parenchyma cells and increased connective tissue.  
Major morphological changes induce granular or nodular appearance and are 
characterized by the presence of septate or collagen throughout the liver
[62]
. 
Liver Cancer: 
The liver is inclined to cancer induction by a variety of human made and 
naturally occurring chemicals. Chemical substance include, Aflatoxin B, Cycasin, and 
Safrole etc among human made substance are DDT, Carbon tetrachloride, 
Chloroform, Thioacetamide. 
 Studies in experimental animals designate quite clearly that development of 
cancer of the liver is associated with the number of obvious non-malignant lesions 
appearing prior to the occurrence of neoplastic malignancy. 
Hepatotoxicity: 
Hepatotoxicity implies chemical-driven liver damage. The liver plays a 
Central role in transforming and clearing chemicals and is disposed to the toxicity 
from these agents. Certain medicinal agents when taken in overdoses and sometimes 
even when introduced within therapeutic ranges may injure the organ. Other chemical 
agents such as those used in laboratories and industries, and natural chemicals (e.g. 
Microcystins) can also induce hepatotoxicity. 
 Chemicals that cause liver injury are called hepatotoxins. The human body 
identifies almost all drugs as foreign substances (i.e. Xenobiotics) and subjects them 
to various chemical processes, (i.e. metabolism) to make them suitable for 
elimination. This involves chemical transformations like reduction in fat solubility 
and alteration in biological activity.  
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Although almost all tissue in the body have some ability to metabolize 
chemicals, smooth endoplasmic reticulum in liver is the principal "metabolic clearing 
house" for both endogenous chemicals (e.g., cholesterol, steroid hormones, fatty 
acids, and proteins), and exogenous substances (e.g. drugs). The central role played 
by liver in the clearance and transformation of chemicals also kinds it susceptible to 
drug induced injury. 
The mechanism of hepatotoxicity in liver can be labelled by two methods. 
1) Direct: - This group comprises the products (or their metabolic products) 
that produce direct injury to the plasma membrane, endoplasmic reticulum and other 
organelles of the hepatocytes. Direct hepatotoxicity may be exemplified as non-
selective destruction of the structural basis of hepatocyte metabolism. 
Some of the direct hepatotoxins comprise Carbon tetrachloride, Chloroform, 
Tetrachloroethane, Iodoform and elemental phosphorus. 
2) Indirect: -These are more selective, and are antimetabolic and related 
compounds that produce hepatic hurt by interference with specific metabolic pathway 
or process.The hepatic damage produced by indirect hepatotoxins may be mainly 
cytotoxicity expressed as necrosis or mainly cholestatic expressed as arrested bile 
flow with or without bile duct injury. 
A group of enzymes located in the endoplasmic reticulum, recognized as 
Cytochrome P-450, is the most important family of metabolizing enzymes in the liver. 
Cytochrome P-450 is the terminal oxidase component of an electron transport chain. 
It is not a single enzyme, but rather covers of a family of closely related 50 isoforms, 
six of them metabolize 90% of drugs
[63]
 (Lynch and Price, 2007). There is a 
remarkable diversity of individual P-450 gene products and this heterogeneity allows 
the liver to perform oxidation on a vast Array of chemicals (including almost all 
drugs).   
Due to its unique metabolism and close relationship with the gastrointestinal 
tract, the liver is subject to injury from drugs and other substances. About 75% of 
blood coming to the liver arrives directly from gastrointestinal organs and then spleen 
via portal veins which carry drugs and Xenobiotics in concentrated form. 
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 Several mechanisms are accountable for either inducing hepatic injury or 
worsening the damage process.  
Many chemicals damage mitochondria, an intracellular organelle that 
produces energy. Its dysfunction releases extreme amount of oxidants which in turn 
injures hepatic cells.  
Activation of some enzymes in the Cytochrome P-450 system such as 
CYP2E1 also chief to oxidative stress injury to hepatocyte and bile duct cells lead to 
accumulation of bile acid inside liver
[64]
  
This promotes further liver damage. Non-parenchymal cells such as Kupffer 
cells, fat storing stellate cells and leukocytes (i.e. neutrophil and monocyte) also have 
role in the mechanism
[65]
. 
More than 900 drugs have been concerned in causing liver injury 
[65]
 and it is 
the most common reason for a drug to be withdrawn from the market. Drug persuaded 
liver injury is responsible for 5% of all hospital admissions and 50% of all acute liver 
failures
 [66]
. 
The liver produces large quantities of oxygen free radicals in the course of 
detoxifying xenobiotic and toxic substances. Reactive oxygen species (ROS) has been 
exposed to be linked to liver diseases, such as hepatitis, cirrhosis, portal hypertension, 
viral contagions and other liver pathological conditions
[67]
 . They play an important 
role in the inflammation process after intoxication by Ethanol, Carbon tetrachloride.  
These radicals and the reactive species resultant from them react with cell 
membrane, induce lipid peroxidation and are responsible for various deleterious 
belongings in cells and tissues where they are generated. ROS induce alterations and 
loss of structural/functional architecture in the cell, leading directly to cytotoxicity 
and/or indirectly to genotoxicity, with numerous serious anomalies favouring 
disharmony and diseases
[68]
. 
 Hepatic injury caused by chemicals, drugs, and virus is a well-known 
toxicological problem to be occupied care of by various therapeutic measures. 
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3.6.PHARMACOLOGICAL REVIEW 
Models of Liver Fibrosis 
Several approaches to induce fibrosis in animals are designated and these 
models can be divided according to their stimulus from inciting injury.  Liver fibrosis 
models are connected with 
 (1) Toxic damage (hepatocytes: CCl4 dimethylnitrosamine (DMN), 
galactosamine; bile duct epithehal cells:  thioacetamide (TAA)) 
 (2) Immunological-induced damage (heterogonous serum and experimental 
schistosomiasis). 
 (3) Biliary damage (common bile duct ligation (BDL) or occlusion)  
 (4) alcohol-induced damage (baboon ethanol diet or Tsukamoto / French 
model in rats). Nowadays, fibrosis-related models are established that have their 
origin in fatty liver disease 
 (5), Fatty liver disease, in particular the 'malignant' inflammatory form non-
alcoholic steatohepatitis (NASH), can increase to liver fibrosis and cirrhosis. 
  It is strongly associated with obesity and diabetes, two modern health 
problems in Western countries. Of the existing animal models for fatty liver disease, 
as reviewed by 
[69]
  
The genetic lepton-deficient (ob/ob) or lepton- resistant (db/db) mice and the 
dietary methionine/ choline-deficient models are cast-off in the majority of published 
research.  Progressive fibrosis was reported only in the methionine/choline-deficient 
models in 100% of the mice. 
 BDL and CCl4 are the most widely used rodent models
 [70]
  in liver fibrosis 
research to assess the effectively of experimental drugs on the pathogenesis, since 
these models represent features of human pathogenesis.  Therefore, these models are 
the best categorized with respect to histological, biochemical, cell and molecular 
changes connected with the development of fibrosis.   
In the past years, there is a tendency in fibrosis - related research to shift from 
rat to mice models, and most of the models originally described ferrates are now 
applied in mice.  Moreover, new testing models arise due to the development of 
transgenic or knock-out mice models, which were developed to elucidate the 
pathogenesis and common pathways in liver fibrosis
[71]
.  
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 Examples of knockouts with spontaneous formation of liver fibrosis are 
mdr2-/- mice
[72]
 1hx2-/- mice,   and the mice models for NASH  mentioned above
[69a]
.  
Acute and Chronic Models with Carbon Tetrachloride (CCl4) 
CCl4 intoxication results in hepatocyte necrosis and apoptosis with damage 
predominantly in zone III (around central vein) of the liver.  
 The mechanism behind this hepatocyte damage is the activation of CCl4 by 
Cytochrome P450, which results in the formation of Trichioromethyl radical in these 
cells and this free radical initiates lipid peroxidation 
[73]
.The damage to hepatocytes by 
CCl4 is replicated by high plasma Alanine  transaminase (ALT) and Aspartate 
transminase (AST) levels after CCl4  administration.   
  CCl4 causes also fatty changes in the hepatocytes.  This initial damage is 
followed by hepatic stellate cell activation and tissue fibrosis.The CCl4 model is 
related with tremendous inflammation, a feature that is also often seen in livers of 
patients with liver fibrosis. Disadvantages of this model are the variations obtained in 
disease induction in the animals and the relatively high rate of mortality alter CCl4 
administration > 20%. 
 In animal models CCl4 treatment is used to get different stages of the fibrotic 
process, ranging from early damage and HSC activation until advanced cirrhosis.  The 
fibrotic stage obtained in the rodents depends on the number of injections of CCl4 that 
are administered.   
The models for CCI4 that are used in liver fibrosis research, are (1) acute 
damage (72 hours after a single injection of CCI4) with HSC activation (2) early and 
establish fibrosis (4-6 week of twice weekly CCl4 dosing),  (3) early cirrhosis (8 week 
of twice weekly CCl4dosing)  and (4) advanced micronodular cirrhosis (12 week of 
twice weekly CCl4dosing). In addition for each of these models (5) spontaneous 
recovery from fibrosis can be studied after cessation of dosing of CCl4.  This latter 
model is a valuable model to determine drug induced acceleration of recovery from 
established fibrosis after removal of the inciting stimulus.  This is similar to treatment 
situations in patients with liver fibrosis in case their inciting stimulus can be 
eradicated for instance after alcohol abstinence or after antiviral therapy beside 
hepatitis virus infections. 
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 CCl4 is administered to the animals via intraperitoneal, subcutaneous or oral 
administration or by inhalation.  For intraperitoneal injections, CCl4 is diluted in olive 
oil and given indosages of 0.5 - 1.0 ml / kg to rats and mice.  
 Often supplementation of phenobarbital in drinking water (resulting in 
induction of hepatocyte Cytochrome P450) is used to get more reproducible fibrosis 
improvement and to accelerate the speed of fibrosis development.  
 Usually, phenobarbital concentrations of 0.3 - 0.4 g/I in drinking water are 
used and started I week before the initial exposure to CCl4. 
In case of inhalation of CCl4 the animals are placed in an inhalation chamber 
twice a week with a progressively increasing exposure time (1.5 min).  Also with this 
procedure, supplementary phenobarbital in drinking water is added.  
To reduce early toxicity and mortality, some research groups vary with the 
dose of CCl4 in time.  In these cases, gradually growing dosages in the first weeks are 
administered to the rats. 
Bile Duct Ligation (BDL)  
The second well-studied experimental animal model of liver fibrosis is the bile 
duct ligation model.This model corresponds with the human pathology of 
biliarycirrhosis, such as extrhepatic biliary atresia and primary sclersoing cholangitis.  
 Ligation of the bile duct causes acute epithelial impairment and the detergent 
action of the subsequently released bile salts in the liver is likely associated with the 
solubilization of plasma membranes and hepatocyte cell death.  This latter is 
envisaged by elevated ALT and AST levels in plasma, in particular proximately after 
ligation (first week).  
 Characteristics of obstruction of the bile are the appearance of bile products, 
such as bilirubin into the blood circulation, which causes jaundice in these animals
[74]
. 
 The initial damage is followed by a massive expansion of the bile duct 
epithelial cells and periductal my fibroblasts, which can be referred to as portal 
expansion (stage 1) In total this results in marked liver enlargement, which can be up 
to twice the weight as compared to normal.  Then, bile duct epithelial cells and my 
fibroblasts in the portal tract are increasingly expanding which results in a gradual 
remodelling of the liver architecture by linking adjacent portal tracts (biliary cirrhosis 
stage IV). 
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 To ligate the bile duct, the abdomen of the rat is opened under general 
anesthesia (preferably N2O/O2/halothane inhalation to agree quick recovery from 
narcosis) to identify the common bile duct.   
The bile duct turns from the helium of the liver, where the hepatic ducts meet, 
through the pancreas, into the lower end of the duodenum.  Of note, threat has no gall 
bladder in contrast to other rodents.   
Three ligatures are located and tied around the bile duct; two close to the liver 
and one close to the duodenum. The first ligatures will prevent formation of a 
reservoir of bile outside the liver.   
After tight closure, the bile duct is cut between the second and third ligation in 
order to prevent restoration of the bile flow by bile duct formation around the ligature.  
Subsequently, the abdomen is closed over and analgesics can be given to the rats. 
We use a local anaesthetic compound (Marcaine which contains bupivacaine), 
but also systemic acting analgesics are sometimes administered (e.g. Temgesic 
(containing buprenorphine) For mice, the procedure is a little bit more complicated 
because a mouse possesses a gall bladder, and consideration should be paid to tightly 
ligate the whole duct, in general more than three ligatures are needed, to prevent 
rupture of the bladder and subsequent problems. 
 Already in the first days after ligation, proliferation of bile duct epithelial 
cells, activation and proliferation of HSC and my fibroblasts, and deposition of extra 
cellular matrix can be detected microscopically starting in the portal areas of the liver 
(zone 3).  After one week, a fibrous expansion of the portal areas is visible and after 
about 10-14 days, portal- portal bridging is visible. 
   Three to four weeks after ligation, these rates develop advanced cirrhosis 
characterized by extensive proliferation of the bile ducts, around which the activated 
and transformed HSC are detectable (Markers: a - smooth muscle action and PDGF 
beta receptor) and around which the interstitial collagens (types I and III) are 
deposited. 
 A major advantage of the BDL   model is the relatively fast development of 
fibrosis (within 3 weeks) in rats. Furthermore, the model is quite reproducible, and the 
mortality due to the ligation procedure in rats is low (<10%).  Disadvantages of the 
BDL models are the limited inflammation associated with this type of fibrosis 
development and the excessive expansion of bile duct epithelial cells.   
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            Another drawback with regard to drug screening is that the BDL-induced 
disease is difficult to reverse with experimental drugs, and a reason for this may be 
because the initiating stimulus (ligation of the bile duct) remains present during 
treatment periods and causes continuous damage as subsequent fibrosis that troubles 
the potential treatment effects. 
Dimethylnitrosamine (DMN): 
DMN induces liver damage leading to fibrosis and cirrhosis.  Characteristic 
for this model is that ongoing administration of this toxic compound finally leads to 
the development of hepatocellular carcinoma in rodents.  DMN induces liver injury 
by starting damage to the hepatocyte.  It is metabolized primarily in hepatocytes by 
Cytochroom P450 (isotype 2E1) to  more toxic compounds with formation of reactive 
oxygen species in hepatocytes and sub-sequent this will lead to lipid peroxidation.  In 
difference to the hepatotoxin CC14 DMN administration does not cause fatty changes, 
steatosis in the hepatocytes
[75]
.  To induce the fibrosis, DMN (10 microliter/kg body 
wt., i.p) is given 3 days a week for 3 weeks to rats. 
 After administration of DMN, hemorrhagic necrosis is evident in centrolobular 
part (zone III) of the liver.  Incomplete septa appear after 7 days and micronodular 
cirrhosis is developed after 3 weeks of treatment with DMN.  Increased numbers of 
HSC and my fibroblasts are found in the formed septa.  Influx of inflammatory cells, 
mainly lymphocytes, is noted early in DMN - induced liver injury. 
 Advantages of this model are that the disease induction is quite reproducible in 
the animals, and this model is associated with a prominent inflammatory reaction.          
Furthermore, this model can be used to study the transition from cirrhosis to 
hepatocellular carcinoma, and the effect of drugs on this process. 
HSC in Culture (In Vitro System): 
 HSC are key players in fibrosis and these cells predominantly orchestrate the 
development of the disease.  To evaluate the ant fibrotic efficacy of experimental 
drugs, these primary cultured cells are useful in assessing specific effects on HSC 
activities.  In particular, the primary isolated HSC are valuable in drug research, 
because in vitro they spontaneously transform into my fibroblasts, and this 
transformation process sis related with cellular activation proliferation and matrix 
production resembling cellular activities that also happen in vivo.  
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           This transformation does not occur in the various HSC cell lines that are also 
used in literature.  Proximately after isolation they signify a inactive stage, e.g. as 
present in the normal healthy liver, with vitamin A droplets as their main 
characteristic.  
         During culture on plastic for about 10-14 days a cell with my fibroblast -like 
features is attained. This transformed cell displays different cellular activities as 
compared to the original isolated one. 
The procedure to isolate HSC is well described by various fibrosis research 
groups Briefly, HSC are isolated from livers of normal rats weighing at least 500g in 
order to achieve a good separation from the other hepatic cells.  The liver is digested 
with pronase, collagenase and DNase by in situ perfusion. Pronase is essential in the 
isolation, yet it affects the viability of other hepatic cells (i.e. hepatocytes) and 
therefore this procedure can only be used isolate HSC from the liver.   
After several centrifuge steps, the cells suspension is subjected to a Nycodenz 
gradient to gather the HSC on top of the Nycodenz layer.  The separation is based on 
the low density of the HSC as compared to other liver cells, as a consequence of their 
high cellular lipid content.  Instead of Nycodenz, also other compounds are used e.g 
Stractan, Metrizamide, or Percoll, to separate the HSC from the other cells by density 
gradients. 
 The yield of HSC after collagenase / pronase digestion and Nycoeenz 
separation is about 20-40 x 10E6 cells per rat liver.  The yield of HSC attained from a 
mouse liver is much smaller and to isolate and purify proper amounts of HSC, about 5 
mice have to be used at the same time in one total isolation (Geerts, personal 
communication) 
           The purity after isolation can be established by phase contrast microscopy or 
by staining of the cells with markers for hepatic cell types.  The isolated cells are 
cultured in DMEM containing 10% FCS 100 U/ml penicillin, and 100 ug/ml 
streptomycin. 
             After 10-14 days in culture, the cells exhibition an activated phenotype as 
assessed by light microscopy and acquires the presence of alpha-smooth muscle 
action.Additionally, it is also conceivable to isolate HSC from human livers.Often 
(parts of) human livers are used that are unbecoming for transplantation or are derived 
from tumor-free parts of the human liver and separated after partial hepatectomy.  
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 Roughly, two methods are used to isolate human stellate cells :   
 Out-growth of the cells by culturing small pieces of the livers in medium 
 A combined digestion with collagenase / pronase, after which HSC were 
separated from other liver nonparenchymal cells by centrifugation over 
density gradients similar to threat procedure. 
The first method will yield a combination of various (myo) fibroblastic cells 
including HSC and myofibroblsts.  These cells are afterward cultured in DMEM< 
supplemented with 5% Fetal Calf Serum and 5% G Human Serum.  
The fibroblastic nature of the cells can be microscopically evaluated, and 
tested for the expression of a smooth muscle acting. 
Liver Slice System 
A second in vitro test system which was recently developed to assess effects 
of ant fibrotic drugs is the liver slice preparation. Drug studies with tissue slices (8mm 
diameter, 250 un thickness that is about 10-12 cell-layers thick) comprising stellate 
cells in their natural environment that uphold there in vivo cellular functional and 
anatomic relationships, may provide additional information about the hepatocellular 
specificity of the experimental drug and their effects on all hepatic cells. 
Hepatoprotective and antioxidant effects of tender coconut water (TCW) were 
examined in carbon tetrachloride (CCl4)-intoxicated female rats. Liver damage was 
showed by the increased levels of serum glutamate oxaloacetate transaminase 
(SGOT), serum glutamate pyruvate transaminase (SGPT) and decreased levels of 
serum proteins and by histopathological studies in CCl4 intoxicated rats.  
Augmented lipid peroxidation was presented by elevated levels of 
thiobarbituric acid reactive substance (TBARS) viz, malondialdehyde (MDA), 
hydroperoxides (HP) and conjugated dienes (CD), and also by significant reduction in 
antioxidant enzymes activities, such as superoxide dismutase (SOD), catalase (CAT) 
and also reduced glutathione (GSH) content in liver.  
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Darkening of urine On the other hand, CCl4 intoxicated rats treated with TCW 
retained almost normal levels of these constituents. Decreased activities of antioxidant 
enzymes in CCl4 intoxicated rats and their reversal of antioxidant enzyme activities in 
TCW treated rats, shows the effectiveness of TCW in combating CCl4 induced 
oxidative stress. Hepatoprotective outcome of TCW is also evidenced from the 
histopathological studies of liver, which did not show any fatty infiltration or necrosis, 
as observed in CCl4 intoxicated rats
 
.  
 
 
3.7.LATERAL RESEARCH  
Plumbago zeylanica 
  The root of Plumbago zeylanica and its constituents are cradited with potential 
therapeutic properties and including Anti-artherogenic, Cardiotonic, Hepatoprotective 
and Neuro protective properties.  
Anti-oxidant effects of the aqueous /alcoholic extracts of root corresponding to 
medicinal preparations and the active ingredients plumbagin, were studied methods 
used included : Ferric reducing /Anti – Oxidant power(FRAP) radical scavenging 
DPPH and 2,2`-azobis-3-ethylbenzthiazoline-6-sulfonic acid (ABTS), lipid 
peroxidation in rat liver mitochondria induced by different agents and estimating  
phenolic and flavanoid content
[76]
. 
Zingiber officinale 
The main pharmacological actions of ginger (Zingiber officinale) and 
compounds isolated there from include immuno-modulatory, Anti-tumerogenic, Anti-
inflammatory, Anti-appoptotic, Anti-hyperglycemic, Antilipidemic and Anti- emetic.    
Ginger is a strong Anti-oxidant substance and may either mitigatic or prevents 
generation of free radicals. 
 
Santalum album 
Over 100 constituents have been identified in Santalum album (Sandalwood 
oil) with major constituent being α-Santalol. Sandal wood oil was mutagenic in spore 
Rec assay and was found to have Anti-Carcinogenic, Anti-viral and bactericidal 
activity
 [78]
. 
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Myristica fragrans 
The effect of the hydro alcoholic extracts of fruits of Myristica fragrans was 
investigated on chlorpromazine - induced glucose and triglyceride elevation in male 
swiss albino mice
 [79]
. 
Syzygium aromaticum 
Syzygium aromaticum (cloves) having Anti-septic, Anti-bacterial, Anti-fungal 
and Anti-viral properties. One of the main constituents of clove oil (Eugenol) exhibits 
broad Anti-microbial activities against Gram - positive and Gram-negative and acid-
fact bacteria as well as fungi. Cloves are well known also for their Anti-emetic and 
Carminative properties
 [80]
. 
Elettaria cardamomum 
Elettaria cardamomum compares the effect of different extraction solvent 
used (chloroform, methanol, ethanol, diethyl ether) and Anti-oxidant, Anti- microbial 
activities of the essential oil oleoresins(Elettaria cardamomum) of seeds and pods
[81]
. 
Bambusa arundinaceae 
Antiarthritic activity of bamboo in treating rheumatoid arthritis using CFA 
induced arthritis animal model was investigated. The methanolic extract of bamboo 
significantly decreased the bone erosion, Spleen enlargement, rheumatoid factor at a 
dose of 100, 200, 300mg/kg compared to the control group
 [82]. 
Piper nigrum 
  The extracts of black pepper were evaluated for antibacterial activity 
by Disc diffusion method. The results indicate inhibition on the growth of gram 
positive bacilli like Staphylococcus aureus, Bacillus cereus, Staphylococcus faecalis 
and gram negative bacilli like Pseudomonas aeruginosa, Salmonella typhi and 
E.coli
[83]
. 
Earlier Studies on Hepatoprotective  
Hydro alcoholic extract of tubers of Momordica tuberosa was subjected to 
preliminary phytochemical screening and assessed for in vitro and in vivo antioxidant 
and hepatoprotective action against CCl4 induced liver damage in rats.  
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Pre-treatment with 70% ethanolic extract of M. tuberosa reversed CCl4 
induced elevation of levels of serum biomarkers to near normal levels, suggesting that 
the tubers of M. tuberosa possess hepatoprotective property and this property may be 
attributed to the antioxidant property of the plant
 [84]
.  
Hepatoprotective and antioxidant effects of tender coconut water (TCW) were 
examined in carbon tetrachloride (CCl4)-intoxicated female rats.  
Liver damage was showed by the increased levels of serum glutamate 
oxaloacetate transaminase (SGOT), serum glutamate pyruvate transaminase (SGPT) 
and decreased levels of serum proteins and by histopathological studies in CCl4 
intoxicated rats.  
Augmented lipid peroxidation was presented by elevated levels of 
thiobarbituric acid reactive substance (TBARS) viz, malondialdehyde (MDA), 
hydroperoxides (HP) and conjugated dienes (CD), and also by significant reduction in 
antioxidant enzymes activities, such as superoxide dismutase (SOD), catalase (CAT) 
and also reduced glutathione (GSH) content in liver. 
On the other hand, CCl4 intoxicated rats treated with TCW retained almost 
normal levels of these constituents. Decreased activities of antioxidant enzymes in 
CCl4 intoxicated rats and their reversal of antioxidant enzyme activities in TCW 
treated rats, shows the effectiveness of TCW in combating CCl4 induced oxidative 
stress.  
Hepatoprotective outcome of TCW is also evidenced from the 
histopathological studies of liver, which did not show any fatty infiltration or necrosis, 
as observed in CCl4 intoxicated rats
 [85]
.  
Laboratory Tests 
 Abdominal ultrasound  
 Autoimmune blood markers  
 Hepatitis virus serologists 
 Liver function tests  
 Liver biopsy to check for liver destruction 
 Paracentesis if fluid is in abdomen  
 Tests for Liver Function  
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Bilirubin:  
Bilirubin is one of the most important factors indicative of hepatitis. It is a red-
yellow pigment that is normally metabolized in the liver and then defecated in the 
urine.  
In patients with hepatitis, the liver cannot process bilirubin, and blood levels 
of this substance rise. High levels of bilirubin cause the yellowish skin tone known as 
jaundice. 
Liver Enzymes (Aminotransferases):  
Enzymes known as aminotransferases, including aspartate (AST) and alanine 
(ALT), are free when the liver is damaged. Measurements of these enzymes, 
particularly ALT, are the least expensive and most non-invasive tests for determining 
sternness of the underlying liver disease and monitoring treatment effectiveness.  
Enzyme levels vary, however, and are not always an accurate indicator of 
disease activity. Alkaline Phosphatase (ALP): 
 High ALP levels can indicate bile duct blockage. GGT (gamma glut amyl 
transpeptidase) is often elevated in those who use alcohol or other liver-toxic 
substances to excess. 
Serum Albumin:  
Serum albumin measures protein in the blood (low levels indicate poor liver 
function). Total protein.Serum total protein events protein in the blood (low levels 
indicate poor liver function).  
Prothrombin Time (PT):  
The PT test measures in seconds the time it takes for blood clots to form (the 
longer it takes the greater the risk for bleeding
 [86]
. 
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4. MATERIALS AND METHODS 
 Drug selection 
In this dissertation purified and prepared “Siringipaerathi Chooranam” was taken as 
a trial drug for Hepatoprotective activity from the Siddha literature “Sarabendra 
Vaidhiya Muraigal”. Soolai, Moola, Kusta, Pitharoga Muraigal, page no: 194-195. 
 
Table: 3 Ingredients 
 NAME OF DRUGS BOTANICAL NAME QUANTITY  
Inji  Zingiber officinalis 560 gm (16 palam) 
Milagu   Piper nigrum 50.4 gm (12 varahan) 
Thippili  Piper longum 33.6gm(8 varahan) 
Thipili moolam Piper longum 16.8 gm(4 varahan) 
Lavanga pathiri Cinnamomum tamala 35 gm(1 palam) 
Elam  Elettaria cardamomum 42 gm (10 varahan) 
Kodiveli ver Plumbago zeylanica 42 gm (10 varahan) 
Lavanga pattai Cinnamomum zeylanicum 35 gm (1 palam) 
Moongil uppu Bambusa arundinaceae 35 gm (1 palam) 
Sandhana thool Santalum album 35 gm (1 palam) 
Vilamichu-ver Plectranthus vettiveroides 35 gm (1 palam) 
Sathikkai  Myristica fragrans 35 gm (1 palam) 
Seeragam  Cuminum cyminum 35 gm (1 palam) 
Kirambu  Syzygium aromaticum 35 gm (1 palam) 
Sugar  Saccharum officinarum  Equal quantity                
Nei English Name : Ghee Sufficient quantity 
 
Collection of the Plant materials 
All the raw materials were bought from the Ramasamy Mudhaliyar Store, Parry’s 
corner, Chennai. 
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Identification and Authentication of the drug 
All the plant materials were identified and authenticated by the Botanists and 
Gunapadam experts in Government Siddha Medical College, Arumbakkam, and 
Chennai-106. The specimen sample of all the herbs have been preserved in PG 
Gunapadam department individually for future reference. 
Purification of the drugs 
All the drugs mentioned here were purified as per the Siddha literature
 [87]
. 
Inji   -  Outer skin of ginger was peeled off. 
                
Milagu   - It was soaked in sour buttermilk for 3 hours and allowed to dry 
 
Thippili  -  Soaked in lemon juice and allowed to dry. 
     
Thippilimoolam -  Remove the nodules and dried. 
                 
Lavangapathiri  -  Dried in sun light. 
 
Elam   -  Roasted in the pan and outer skin was removed.  
 
Kodiveli-ver   -  The root was cleaned with a white cloth.   
      
Lavangapattai   -  Dried in sun light. 
  
Sandhana kattai  -  The skin was peeled off to get purified and powdered  
 
Vilamichu-ver  -  The root was cleaned with a white cloth. 
     
Sathikkai     -  Cleaned and cut into small pieces and dried. 
 
Seeragam    -  Clean the dust particles and allowed it to dry. 
 
Kirambu   -  Flower buds were removed.  
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4.1. Preparation of the Drug 
Procedure 
             In order to obtain the purified form of ginger, the upper skin of ginger was 
peeled off and then sliced into small pieces. The sliced pieces were dried in sunshade 
for two days. After complete drying 560 grams of dried ginger was taken and fried 
well in ghee and then powered.    
            50.4 grams of Purified Pepper, 33.6 grams of Thippili, 16.8 grams of 
Thipplimoolam, 42 grams of Kodiveli-ver, 35 grams of Moongil uppu, 
Lavangapathiri, Sandhana thool, Vilamichu-ver, Lavanga Pattai, Adhikari, 
Seeragam, Kirambu were taken and powered separately then mixed together with 
processed ginger powder. 
           Finally, the mixture was ground well which favors the homogenous 
preparation. Then the mixture powder was sieved through the thin clean white cloth. 
After that twice the weight of   sugar was added to the mixture and again it was 
ground well. 
           Finally, the end product was obtained, which was kept in an air tight container 
and labeled as “Siringipaerathi Chooranam” (SPC). 
Purification of the Chooranam: steaming process (Pittaviyal murai) 
The “Siringipaerathi Chooranam” was purified by pittaviyal method (steam 
cooking in milk) as per Siddha classical literature. A mud pot was taken and it was 
half filled by milk and mixed with equal quantity of pure water. The mouth of the pot 
was sealed by a cloth. This chooranam was placed over a clean dry cloth and tied 
firmly around the mouth of mud pot. The gap between mud pots was tied with a wet 
cloth to avoid evopration.The mud pot was kept on fire and boiled until the cow’s 
milk reduced in the lower pot. 
The same drug was later dried and powdered then sieved again. It was used for 
the further study
 [88]
. 
Storage of the drug 
The prepared test drug was stored in a clean, air tight glass container.  
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Administration of the drug 
Form of the medicine  : Chooranam 
 Route of Administration : Enteral 
 Dose    : 2 gm twice a day depending on the severity 
Adjuvant     : honey 
Indication: 
            Kamaalai, Marbuvali, Kirani, Suram, Vaanthi, Peenisam.  
Fig: 1 Ingredients of Siringipaerathi Chooranam 
     
     Fig: 1.1 Zingiber officinalis             Fig: 1.2 Zingiber officinalis (cut into pieces)    
         
       Fig: 1.3 Fried Zingiber officinalis  Fig: 1.4 Piper nigrum 
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             Fig: 1.5 Piper longum      Fig: 1.6 Piper longum   
            
      Fig: 1.7 Cinnamomum tamala    Fig: 1.8 Elettaria cardamomum 
            
       Fig: 1.9 Plumbago zeylanica         Fig: 1.10 Cinnamomum zeylanicum 
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        Fig: 1.11 Bambusa arundinaceae                   Fig: 1.12 Santalum album 
        
       Fig: 1.13 Plectranthus vettiveroides                    Fig: 1.14 Myristica fragrans 
                     
Fig: 1.15 Cuminum cyminum                   Fig: 1.16    Syzygium aromaticum 
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Fig: 1.17 Ghee 
 
      Final Product (Siringipaerathi Chooranam) 
4.2. STANDARDIZATION OF THE DRUG 
Standardization of the drug brings the validation to be used as a medicine by 
subjecting the drug to many analysis and determining its quality and effectiveness. 
Standardization includes many studies such as its organoleptic properties, physical 
characteristics and phytochemical properties and also to assess the active principles 
and elements present in the drug. Thus standardization brings the efficacy and 
potency of the drug. 
4.2.1. Organoleptic character 
 The organoleptic characters of the sample drug were evaluated. 1gm of the test 
drug was taken and the color, texture, particle size and other morphology were viewed 
by naked eye under sunlight. Then the result was noted. 
 
MATERIALS AND METHODS 
 
 
HEPATOPROTECTIVE  ACTIVITY OF SIRINGIPAERATHI CHOORANAM 94 
 
 
4.2.2 PHYSICOCHEMICAL ANALYSIS 
 Physicochemical studies of the trial drug have been done
 [89]
.  
Determination of Ash Values 
 Total Ash 
3g of the test drug was accurately weighed and incinerated in a crucible dish at 
a temperature not exceeding 450
o
C until it was free from carbon. It was then cooled 
and weighed. The % w/w of ash with reference to the air-dried powder was 
calculated. 
Water Soluble Ash 
The total ash was obtained as the above method for preparation of total ash. 
The ash was boiled with 25ml of water for 5mins. The insoluble ashes were collected 
using filter paper. It was then washed with hot water and transferred to the silica 
crucible. It was then ignited for 15minutes at temperature not exceeding 450
o
C. For 
determination of weight of the water soluble ash the silica crucible and residue were 
weighed until constant weight was attained. The weight of the water soluble ash was 
determined by subtracting the weight of insoluble ash from the weight of total ash. 
Acid insoluble Ash 
The total ash was obtained as the above method for preparation of total ash. 
The ash was boiled for 5minutes with 25ml 10% Hcl. The insoluble ashes were 
collected using filter paper and washed with hot water. It was then transferred to the 
silica crucible and ignited for 15minutes at temperature not exceeding 450
o
C. The 
silica crucible and residue were weighed until constant weight was attained. 
Determination of Extractive Value 
 Alcohol Soluble Extractive Value 
3g of test drug powder was weighed and macerated with 100ml of ethanol in a 
closed container for 24 hours. The resulting solution was shaken continuously for 6 
hours. It was then allowed to stand and soak for 18 hours.  
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The solution was filtered and evaporated of the filtrate in a flat bottomed 
shallow dish and dried at 105
o
C. Then the content was cooled and weighed. 
Water soluble Extractive value 
3g of test drug powder was weighed and macerated with chloroform and 
water, respectively, at 80
o
C for 24 hrs. The resulting solution was shaken 
continuously for 6 hours and allowed to stand and soak for 24hrs then filtered. The 
solution from both chloroform and water respectively was filtered and evaporated of 
the filtrate in a flat bottomed shallow dish. It was dried at 105
o
C then cooled and 
weighed. 
Loss on Drying 
The powdered drug was taken and dried in the oven at 100- 105°C to constant 
weight. The result was noted.  
Physical characterization 
Solubility: A little of the sample was shaken well with distilled water. . A 
little of the sample was shaken well with con Hcl and Con H2SO4. Sparingly soluble 
character indicates the presence of Silicate. 
pH value: Potentiometrically pH value was determined by a glass electrode 
and a suitable pH meter. 
Action on heat: A small amount of the sample was taken in a dry test tube 
and heated gently. If there was a strong white fumes evolving it indicates the presence 
of Carbonate. 
Flame test: A small amount of the sample was made into a paste with con.Hcl 
in a watch glass. It was then introduced into non-luminous part of the Bunsen flame. 
Appearance of bluish green flame indicates the presence of Copper. 
Ash Test: A filter paper was soaked into a mixture of sample and cobalt 
nitrate solution. It was then introduced into the Bunsen flame and ignited. Appearance 
of yellow colour flame indicates the presence of Sodium. 
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4.2.3. PHYTOCHEMICAL ANALYSIS 
The Phytochemical screening of the extract gives general idea regarding the 
nature of chemical constituents present in the crude drug. The phytochemical tests 
were done as the method illustrated
 [90]
.  
Test for Alkaloids 
A small portion of solvent free extracts were stirred separately with few drops 
of dilute hydrochloric acid and filtered & tested carefully with various alkaloidal 
reagents. 
Mayer’s reagent  - Cream precipitate 
Dragendroff’s reagent - Orange brown precipitate 
Hager’s reagent  - Yellow precipitate 
Wagner’s reagent  - Reddish brown precipitate 
Test for Carbohydrates and Reducing Sugars 
The minimum amount of extracts were dissolved in 5ml of distilled water & 
filtered. The filtrate was subjected to test for carbohydrates & glycosides. 
a) Molisch’s test 
The filtrate 1 ml was treated with 2-3 drops of 1% alcoholic alpha naphthol & 
2ml concentrated sulphuric acid was added along the sides of test tube. Violet ring 
was observed at the junction of 2 layers which showed the presence of carbohydrate. 
b) Benedict’s test 
The filtrate 1 ml was treated with Benedict’s reagent and heated gently. 
Orange red precipitate indicates the presence of reducing sugars. 
c) Fehling’s test 
The filtrate 1 ml was treated with equal volume of Fehling’s solution A and B 
and heated gently. Orange red precipitate indicates the presence of reducing sugars. 
Test for Glycosides 
The extract was hydrolyzed with dil. HCl and subjected to test for glycosides. 
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a) Modified Borntrager’s test 
To the hydrolysate extract, 1 ml of Ferric chloride solution was added and 
immersed in boiling water for about 5 min. The mixture was cooled and extracted 
with equal volume of benzene. The benzene layer was separated and treated with 
ammonia solution. Formation of rose pink colour in the ammoniacal layer indicates 
the presence of Anthranol glycosides. 
b) Legal’s test 
The hydrolysate extract was treated with Sodium nitropruside in pyridine and 
sodium hydroxide. Formation of pink to blood red colour indicates the presence of 
Cardiac glycosides.  
Test for Saponins 
The extract 0.5 ml was shaken with 5 ml distilled water. The presence of 
saponins was indicated by formation of copious lather. 
Test for Tannins 
Gelatin test 
To the extract, 1% gelatin solution containing sodium chloride was added. 
Formation of white precipitate indicates the presence of tannins. 
Test for Phenolic compounds 
To 0.5 ml of extract, 1 ml of alcoholic ferric chloride solution was added. 
Formation of bluish green or bluish black indicates the presence of Phenolic 
compounds. 
Test for Phytosterols 
Ferric chloride – acetic acid test 
1 ml of extract was treated with 1 ml of chloroform and then, 2 ml of ferric 
chloride acetic acid reagent was added followed by 1 ml of conc. sulphuric acid. 
Appearance of reddish pink colour shows the presence of Phytosterols. 
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Test for Diterpenes 
Copper acetate test 
1 ml of extract was dissolved in water and treated with 3-4 drops of Copper 
acetate solution. Formation of emerald green colour indicates the presence of 
diterpenes. 
Test for Triterpenes 
Salkowski’s test 
1 ml of extract was treated with 1 ml of chloroform followed by 1 ml of conc. 
sulphuric acid, shaken and allowed to stand. Appearance of golden yellow colour 
shows the presence of Triterpenes. 
Test for Flavonoids 
a) Alkaline reagent test 
To 1 ml of extract, 1 ml of 10% sodium hydroxide solution was added. 
Formation of dark yellow colour indicates the presence of flavonoids. 
b) Lead acetate test 
To 1 ml of extract, 3-4 drops of 10% lead acetate solution was added. 
Formation of yellow precipitate indicates the presence of flavonoids. 
c) Ferric chloride test 
To 1 ml of extract, 3-4 drops of ferric chloride solution was added. Formation 
of dark green colour indicates the presence of flavonoids. 
d) Shinoda test 
To 1 ml of extract, few mg of magnesium turnings was added followed by few 
drops of conc. hydrochloric acid and boiled for five minutes in a boiling water bath. 
Formation of red colour indicates the presence of flavonoids. 
Test for Proteins and Free Amino Acids 
a) Xanthoproteic test 
To 1 ml of extract, 3-4 drops of conc. nitric acid was added. Formation of 
yellow precipitate indicates the presence of proteins. 
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b) Million’s test 
To 0.5 ml of extract, 2.5 ml of Million’s reagent was added. Formation of 
white precipitate and the precipitate warmed indicates the presence of proteins. 
c) Biuret test 
 To 0.5 ml of extract, 2.5 ml of diluted Biuret reagent was added.  Appearance 
of purple colour or brick red precipitate showed the presence of proteins and free 
amino acids. 
Test for Quinones 
Sodium hydroxide test 
To 0.5 ml of extract, 1 ml of 10% sodium hydroxide was added.  Appearance 
of blue or green or red colour shows the presence of quinones. 
TLC/ HPTLC finger print studies  
HPTLC finger printing was carried out as per the reference.
 [91] 
Preparation of spray reagent-vanillin-sulphuric acid reagent 
Vanillin (1g) was dissolved in ice cold ethanol (95ml).  Add to 5ml of 
cooled concentrated sulphuric acid. Ice was added and stirred well. The solution 
was stored in refrigerator.   
Chromatographic conditions  
Instrument    : CAMAG (Switzerland). 
Sample Applicator   : Camag Linomat - IV applicator with N2 gas flow. 
Photo documentation System : Digi store - 2 documentation system with Win Cat 
  & video scan software. 
Scanner   : Camag HPTLC scanner - 3 (030618), Win Cats - IV. 
Development Chamber  : Camag HPTLC 10X10, 10 X 20 twin trough linear 
   development chamber. 
 
Quantity applied  : 5, 10 µl for extracts and 5 µl for standards 
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Stationary phase  : Aluminium plate pre-coated with silica gel 60  
    (E. Merck) 
Plate thickness   : 0.2 mm. 
Mobile Phase : For Chloroform extract - Toluene: Ethyl acetate (9:1) 
and ethanol extract - Toluene: Ethyl acetate (1:1).   
Scanning wavelength  : 254 nm 
Laboratory condition  : 26 ± 5
o
C and 53 % relative humidity 
The plate was developed up to a height of 8 cm, air dried, spots were observed 
under the UV light at 254 and 366 nm. Finally the plates were derivatized using 
vanillin-sulphuric acid reagent heated at 105° till colour spots appeared.  
4.2.4. BIO-CHEMICAL ANALYSIS 
Preliminary Basic and Acidic radical studies  
Preparation of extract 
              10g of sample was taken in a 250 ml of clean beaker and 50 ml of distilled 
water was added to it. Then it was boiled well for about 10 mins. Then it was allowed 
to cool and filtered in a 100 ml volumetric flask and made up to 100 ml with distilled 
water. This preparation was used for the qualitative analysis of acidic/ basic radicals 
and biochemical constituents in it.  
Test for Basic radicals 
1. Test for Potassium 
 To a pinch of the SPC 2 ml of sodium nitrate and 2 ml of cobalt nitrate 
solution in 30% glacial acetic acid was added and observed for the presence of yellow 
precipitate. 
2. Test for Calcium 
To 2 ml of SPC extract, 2 ml of 4% ammonium oxide solution was added and 
observed for the formation of white precipitate. 
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3. Test for Magnesium: 
To 2ml of SPC extract, drops of sodium hydroxide solution was added and 
watched for the appearance of white precipitate. 
4. Test for Ammonium: 
To 2ml of SPC extract few ml of Nessler's reagent and excess of sodium 
hydroxide solution are added for the appearance of brown colour. 
5. Test for Sodium 
Hydrochloric acid was added with a pinch of the SPC, made as paste and 
introduced into the blue flame of Bunsen burner and observed for the appearance of 
intense yellow colour.  
6. Test for Iron (Ferrous) 
The SPC extract was treated with Conc. HNO3 and ammonium thiocyanate 
and waited for the appearance of blood red colour.   
7. Test for Zinc 
To 2 ml of the SPC extract drops of sodium hydroxide solution was added and 
observed for white precipitate formation.  
8. Test for Aluminium 
To the 2m1 of the SPC extract sodium hydroxide was added in drops and 
changes are noted for white precipitate formation. 
9. Test for Lead 
To 2 ml of SPC extract 2ml of potassium iodide solution was added and noted 
for yellow colored precipitate.  
10. Test for Copper 
a. A pinch of SPC was made into a paste with con. Hcl in a watch glass and 
introduced into the non-luminous part of the flame and noted for blue color 
appearance. 
b. To 2 ml of SPC extract excess of ammonia solution was added and 
observed for the appearance of blue coloured precipitate.  
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11. Test for Mercury 
 To 2m1 of the SPC extract sodium hydroxide solution was added and noted 
for yellow precipitate formation.  
12. Test for Arsenic   
 To 2 ml of the SPC extract 2ml of sodium hydroxide solution was added and 
brown or red precipitate formation was noted.  
Test for acid radicals 
1. Test for Sulphate 
 To   2 ml of the SPC extract 5% of barium chloride solution was added and 
observed for the appearance of white precipitate.  
2. Test for Chloride 
 The SPC extract was treated with silver nitrate solution and observed for the 
appearance of white precipitate. 
3. Test for Phosphate 
         The SPC extract was treated with ammonium molybdate and conc. HNO3 and 
observed for the appearance of yellow precipitate. 
4. Test for Carbonate 
        The SPC extract was treated with conc.Hcl and observed forth appearance of 
effervescence. 
5. Test for Fluoride & Oxalate: 
To 2ml of SPC extract 2ml of dil.acetic acid and 2ml calcium chloride solution 
was added and heated and watched for cloudy appearance. 
6. Test for Nitrate: 
 To 1 gm of the SPC, copper turnings was added and again conc.H2SO4 was 
added, heated and the test tube was tilted vertically down  and observed for yellowish 
red color. 
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4.2.5. AVAILABILITY OF BACTERIAL LOAD: 
Enumeration of bacteria by plate count – Agar plating technique 
 The plate count technique was one of the most routinely used procedures 
because of the enumeration of viable cells by this method.
 [92]
  
Principle:  
 This method is based on the principle that when material containing bacteria 
are cultured, every viable bacterium develops into a visible colony on a nutrient agar 
medium. The number of colonies therefore is the same as the number of organisms 
contained in the sample. 
Dilution:  
 A small measured volume is mixed with a large volume of sterile water or 
saline called the diluents or dilution blank. Dilution is usually made in multiples of 
ten. A single dilution was calculated as follows: 
    Volume of the sample 
  Dilution =  
    Total volume of the sample and the diluents 
Requirements: 
 Sample or Bacterial suspension 
 9 ml dilution blanks (7) 
 Sterile petri dishes (12) 
 Sterile 1 ml pipettes(7) 
 Nutrient agar medium (200 ml) 
 Colony counter  
 
Procedure: 
1. Label the dilution blanks as 10-1, 10-2, 10-3, 10-4, 10-5, 10-6, and 10-7. 
2. Prepare the initial dilution by adding 1 ml of the sample into a 9 ml 
dilution blank labeled 10
-1
 thus diluting the original sample 10 times. 
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3. Mix the contents by rolling the tube back and forth between hands to 
obtain uniform distribution of organisms. 
4. From the first dilution transfer 1 ml of the suspension while in motion, to 
the dilution blank 10
-2
 with a sterile and fresh 1 ml pipette diluting the 
original specimen to 100 times. 
5. From the 10-2 suspension, transfer 1 ml of suspension to 10-3 dilution blank 
with a fresh sterile pipette, thus diluting the original sample to 1000 times. 
6. Repeat this procedure till the original sample has been diluted 10,000,000 
times using every time a fresh sterile pipette. 
7. From the appropriate dilutions transfer 1ml of suspension while in motion, 
with the respective pipettes, to sterile petri dishes. Three petri dishes are 
used for each dilution. 
8. Add approximately 15 ml of the nutrient medium, melted and cooled to 
45
0
c, to each petri dish containing the diluted sample. Mix the contents of 
each dish by rotating gently to distribute the cells throughout the medium. 
9. Allow the plates to solidity. 
10.  Incubate these plates in an inverted position for 24-48 hours at 370c. 
Observation: 
 Observe all the plates for the appearance of bacterial colonies. Count the 
number of colonies in the plates. 
 Calculate the number of bacteria per ml of the original suspension as follows: 
          
    Number of colonies (average of 3 replates) 
Organisms per millimeter =  
    Amount of plated × dilution 
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4.2.6. SOPHISTICATED INSTRUMENTAL ANALYSIS 
FT-IR (Fourier Transform Infra-Red) 
Fig: 2 FTIR (Fourier Transform Infrared Spectroscopy) 
 
Fig: 2.1 FTIR-INSTRUMENT 
 
                          Fig: 2.2 FTIR-MECHANISMS                                                                                    
Model   : Spectrum one: FT-IR Spectrometer 
Scan Range   :  MIR 450-4000 cm-1 
Resolution   :  1.0 cm-1 
Sample required :  50 mg, solid or liquid. 
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It is the preferred method of infrared spectroscopy. FT-IR is an important and 
more advanced technique. It is used to identify the functional group, to determine the 
quality and consistency of the sample material and can determine the amount of 
compounds present in the sample. It is an excellent tool for quantitative analysis.
 [93] 
In FT-IR infrared is passed from a source through a sample. This infrared is 
absorbed by the sample according to the chemical properties and some are 
transmitted. The spectrum that appears denotes the molecular absorption and 
transmission. It forms the molecular fingerprint of the sample. Like the finger print 
there is no two unique molecular structures producing the same infrared spectrum. It 
is recorded as the wavelength and the peaks seen in the spectrum indicates the amount 
of material present. 
FT-IR is the most advanced and the major advantage is its 
 Speed 
 Sensitivity 
 Mechanical Simplicity 
 Internally Calibrated 
Fig: 3 SEM (SCANNING ELECTRON MICROSCOPE) 
 
Fig: 3.1    SEM INSTRUMENT 
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Fig: 3.2 SEM MECHANISM 
               In scanning electron microscope high-energy electron beam was focused 
through a probe towards the sample material. Variety of signals was produced on 
interaction with the surface of the sample. This results in the emission of electrons or 
photons and it is collected by an appropriate detector.  
The types of signal produced by a scanning electron microscope include  
 Secondary electrons 
 back scattered electrons 
 characteristic x-rays, light 
 specimen current 
 Transmitted electrons. 
This gives the information about the sample and it includes external morphology, 
texture, its crystalline structure, chemical composition and it displays the shape of the 
sample
 [94]
. 
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Fig: 4 ICP-OES (INDUCTIVELY COUPLED PLASMA OPTIC EMISSION 
SPECTROMETRY) 
 
 
Fig: 4.1 ICP-OES ANALYSER (Perkin Elmer Optima 5300 DV) 
                                        
           
  
Fig: 4.2   Mechanism of ICP-OES analyzer 
 
Manufacturer: Perkin Elmer 
Model:  Optima 5300 DV ICP-OES Inductively Coupled Plasma 
Spectrometer (ICP) 
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Principle: 
An aqueous sample is converted to aerosols via a nebulizer. The aerosols are 
transported to the inductively coupled plasma which is a high temperature zone 
(8,000– 10,000ºC). The analysts are heated (excited) to different (atomic and/or ionic) 
states and produce characteristic optical emissions (lights).  
These releases are separated based on their respective wavelengths and their 
strengths are measured (spectrometry). The intensities are proportional to the 
concentrations of analyses in the aqueous sample. The quantification is an external 
multipoint linear standardization by comparing the emission intensity of an unknown 
sample with that of a standard sample. Multi-element calibration standard solutions 
are prepared from single- and multi element primary standard solutions. With respect 
to other kinds of analysis where chemical speciation is relevant (such as the 
concentration of ferrous iron or ferric iron), only total essential concentration is 
analyzed by ICP-OES. 
Application: 
The analysis of major and minor elements in solution samples. 
Objectives: 
 Determine elemental concentrations of different metals. 
 Learn principles and operation of the ICP-OES instrument 
 Develop and put on a method for the ICP-OES sample analysis 
 Enhance the instrumental conditions for the analysis of different elements 
 probes the outer electronic structure of atoms 
Mechanism:  
In plasma emission spectroscopy (OES), a sample solution is presented into 
the core of inductively coupled argon plasma (ICP), which generates temperature of 
approximately 8000°C. At this temperature all elements become thermally excited 
and emit light at their characteristic wavelengths. This light is collected by the 
spectrometer and passes through a diffraction grating that serves to resolve the light 
into a spectrum of its essential wavelengths. Within the spectrometer, this deflected 
light is then collected by wavelength and amplified to yield an strength of  
measurement that can be converted to an elemental concentration by comparison with 
standardization values. 
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The Inductively coupled plasma optical emission spectrometric (ICP-OES) 
analysis was done in SAIF, IIT MADRAS, and Chennai-36 using Perkin Elmer 
Optima 5300 DV
 [95]
. 
Sample preparation: 
Inductively Coupled Plasma Spectroscopy techniques are the so-called "wet" 
sampling methods whereby samples are introduced in liquid form for analysis. 
100 mg “Siringipaerathi Chooranam” was occupied in a clean, dry test tube. 
To this, 3 ml Nitric acid was added and mixed well and allowedfor few minutes untill 
the reactions were completed. And then, 25 ml of Refined water, was added to 
prepare digested solution.  
The digested sample solution was shifted into plastic containers and labeled 
properly. It was completed in Bio-chemistry lab, Govt. Siddha Medical College, 
Chennai-106. 
 
4.3. TOXICOLOGICAL STUDIES 
Introduction:  
The acute toxic class method is a stepwise procedure with the use of 3 animals 
of a single sex per step. Depending on the mortality and/or the moribund status of the 
animals, on average 2-4 steps may be necessary to allow judgment on the acute 
toxicity of the test substance. 
 
 Morbid animals or animals obviously in pain or showing signs of severe and 
enduring distress shall be humanely killed, and are considered in the interpretation of 
the test  results  in  the  same  way  as  animals  that  died  on  test.   
 
The method allows for the determination of an LD50 value only when at least 
two doses result in mortality higher than 0% and lower than 100%. 
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4.3.1. ACUTE ORAL TOXICITY – OECD GUIDELINES - 423  
Acute toxicity study was carried out as per OECD guideline. (Organization for 
Economic Co - operation and Development, Guideline-423
[96]
. 
The experimental protocol was approved by the institutional ethical committee 
(IAEC) under CPCSEA (approval no: IAEC/XLIV/31/CLBMCP/2014. 
Animal: Healthy Wistar albino female rat weighing 200–220 gm 
Studied carried out at three female rats under fasting condition, signs of 
toxicity was observed for every one hour for first 24 hours and every day for about 14 
days from the beginning of the study. 
Principle:  
It is the principle of the test that based on a stepwise procedure with the use of 
a minimum  number  of  animals  per  step,  sufficient  information  is  obtained  on  
the  acute toxicity  of  the  test  substance  to  enable  its  classification.  The substance 
is administered orally to a group of experimental animals at one of the defined doses.  
The substance is tested using a stepwise procedure, each step using three animals of a 
single sex. 
 Absence or presence of compound-related mortality of the animals dosed at 
one step will determine the next step, i.e.; − no further testing is needed − dosing of 
three additional animals with the same dose − dosing of three additional animals at the 
next higher or the next lower dose level. The method will enable a judgment with 
respect to classifying the test substance to one of a series of toxicity classes.   
 
METHODOLOGY   
Selection of animal species:  
The preferred rodent species was rat, although other rodent species may be 
used.   
Healthy young adult animals of commonly used laboratory strain Swiss albino 
rat were obtained from Animal house of king’s institute, Guindy, Chennai. Female 
should be nulliparous and non-pregnant.  
MATERIALS AND METHODS 
 
 
HEPATOPROTECTIVE  ACTIVITY OF SIRINGIPAERATHI CHOORANAM 112 
 
 Each animal at the commencement of its dosing should be between 8 and 12 
weeks old and its weight should fall in an interval within±20 % of the mean weight of 
the animals.  The studies were conducted in the animal house of C.L.Baid Metha 
College of pharmacy, Duraipakkam, Chennai. 
Housing and feeding conditions:   
  The  temperature  in  the  experimental  animal  room  should  be  22ºC  
(+3ºC). Although  the  relative  humidity  should  be  at  least  30%  and  preferably  
not  exceed  70% other than during room cleaning the aim should be 50-60%. 
Lighting should be artificial, the sequence being 12 hrs light, 12 hrs dark. For feeding, 
conventional laboratory diets may be used with an unlimited supply of drinking water. 
Animals may be grouped and tagged by dose, but the number of animals per cage 
must not interfere with clear observations of each animal.   
Preparation of animals:   
 The animals are randomly selected, marked to permit individual 
identification, and kept in their cages for at least 7 days prior to dosing to allow for 
acclimatization to the laboratory conditions. 
EXPERIMENT PROCEDURE: 
Administration of doses 
“Siringipaerathi Chooranam” prepared as per the classical Siddha literature 
was suspended in 2% CMC with uniform mixing and was administered to the groups 
of Wistar albino rats. 
It was given in a single oral dose by gavages using a feeding needle. Animals 
were fasted prior to dosing. Following the period of fasting, the animals were weighed 
and then the test substance was administered. After the substance has been 
administered, food was withheld for a further 3-4 hours.  
The principle of laboratory animal care was followed. Observations were 
made and recorded systematically and continuously observed as per the guideline 
after substance administration.  
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The visual observations included skin changes, mobility, and aggressiveness, 
sensitivity to sound and pain, as well as respiratory movements. They were deprived 
of food, but not water 16–18 h prior to the administration of the test suspension.  
Finally, the number of survivors was noted after 24 h and these animals were 
then maintained for a further 14 days and observations made daily. The toxicological 
effect was assessed on the basis of mortality.  
Number of animals and dose levels 
Since this test drug has been under practice for long time and likely to be non-
toxic, a limit test at one dose level of 2000 mg/kg body weight will be carried out with 
6 animals   (3 animals per step). 
Duration of Study                            :   48 hrs 
Evaluation                                        :   14 Days 
Limit test 
 The limit test was primarily used in situations where the experimenter has 
information indicating that the test material is likely to be nontoxic, i.e., having 
toxicity only above regulatory limit doses. A limit test at one dose level of 2000 
mg/kg body weight was carried out with three animals per step. The test substance-
related mortality was not produced in animals, so further testing at the next lower 
level need not be carried out.  
Observations 
 The animals were observed individually after dosing at least once during the 
first 30mins and periodically during the first 24 hrs. 
 Special attention: First 1-4 hrs after administration of drug, and  
 It was observed daily thereafter for a total of 14 days, except when they 
needed to be removed from the study and killed humanely for animal welfare 
reasons or are found dead. 
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a. Mortality 
Animals will be observed intensively at 0.5, 2.0, 4.0, 6.0, 12.0, 24.0 and 48.0 
hour following drug administration on day 1 of the experiment and daily twice 
thereafter for 14 days.   
b. Body weight 
Body weights will be recorded at day: ‐1, day 1, 2, 7 and 14 of the study 
c. Cage-side observation 
These include changes in skin and fur, eyes and mucous membranes and also 
respiratory, circulatory, autonomic and central nervous systems, somatomotor activity 
and behaviour patterns. Attention should be directed to observations of tremors, 
convulsions, salivation, diarrhoea, lethargy, sleep and coma. 
d. Gross necropsy 
All animals (including those which die during the test period are removed 
from the study) will be subjected to gross necropsy. Gross necropsy includes 
examination of the external surface of the body, all orifices, cranial, thoracic and 
abdominal cavities and their contents, brain, eye, thymus, lungs, heart, spleen, liver, 
kidneys, adrenals, testes and uterus of all animals 
Histopathology 
Microscopic examination will be carried out  in organs to show the evidence of 
any toxicity in gross pathology. 
Data and reporting 
All the data were summarised in tabular form showing the animals used, 
number of animals displaying signs of toxicity, the number animals found dead during 
the test or killed for humane reasons, a description and the time course of toxic effects 
and reversibility, and necroscopic findings. 
Test substance and Vehicle  
  In order to ensure the uniformity in drug distribution in the medium the 
suspension was made by mixing “Siringipaerathi Chooranam” with 2% CMC 
solution and it was found suitable for dose accuracy.  
Justification for choice of vehicle 
The vehicle selected as per the standard guideline is pharmacologically inert 
and easy to employ for new drug development and evaluation technique
 [97]
. 
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4.3.2. REPEATED DOSE 28 DAYS ORAL TOXICITY STUDY OF 
“SIRINGIPAERATHI CHOORANAM” ON RATS – (OECD-407 guidelines) [98]. 
Justification for Dose Selection 
The results of acute toxicity studies in Wistar albino rats indicated that 
“Siringipaerathi Chooranam” was non-toxic and no behavioral changes was 
observed up to the dose level of 2000 mg/kg body weight. On the basis of body 
surface area ratio between rat and human, the doses selected for the study 
were100mg/kg, 200 mg/kg and 400 mg/kg body weight. The oral route was selected 
for use because oral route is considered to be a proposed therapeutic route. 
Preparation and administration of dose 
“Siringipaerathi Chooranam” at three doses respectively was suspended in 2 
ml of 2% CMC in distilled water. It was administered to animals at the dose levels of 
100, 200 and 400 mg/kg. The test substance suspensions were freshly prepared every 
day for 28 days. The control animals were administered vehicle only. Administration 
was by oral (gavages), once daily for 28 consecutive days. 
METHODOLOGY 
Randomization, Numbering and Grouping of Animals 
 Ten rats (Five Male and Five Female) were in each group randomly divided 
into four groups for dosing up to 28 days. Animals were allowed acclimatization 
period of 7 days to laboratory conditions prior to the initiation of treatment. Each 
animal was fur marked with picric acid. The females were nulliparous and non-
pregnant. 
OBSERVATIONS 
Experimental animals were kept under observation throughout the course of 
study for the following:  
Body Weight: Weight of each rat was recorded on day 0, at weekly intervals 
throughout the course of study and at termination to calculate relative organ weights. 
From the data, group mean body weights and percent body weight gain were 
calculated.  
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Clinical signs: All animals were observed daily for clinical signs. The time of 
onset, intensity and duration of these symptoms, if any, were recorded. 
Mortality: All animals were observed twice daily for mortality during entire 
course of study. 
Functional Observations: At the end of the 4
th
 week exposure, ‘sensory 
reactivity’ to graded stimuli of different types (auditory, visual and proprioceptive 
stimuli), ‘motor reactivity’ and ‘grip strength’ were assessed. 
Laboratory Investigations: Following laboratory investigations were carried 
out on day 29 in animal’s fasted over-night. Blood samples were collected from 
orbital sinus using sodium heparin (200IU/ml) for Blood chemistry and potassium 
EDTA (1.5 mg/ml) for Haematology as anticoagulant. Blood samples were 
centrifuged at 3000 r.p.m. for 10 minutes. On 28th day of the experiment, 24h urine 
samples were collected by placing the animals in the metabolic cage with free access 
to tap water but no feed was given.  
 The urine was free from fecal contamination. Toluene was used as a 
preservative while collecting the sample. The sediments present in the urine were 
removed by centrifugation and the collected urine was used for biochemical 
estimations.  
On 29th day, the animals were fasted for approximately 18 h, and then slightly 
anesthetized with ether and blood samples were collected from the retro-orbital plexus 
into two tubes:  
One with EDTA for immediate analysis of haematological parameters, the 
other without any anticoagulant and was centrifuged at 4000 rpm at 4 °C for 10 
minutes to obtain the serum. Serum was stored at 20 °C until analyzed for 
biochemical parameters. 
Haematological Investigations: Blood samples of control and experimental 
rats was analyzed for hemoglobin content, total red blood corpuscles (RBC), white 
blood corpuscles (WBC) count and packed cell volume (PCV).  
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Biochemical Investigations: Serum was used for the estimation of 
biochemical parameters. Samples of control and experimental rats were analyzed for 
protein, bilirubin, urea, BUN, Creatinine, triglyceride, cholesterol and glucose levels 
was carried using standard methods. Activities of glutamate oxaloacetate 
transaminase/ Aspartate aminotransferase (GOT/AST), glutamate pyruvate 
transaminase/ Alanine amino transferase (GPT/ALT) and alkaline phosphatase were 
estimated as per the colorimetric procedure.  
Urine analysis: Urine samples were collected on end of treatment for 
estimation of normal parameters. The estimations were performed using appropriate 
methodology.  
Necropsy: All the animals were sacrificed on day 29. Necropsy of all animals 
was carried out and the weights of the organs including liver, kidneys, spleen, brain, 
heart, and lungs were recorded. The relative organ weight of each animal was then 
calculated as follows; 
                  Absolute organ weight (g) 
Relative organ weight = ____________________________________________ ×100 
                         Body weight of animal on sacrifice day (g) 
 
Histopathology: Histopathological investigation of the vital organs was done. 
The organ pieces (3-5µm thick) of the highest dose level of 400 mg/kg were 
preserved and were fixed in 10% formalin for 24 h and washed in running water for 
24 h. 
  Samples were dehydrated in an auto technique and then cleared in benzene to 
remove absolute alcohol.   
Embedding was done by passing the cleared samples through three cups 
containing molten paraffin at 50°C and then in a cubical block of paraffin made by the 
“L” moulds. It was followed by microtome and the slides were stained with 
Haematoxylin-eosin.  The organs included heart, kidneys, liver, ovary, pancreas, 
brain, spleen and stomach, of the animals were preserved they were subjected to 
histopathological examination
 [99]
. 
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Statistical analysis: Findings such as clinical signs of intoxication, body 
weight changes, food consumption, hematology and blood chemistry were subjected 
to One-way ANOVA followed by Dunnet’s multicomparision test using a computer 
software programme GRAPH PAD INSTAT-3 version. 
4.4. PHARMACOLOGICAL STUDIES 
 
4.4.1. HEPATO PROTECTIVE ACTIVITY OF “SIRINGIPAERATHI 
CHOORANAM” (SPC) IN CCL4 INDUCED HEPATOTOXICITY RATS 
Experimental design:  
Animals were divided into six groups of 6 rats each. Group I animals served as 
control and received liquid paraffin (LP) subcutaneously at the dose of 3 ml/kg body 
weight of each animal. Group II animals received CCl4+ LP (for 14 days) at the dose 
1 ml CCl4/kg body weight, in a suspension of double the volume of LP (which served 
as vehicle) subcutaneously at lower abdomen on every 14 days of the treatment .  
Group III and IV animals received subcutaneous administration of CCl4+ LP. 
They also received test drugs orally at the dose of 100, 200 mg/kg body weight 
respectively as a suspension of water. Group VI received in addition to CCl4 
suspension, Silymarin (100 mg/kg body weight) daily. Silymarin was used as a 
standard reference drug. 
The animals were kept starved overnight on 14
th
 day of experiment. On the 
next day the animals were sacrificed by decapitation, and the blood was collected by 
cutting the jugular vein. The liver and kidney in each case were dissected out, blotted 
of blood, washed in saline and stored in a freezer. Liver, kidney and serum were used 
for various biochemical estimations
 [100]
. 
Biochemical parameters studied 
 The activities of serum glutamate pyruvate transaminase, and serum glutamate 
oxaloacetate transaminase were estimated using standard methods. Estimation of 
serum ALP, serum bilirubin and electrolytes were also carried out to assess the acute 
hepatic damage caused by CCL4.  
 
MATERIALS AND METHODS 
 
 
HEPATOPROTECTIVE  ACTIVITY OF SIRINGIPAERATHI CHOORANAM 119 
 
Statistical analysis 
 The data obtained from the study were subjected to statistical analysis by one 
way ANOVA followed by Dunnet‘t’ test, and results were expressed in terms of 
Mean±SEM values. Statistical analysis was performed using INSTAT- V3 Software 
programme.
 
 
4.4.2. EXPERIMENTAL DESIGN FOR HEPATOPROTECTIVE ACTIVITY 
OF “SIRINGIPAERATHI CHOORANAM” AGAINST PARACETAMOL 
INDUCED HEPATOTOXICITY IN RATS MODEL 
Experimental design:  
 Paracetamol induced hepatotoxicity in rats model was used for evaluation of 
hepato-protective activity for the Siringipaerathi Chooranam. Animals were divided 
into five groups, each group containing five animals.  
Group I (normal) received distilled water or 2% CMC for 14 days. Group II 
(Control) received paracetamol 1ml/kg, i. p. 1:1 dilution with coconut oil on 5th day. 
Group III received standard marketed drug Silymarin (25mg/kg per day, p.o.) for 14 
days and paracetamol induction on 5
th
 day.  Groups IV- V, received Siringipaerathi 
Chooranam (5mg/kg and 10mg/kg p.o) for 14 days and paracetamol induction on 5th 
day. 
After 14 days of experimental period blood sample had been collected 
individually for all the animals by retro-orbital puncture method and the blood was 
allowed to clot for 30 min; serum was separated by centrifuging and was used for 
various parameter estimations.  
Later all the animals were sacrificed by cervical dislocation, liver samples 
were collected and the individual weights of the livers were estimated. For 
histopathological study, liver tissue was quickly removed after autopsy and fixed in 
10% formalin in saline.  
Biochemical parameters studied 
 The activities of serum glutamate pyruvate transaminase, and serum glutamate 
oxaloacetate transaminase were estimated using standard methods. Estimation of 
serum ALP, serum bilirubin and electrolytes were also carried out to assess the acute 
hepatic damage caused by paracetamol.  
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Statistical analysis 
 The data obtained from the study were subjected to statistical analysis by one 
way ANOVA followed by Dunnet‘t’ test, and results were expressed in terms of 
Mean±SEM values. Statistical analysis was performed using INSTAT- V3 Software 
programme.
 [101] 
4.4.3. ANTIOXIDANT ACTIVITY OF “SIRINGIPAERATHI CHOORANAM”  
DPPH ASSAY (2, 2-diphenyl -1-picrylhydrazyl) 
  The radical scavenging activity of different extracts was determined by using 
DPPH assay
 [102]
. The decrease in the absorption of the DPPH solution after the 
addition of an antioxidant was measured at 517 nm. 
Ascorbic acid (10mg/ml DMSO) was used as reference. 
Principle  
1, 1-diphenyl-2-picryl hydrazyl is a stable free radical with red colour which 
turns yellow when scavenged. The DPPH assay uses this character to show free 
radical scavenging activity. The scavenging reaction between (DPPH) and an 
antioxidant (H-A) can be written as,  
DPPH + [H-A] →DPPH-H + (A) 
Antioxidants react with DPPH and reduce it to DPPH-H and as consequence 
the absorbance decreases. The degree of discoloration indicates the scavenging 
potential of the antioxidant compounds or extracts in terms of hydrogen donating 
ability. 
Reagent Preparation 
0.1mM DPPH solution was prepared by dissolving 4mg of DPPH in 100ml of 
ethanol.  
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Procedure 
Different volumes of plant extracts were made up to 40µl with DMSO and 
2.96ml DPPH (0.1mM) solution was added. The reaction mixture incubated in dark 
condition at room temperature for 20 minutes. After 20 minutes, the absorbance of the 
mixture was read at 517nm.3ml of DPPH was taken as control. 
Calculation 
% inhibition = control-test × 100 
     Control 
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5. RESULTS AND DISCUSSION 
Many studies have been carried out to bring the efficacy and potency of the 
drug Siringipaerathi Chooranam. The study includes literary collections, organoleptic 
character, physicochemical and phytochemical analysis, instrumental analysis, 
toxicological study and pharmacological study.  
The study Siringipaerathi Chooranam has been selected for Hepatoprotective 
activity in reference with the text “SARABENDRA VAIDHIYA MURAIGAL”. 
 Literary collections about the drug from various text books were done. Siddha 
literatures related to the drug bring the evidence and importance of its utility in 
treating the jaundice.  
 Botanical aspect explains the identification, description, active principle and 
medicinal uses of the plants.  
 Gunapadam review brings the effectiveness of the drug in treating Jaundice.  
 Pharmaceutical review describes about the Chooranam and its properties.  
 The pharmacological review explains about the methodology of 
Hepatoprotective Activity and the drugs used.  
 Modern and Siddha aspect of the disease was also reviewed. 
STANDARDIZATION OF THE TEST DRUG 
 Standardization of the drug is more essential to derive the efficacy, potency of 
the drug by analyzing it by various studies. Following are the results of 
physicochemical and phytochemical analysis. Physical characterization and 
estimation of basic and acidic radicals have been done and tabulated.  
Toxicological results of the drug and pharmacological activity of the drug are 
derived. Its result has been tabulated and interpretation is made below. Thus, it is to 
give a complete justification, to bring the effectiveness of the trial drug 
Siringipaerathi Chooranam.  
The extensive review on botanical aspect gave information about the 
microscopical, macroscopical, medicinal uses, constituents and the importance of the 
herbs in detail Most of the herbs included in the formulation are hepatoprotective in 
activity. The studies strongly supported the fact through these results.  
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They are discussed below: 
 Milagu is indicated for diseases of   Liver, Spleen. 
 Thippili has an action of tonic to Liver. 
 Moongil uppu is used in the treatment of biliousness. 
 Seeragam is indicated for curing Jaundice and also used for 
strengthening of body. 
 Inji is a rejuvenating herb used for biliousness 
 Kodiveli ver is indicated for the treatment of Liver diseases. Tonic in 
action. 
 Lavanga pattai is indicated for biliousness. 
 Discussion on pharmacological aspect 
The pharmacological aspect of the drug says about their mode of action and 
side effects which were used worldwide since ancient times. The current 
pharmacological methods available for carrying out the Hepatoprotective activity 
studies were explained clearly and the suitable In-vivo model and Anti-oxidant in In-
vitro models carrying out the activities were discussed. Result from the 
pharmacological study denotes the effects of Siringipaerathi Chooranam (SPC) 
showed promising effects in treating liver damage. Moreover, the increased levels of 
the serum enzymes were significantly decreased by the treatment with Siringipaerathi 
Chooranam implying that the drug prohibited the liver damage.  
Discussion on Pharmaceutical review 
This review explained the preparation of Chooranam in detail including the 
purification of raw drugs, methods of manufacturing Chooranam and the Siddha 
parameters for the standardization of analyzing Chooranam. The shelf life of the drug 
is improved by proper purification methods and preservation.  
Discussion on Materials and Methods 
The preparation of the drug was done carefully so as to achieve the highest 
potency. Chooranam are fine dry powders of drugs. The term Chooranam may be 
applied to the powders of single drug or a mixture of two or more drugs.  
On purification (pittaviyal), the weight of the Chooranam is differed from the 
exact value but not from the mean value when calculated. 
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 The Chooranam were also subjected to Siddha parameters of testing like, 
 Chooranam tends to be amorphous. 
 It should be never damp. 
 The fineness of the sieve should be100 mesh or still finer. 
 The standardization of the drugs was achieved through various procedures like 
analyzing the organoleptic characters, physico-chemical characters, elements present 
in the drug and the results and discussion of standardization parameters is described 
below. 
ORGANOLEPTIC CHARACTER 
The following characters have been noted in Siringipaerathi Chooranam.  
Table: 4. Organoleptic characters 
Colour Brown 
Odour Pleasant  
Taste Bitter 
Texture Fine powder 
Particle size Completely pass through sieve 
no 92 
 
Table: 5. Physicochemical Analyses 
 
S.No 
Parameter Result 
1. pH 6.4 
  2. Ash (%) 13.23 
3. Acid Insoluble ash (%) 0.79 
4. Water soluble ash (%) 5.79 
5. Loss on drying (%) 9.26 
6. Solubility  Positive 
7. Action on heat  Negative 
8. Flame test Negative 
9. Ash test Negative 
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Interpretation 
The physicochemical analysis of the drug result reveals the pH, Moisture, Solubility, 
Water soluble ash, Ash and Acid insoluble ash.  
 pH:   
pH is a measure of hydrogen ion concentration; it is the measure of the acidic 
or alkaline nature. 7.0 is a neutral, above 7.0 is an alkaline and below are 
acidic. The pH of the drug Siringipaerathi Chooranam is 6.4 which are weak 
acidic in nature. Acidic drug is essential for its bioavailability and 
effectiveness. Acidic drugs are better absorbed in stomach.
 [103]
 
 
 Ash:  
Ash constitutes the inorganic residues obtained after complete combustion of a 
drug. Thus Ash value is a validity parameter describe and to assess the degree 
of purity of a given drug. Total ash value will determine the amount of 
minerals and earthy materials present in the drug. The total ash value of SPC 
is 13.23 % which determines the absence of inorganic content. 
 
 Acid insoluble ash:  
The acid insoluble ash value of the drug denotes the amount of siliceous 
matter present in the plant. The quality of the drug is better if the acid 
insoluble value is low. Acid insoluable ash is 0.79 for SPC. 
 
 Water soluble ash:  
Water-soluble ash is the part of the total ash content, which is soluble in water. 
It is 5.79 for SPC. 
 
 Moisture (Loss on drying):  
 The moisture present in the drug was established in loss on drying. 
 The moisture content of the drug reveals the stability and its shelf-life.  
 High moisture content can adversely affect the active ingredient of the 
drug. Thus low moisture content could get maximum stability and 
better shelf life. Loss on drying of SPC is 9.26%
 [104]
. 
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PHYTOCHEMICAL ANALYSIS 
 
 Table: 6. Phytochemicals screening test 
Phytochemicals Test Result 
1. Alkaloids Mayer’s test Present 
2. Carbohydrates Molisch’s test Present 
3.  Glycosides Modified Borntrager’s test Absent 
4. Saponins Froth test Absent 
5. Phenols Alcoholic Ferric chloride test Present 
6. Phytosterols Ferric chloride acetic acid test Absent 
7. Triterpenes Salkowski’s test Present 
8. Flavanoids Alkaline reagent test Present 
9. Proteins and amino acids Xanthoproteic test Present 
10. Quinones Sodium hydroxide test Absent 
 
Interpretation: 
Phytochemicals are natural bioactive compounds, found in plants and fibres, which 
act as a defense system against diseases and more accurately protect against diseases. 
The phytochemical analysis reveals that the presence of Alkaloids, glycosides, 
phenol, Triterpenes, Flavanoids and Quinones
 [105]
. 
Alkaloids 
 Alkaloids possess antispasmodic, analgesic, bactericidal effects. 
 Alkaloids are the active principles producing many essential effects in 
protecting the body
 [106]
. 
Carbohydrates 
 Carbohydrates play important role in storage of  glucose 
 Carbohydrates play important role in homeostasis of glucose and fatty 
acids in liver
 [107]
. 
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Phenols 
 They possess rich Anti-Oxidant property and protect body from oxidative 
stress. 
 Phenol groups are the essential part of many anti-oxidant compounds. 
 It is an Anaesthetic or pain reliever [108]. 
Phytosterols 
 Phytosterols are plant sterols, Phytosterols have anti-inflammatory effect, 
Phytosterols reduce oxidative stress  
 Various bioactivities of Phenolic compounds are responsible for their  chemo 
preventive properties  
 Phytosterols have an anti-oxidant property [109]. 
 Triterpenes 
 Suppress the inflammatory response. 
 The Triterpenes are the best immunomodulator and have anti-oxidant 
property. 
  Anti microbial activity. 
 Anti bacterial agent [110]. 
Flavonoids 
 It is the most important group of polyphenol compounds in plants. 
 Flavonoids are a group of plants metabolites which provide health benefits 
through cell signaling pathways and antioxidant effects.  
 Flavonoids can exert their Anti-Oxidant activity by scavenging the free 
radicals, by chelating metal ions or by inhibiting enzymatic systems 
responsible for free radical generation. 
 Flavanoids are immunomodulator [111]. 
Protein and amino acids 
 Proteins and  amino acids helps in  liver regeneration and energy production  
 Boosts glutathione production to protect the liver  
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 Increases satiety to promote weight loss and reduce fat accumulation in the 
liver  
 Protein is an amalgamation of amino acids .It is an important component of 
every cell in the body. 
 Body uses protein to build and repair tissues [112]. 
 A synergistic effect of all these flavonoids, alkaloids, carbohydrates, phenols, 
Phytosterols, Triterpenes increases the potency of the drug against hepatic damage. 
 
TLC/HPTLC analysis of chloroform extract 
 
HPTLC analysis 
 Chloroform extract was applied in TLC aluminum sheet silica gel 60(E. MERCK) 
and plate was developed using the solvent system Toluene: Ethyl acetate (9:1). After 
development, the plate is allowed to dry in air and examined under UV - 254nm, 366 
nm and Visible light (Vanillin - Sulphuric acid).   
Fig 5.1 HPTLC Chloroform extracts Photos 
   
λ 254 nm λ366 nm White light 
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Table: 7. Rf Values for the chloroform extract 
Color Rf  value(s) Color Rf  value(s) Color Rf  value(s) 
Green 0.08 Green 0.12 Red 0.60 
Green 0.35 Pale green 0.46 Violet blue 0.90 
Green 0.47 
Fluorescent 
yellow 
0.59 Magenta blue 0.95 
Green 0.62 Blue 0.70 Magenta blue 
0.98 
 
  Blue 0.82   
  Magenta blue 0.88   
  Violet 0.98   
 
HPTLC finger print analysis for chloroform extract 
 The finger print chromatogram was recorded at 366 nm. It showed 8 peaks of 
which peaks at Rf. and were the major peaks and others were moderately smaller 
peaks. 
= 366 nm  
 
 
    Fig 5.2 HPTLC finger print for chloroform extract 
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Table: 8.Chloroform extracts - Rf values in HPTLC finger print 
 
 Interpretation:  
 The quantitative analysis of compounds present in the SPC has been 
performed by HPTLC. The method may be applied to identify the SPC from 
other manufacturing process. It provides the identification of constituents, 
determination of impurities and quantitative determination of active substance 
present in the SPC. They provide the identification of constituents, 
determination of impurities and quantitative determination of active substance 
present in the SPC.
[113]
  
 The Rf value of the SPC supports the better standardization of the drug. 
 The present study revealed that SPC showed best results in Toluene: Ethyl 
acetate (9:1). Solvent system. After scanning and visualizing the plates in 
absorbance mode at 254nm, 366 nm and visible light range, best results were 
shown at visible light range. 
 TLC plate showed different colour phyto constituents of chloroform extract of 
SPC. The bands revealed presence of six green, two blue, and one fluorescent 
yellow, bands showing the presence of alkaloids, glycosides, phenols, 
Triterpenes, flavonoids and quinones. 
 The results from HPTLC finger print scanned for chloroform extract of SPC. 
There are thirteen polyvalent phyto constituents and corresponding ascending 
order of Rf values start from 0.02 to 0.91 in which highest concentrations of 
the phyto constituents was found to be 53.95% and 22.47 % with its 
corresponding Rf value were found to be 0.02 and 0.91 respectively. 
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Table: 9. Results of basic radicals studies 
S.NO Parameter Observation Result 
1 Test for Potassium Formation of yellow colour 
precipitate 
Positive 
2 Test for Calcium 
 
Formation of white colour 
precipitate 
Negative 
3 Test For Magnesium 
. 
Formation of white colour 
precipitate 
Positive 
4 Test For Ammonium 
. 
Appearance of brown 
colour 
Negative 
5 Test For Sodium 
 
Appearance of intense 
yellow colour 
Negative 
6 Test for Iron (Ferrous) Appearance of blood red 
colour 
Positive 
 
7 Test For Zinc 
 
Formation of white colour 
precipitate 
Positive 
8 Test For Aluminium 
 
Characteristic changes Negative 
9 Test For Lead 
 
Formation of yellow colour 
precipitate 
Negative 
10 Test for Copper 
 
Formation of blue colour 
precipitate 
Negative 
11 Test For Mercury 
 
Formation of yellow colour 
precipitate 
Negative 
12 Test for Arsenic 
 
Formation of brownish red 
precipitate 
Negative 
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Interpretation  
The sample contains Potassium, Magnesium, Iron, Phosphorus, and Zinc. 
These trace quantities of minerals along may play an important role in the functioning 
of various enzymes in biological systems and have immunomodulatory functions and 
thus influence the susceptibility to the course and the outcome of a variety of viral 
infections. 
Potassium 
 Potassium is important for maintaining the integrity of cell membranes and 
functions as a vital electrolyte. 
 Potassium is absorbed through the small intestine; severe lack of potassium 
can disrupt liver function.  
 If potassium level falls below 30% to 40% are prone to liver disease [114]. 
 
Magnesium 
 It enhances immune system. 
 Depletion of Magnesium level leads to Cirrhosis, Fatty liver syndrome,  
 Thus magnesium is essential for liver to prevent Liver diseases.[115] 
Iron 
 Needed for energy metabolism.  
 It is crucial for oxygen transport, energy production, and cellular growth and 
proliferation. 
Zinc 
 The liver plays a central role in zinc homeostasis. 
  Zinc is a trace mineral that is essential to the normal functioning of the 
immune system. 
 Zinc is essential for many metabolic and enzymatic functions. 
 Liver as a powerful antioxidant. 
 Deficiency of zinc leads to malabsorption syndrome , Cirrhosis of liver.[116] 
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 The basic radical test shows the presence of Potassium, Magnesium, Iron 
and Zinc   absence of heavy metals such as lead, arsenic and mercury. 
Table: 10. Results of acid radical studies 
S.NO Parameter Observation Result 
1 Test for Sulphate Formation of white 
precipitate 
Positive 
2 Test for Chloride Formation of white 
precipitate 
Negative 
3 Test for Phosphate Formation of yellow 
precipitate 
Negative 
 
4 Test for Carbonate 
 
Formation of effervescence Negative 
5 Test for fluoride 
&oxalate 
 
Formation of cloudy 
appearance 
Negative 
6 Test For Nitrate 
 
Characteristic changes Negative 
 
Interpretation: 
 The acidic radicals test shows the presence of sulphate. 
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Availability of bacterial and fungal load in Siringipaerathi Chooranam 
 Table: 11. Bacterial and fungal dilutions 
 
MICROBES 
 
DILUTION 
 
RESULT 
 
BACTERIA 
 
10
-4 
 
7 
 
BACTERIA 
 
10
-6 
 
4 
 
FUNGI 
 
10
-2 
 
3 
 
FUNGI 
 
10
-3 
 
4 
 
Interpretation: 
 The availability of bacterial load in the SPC has been performed by Agar plate 
technique.  
 SPC is an herbal drug which are prepare from plant material they are prone to 
contamination. The contamination of herbal drugs by micro organism not only 
cause bio deterioration but also reduces the efficacy of drugs. 
 The toxin produces by microbes makes herbal drugs unfit for human 
consumption because the contaminated drug may develop unwanted disease 
instead of disease being cured. 
 The contamination of SPC has been examined by bacterial and fungal load. 
 Total bacterial load in 10-4 dilution is 7 and 10-6 dilution is 4. 
 Total fungal load in 10-2 dilution is 3 and10-3 dilution is 4.  
Here, the result shows presence of bacterial and fungal load in the trial drug 
(SPC).They present within the normal limits
 [117]
. 
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INSTRUMENTAL ANALYSIS 
 
Fig: 6 FT-IR (Fourier Transform InfraRed spectroscopy) 
FTIR 
Siringipaerathi Chooranam.  
Table: 12. FT-IR 
 
Absorption peak cm
-
1 
 
Stretch 
 
 
Functional group 
3415 O-H Stretch, bonded 
N-H Stretch 
Alcohol 
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2923 C-H Stretch 
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O-H Stretch Acid 
1635 N-H Bending 
C=C Stretch 
Amide 
Alkane 
1512 C=C Stretch 
C-Br Stretch 
Aromatic 
Alkyl Halide 
1454 C=C Stretch 
-C-H Bending 
Aromatic 
Alkane 
1375 -C-H Bending 
C-F Stretch 
N-O Stretch 
Alkane 
Alkyl Halide 
Nitro 
1324 C-F Stretch Nitro 
1245 C=O Stretch 
C-N Stretch 
C-O Stretch 
Acid 
Amine 
Ether 
1036 C-O Stretch 
C=O Stretch 
Ether 
Ester 
880 ==C-H Bending Alkene 
816 ==C-H Bending Alkene 
774 C-Cl Stretch Alkyl Halide 
711 C-Cl Stretch 
==C-H Bending 
Alkyl Halide 
Alkene 
665 C-Cl Stretch Alkyl Halide 
614 C-Cl Stretch Alkyl Halide 
576 C-Br Stretch Alkyl Halide 
524 C-Br Stretch Alkyl Halide 
468 C-Br Stretch Alkyl Halide 
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Interpretation 
FTIR instrumental analysis was done. The test drug was identified to have 15 
peaks. They are the functional groups present in the trial drug Siringipaerathi 
Chooranam. The above table shows the presence of amide, phenols, alkanes, alkyl 
halide, acid, aromatic, ester, ether and alcohol groups which represents the peak 
value. 
 OH group has higher potential towards inhibitory activity against 
microorganisms.  
 Phenols possess highly Anti-Oxidant property which enhances the drug effect 
against the disease. 
 Amines enhance the drug effect against the disease [118]. 
SEM (SCANNING ELECTRON MICROSCOPE) 
The above SEM studies of microscopic resolution of 1.00kx and examining 
surface area of 800x800µm
2
, showed objects of sizes ranging from 265nm to 
409nm.The surface of the sample grains is uniformly arranged in agglomerates. They 
are micro particles ranging from 265nm, 276nm, 303nm, 409nm. 
 
                                   
Fig: 7.1 SEM (Scanning Electron Microscope) 
 
186nm 
  232nm 
347nm 
 
 202nm 
197nm 
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Fig: 7.2 SEM (Scanning Electron Microscope) 
Interpretation for SEM 
 Micro particles are defined as particulate dispersion or solid particles with a size 
in the range of 100-1000nm in diameter. 
 Size and surface of micro particles can be easily manipulated to achieve both 
passive and active drug targeting. 
 They control and sustain the release of drug during the transportation and at the 
site of localization, alter drug distribution in the body and subsequent clearance of 
the drug so as to achieve increased drug therapeutic efficacy thereby bio-
availability and reduced side effects
 [120]
.  
Hence Siringipaerathi Chooranam which is prepared biologically contains 
nanoparticles to enhance the pharmacological action in the target site.  
Table: 13. ICP-OES RESULTS OF SIRINGIPAERATHI CHOORANAM 
S. No Elements Detected levels 
1. Arsenic  BDL 
2. Calcium  54.120 mg/L 
3. Cadmium  BDL 
4. Iron  12.300 mg/L 
5. Mercury  BDL 
6. Potassium  60.821 mg/L 
7. Sodium  03.110 mg/L 
8. Nickel  BDL 
9. Lead  BDL 
10. Phosphorus 08.541 mg/L 
11. Sulphur BDL 
 128nm 
327nm 
  142nm 
296nm 
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The toxic metals and the permissible limits 
Heavy metals WHO & FDA limits 
Arsenic (As) 3ppm 
Mercury (Hg) 1ppm 
Lead (Pb) 10ppm 
Cadmium (Cd)  0.30ppm 
 
Discussion: 
  The above results indicate that the trial drug is extremely safe as it contains heavy 
metals within specified limits. 
 The presence of Ca(54.120 mg/l), Fe(12.300 mg/l), K(60.821 mg/dl), Na(0.3110 
mg/l), P(8.541 mg/dl) has physiologically important. In Siringipaerathi 
Chooranam, the heavy metals like As, Cd, Hg, Pb,S and Ni were below detectable 
level. This reveals the safety of the drug. 
From the above results the heavy metals are observed with in permissible limits. 
Hence the safety of the drug is ensured. 
TOXICITY STUDY RESULTS 
Table: 14. Dose finding experiment and its behavioral Signs of Toxicity for 
Siringipaerathi Chooranam 
Observation done: 
Group Day 
 Body weight  Increased 
 Assessments of posture  Normal 
 Signs of Convulsion 
 Limb paralysis 
 Absence  (-) 
 Body tone  Normal 
 Lacrimation  Absence 
 Salivation  Absence 
 Change in skin color  No significant colour change 
 Piloerection  Normal 
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Group Day 
 Defecation  Normal 
 
 Sensitivity response  Normal 
 Locomotion  Normal 
 Muscle gripness  Normal 
 Rearing  Mild 
 Ur 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1111111111111111ination 
 No 
 
 
Rmal 
 
Table: 15. Dose finding experiment and its behavioral Signs of Toxicity for 
Siringipaerathi Chooranam 
1. Alertness 2.Aggressiveness 3. Pile erection 4. Grooming   5.Gripping 
6.TouchResponse 7. Decreased Motor Activity   8.Tremors 9 Convulsions  
10. Muscle Spasm 11. Catatonia 12.Musclerelaxant 13.Hypnosis 14.Analgesia 
15.Lacrimation 16. Exophthalmos 17. Diarrhea   18. Writhing 19 Respirations 
 20.  Mortality 
Interpretation: 
In the acute toxicity study, the rats were treated with different concentration of 
Siringipaerathi Chooranam from the range of 5mg/kg to 2000mg/kg which did not 
produce signs of toxicity, behavioral changes, and mortality in the test groups as 
compared to the controls when observed during 14 days of the acute toxicity 
experimental period. These results showed that a single oral dose of the extract 
showed no mortality of these rats even under higher dosage levels indicating the high 
margin of safety of this extract. In acute toxicity test the Siringipaerathi Chooranam 
was found to be non-toxic at the dose level of 2000mg/ kg body weight. 
 
 
 
Dose 
mg/kg 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
2000 + - - - - + - - - - - - - - - - - - + - 
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Weight gain of rats 
Table: 16 Body weight (g) changes of rats when exposed to SPC 
Dose 
(mg/kg/day) 
Days 
0 7 14 21 28 
Control 120.59±0.92 122.79±0.87 123.52±1.18 127.24±1.12 131.25±1.05 
100 121.53±0.93 124.14±0.58 127.24±1.15 128.92±1.40 132.23±1.05 
200 122.65±0.91 127.83±0.90 128.23±1.15 130.59±1.59 134.05±0.98 
Values are expressed as mean  S.E.M; N=3; *P<0.05, **P<0.01, ***P<0.001 vs control.  
Interpretation 
The total body weight of the animals was weighed on 1
st
, 7
th
, 14
th
, 21
st
, 28
th 
day and is shown in the table. It was found that the test drug produced significant 
weight gain than control, with administration of the drug.  
Similarly the test drug at all dose levels induced weight gain and we could see 
longer the duration of administration of drug higher was the weight gain. 
Results of organ weight in rats 
Table. : 17 .Effect of Siringipaerathi Chooranam on organ weight in rats 
Organ Control 100 mg/kg 200 mg/kg 
Liver (g) 3.070.20 4.41±0.32 4.72±0.32 
Heart (g) 0.320.04 0.37±0.01 0.42±0.02 
Lung (g) 0.280.05 0.32±0.01 0.38±0.01 
Spleen (g) 0.740.07 0.68±0.17 0.78±0.08 
Brain (g) 0.370.05 0.47±0.02 0.54±0.03 
Kidney (g) 0.760.05 0.89±0.01 0.91±0.02 
     Values are expressed as mean  S.E.M; N=3; *P<0.05, **P<0.01, ***P<0.001    vs control.  
Interpretation 
There is a slight significant change in the organ weight of the rats treated with 
different doses of test drug and the control. 
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 Results of Haematological parameters 
Table: 18 Effect of Siringipaerathi Chooranam on Haematological parameters in 
rats  
Parameter Control 100mg/kg 200 mg/kg 
RBC(x 10
6
/mm
3
) 8.29±0.43 8.27±0.44 8.26±0.44 
PCV (%) 49.66±0.77 47.98±1.04 47.20±0.91 
Hb (%) 15.13±0.39 14.83±0.40 15.03±0.39 
WBC(x 10
3
/mm
3
) 11.75±0.85 11.73±0.85 11.74±0.85 
 Neutrophils (%) 23.29±0.73 21.94±1.03 22.96±0.49 
Eosinophills (%) 4.10±0.23 3.8±0.25 3.97±0.23 
Lymphocyte (%) 85.5±0.46 83.7±0.72 84.87±0.32 
Platelets(x 10
3
/mm
3
) 425.73±1.35 423.43±1.47 425.03±1.26 
Values are expressed as mean  S.E.M; N=3; *P<0.05, **P<0.01, ***P<0.001 vs control.  
Interpretation 
The haematological investigation results of the rats conducted on 28
th
 day after 
the repeated dose of the drug revealed the values of different parameters. There is a 
slight variation in the values of RBC count values in the dose group of 100 and 200 
when compared with that of the control. The increase and decrease in the values 
obtained were all within the normal biological and laboratory limits. 
Results of Biochemical Parameters 
 
Table.No:19 Effect of Siringipaerathi Chooranam on biochemical parameters in 
rats 
 
Parameters Control 100 mg/kg 200 mg/kg 
Protein (g/dl) 8.58 ± 0.68 7.56±0.61 6.76±0.44 
Albumin (g/dl) 5.34 ± 0.40 5.29±0.44 3.5±0.54 
BUN (mg/dl) 22.06 ± 1.55 22.72±1.9 25.53±1.8 
Urea  (mg/dl) 64.24 ± 3.11 66.7±5.3 69.2±2.9 
Creatinine (mg/dl) 0.85 ± 0.07 0.6±0.24 0.71±0.25 
Total Cholesterol ( mg/dl) 93.21 ± 1.16 92.17±1.13 91.53±1.35 
Triglycerides  ( mg/dl) 52.58 ± 1.56 52.16±1.3 52.93±1.7 
Glucose (mg/dl) 108.63 ± 0.81 107.97±1.12 109.4±0.51 
Total Bilirubin (mg/dl) 0.205 ± 0.04 0.16±0.08 0.10±0.03 
SGOT (U/L) 73 ± 2.4 72.67±1.64 65.52±2.4 
SGPT(U/L) 28.4 ± 1.2 25.77±0.64 23.99±0.70 
Alkaline phosphatase(U/L) 102.4 ± 3.6 101.3±1.5 91.33±4.26 
Values are expressed as mean  S.E.M; N=3; *P<0.05, **P<0.01, ***P<0.001 vs control. 
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Interpretation 
The biochemical investigations were conducted on 28
th
 day and the results are 
produced. The results revealed that there is a slight significant change in the values of 
different parameters with that of the control. All the values were within the normal 
biological and laboratory limits. 
 
Results of Urine parameters 
Table.No:20 Effect of Siringipaerathi Chooranam on Urine parameters in rats 
Parameters Control 100 mg/kg 200 mg/kg 
Colour Yellow Yellow Yellow 
Transparency Clear Clear Clear 
Specific gravity 1.01 1.02 1.02 
PH 7.2 7.4 7.3 
Protein Nil Nil Nil 
Glucose Nil Nil Nil 
Bilirubin -ve -ve -ve 
Ketones -ve -ve -ve 
Blood Absent Absent Absent 
RBCs Nil Nil Nil 
Epithelial cells Nil Nil Nil 
Casts Nil Nil Nil 
 
 
Interpretation 
Urine analysis data of control group and the test groups of animals taken on 
28
th
 day showed no abnormal results. 
The above results showed that all parameters remained within normal limits. 
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Interpretation 
 The above slides show the histopathology studies of sub-acute toxicity. There 
is no toxicological abnormality seen in the vital organs after administration of the test 
drug Siringipaerathi Chooranam. Thus the safety of the drug is revealed so that it can 
be administered for long time without any side effects. 
PHARMACOLOGICAL RESULT: 
CCL4 INDUCED HEPATOTOXICITY 
Table: 21 Effects of Serum Enzymes on SPC 
 
Group Treatment SGPT 
U/L 
SGOT 
U/L 
1 Control 24.185 ±1.62 28.95 ±1.46 
2 CCL4 + LP 102.8 ±1.25 167.84 ±2.94 
3 Standard  
(Silymarin – 100 mg) 
30.95 ±2.34 43.8 ±2.35** 
4 CCL4 + low dose 
SPC – 100 mg 
68 ±2.51 70.76 ±1.43 
5 CCL4 + high dose 
SPC – 200 mg 
34.53 ±3.38* 40.05 ±1.72* 
Values are expressed as mean  S.E.M; N=6; *P<0.05, **P<0.01, ***P<0.001 vs control.  
 
Chart: 1   Effect of Serum Enzymes on SPC 
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Table: 22. Effect of Serum Enzyme (ALP) on SPC 
 
Group Treatment ALP 
(mg/dl) 
1 Control 39.86 ±3.46 
2 CCL4 + LP 89.33 ±0.97 
3 Standard  
(Silymarin -100mg) 
47.81 ±4.69** 
4 CCL4 + low dose 
SPC – 100 mg 
76.05 ±2.96* 
5 CCL4 + high dose 
SPC – 200 mg 
54.31 ±3.84* 
Values are expressed as mean  S.E.M; N=6; *P<0.05, **P<0.01, ***P<0.001 vs control.  
 
 
Chart: 2. Effect of Serum Enzyme (ALP) on SPC 
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Table: 23. Effects of Bilirubin Levels on SPC 
Group Treatment Total Bilirubin 
mg/dl 
Direct Bilirubin 
mg/dl 
1 Control 0.253 ±0.003 0.17 ±0.003 
2 CCL4 + LP 1.5 ±0.1 1.53 ±0.01 
3 Standard  
(Silymarin – 100mg) 
0.44 ±0.007** 0.24 ±0.004* 
4 CCL4 + low dose 
SPC – 100 mg 
1.25 ±0.015 1.21 ±0.040 
5 CCL4 + high dose 
SPC – 200 mg 
0.52 ±0.002* 0.20 ±0.018* 
Values are expressed as mean  S.E.M; N=6; *P<0.05, **P<0.01, ***P<0.001 vs control.  
 
 
Chart: 3. Effects of Bilirubin Levels on SPC 
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 Group I: Control rat showing normal central vein and normal hepatocytes 
 Group II: Showing dilated central vein and hepatocytes with degeneration 
 Group III: Liver tissue of rats treated with SPC at 100mg/kg showing mild 
degree of necrosis (N) with normal cells (C) 
 Group IV: Central vein showing normal hepatocytes with regenerating 
hepatocytes and mild inflammation in the portal area  
 Group V: Photomicrograph of liver tissue treated with Silymarin showing 
normal hepatocytes, portal vein (V) and portal artery. 
Interpretation 
Discussion on hepatoprotective activity against CCl4 induced hepatotoxicity in 
rats. 
 The present studies were performed to assess the hepatoprotective activity in 
rats against Carbon tetrachloride as hepatotoxins. Clinical signs in rats that 
received CCl4 (Group 2) included dullness and loss of appetite.   
 The serum enzymes like SGOT, SGPT, ALP, Direct Bilirubin and Total 
Bilirubin treated animals were significantly reduced by seven days 
pretreatment of SPC at two dose levels 100mg/kg and 200mg/kg, when 
compared with CCl4 treated control. No significant clinical abnormalities in 
other groups.  
 Changes in the serum constituents In Table: 21,22,23 the activities of serum 
SGPT, SGOT and ALP and Total Bilirubin and Direct Bilirubin in the SPC 
treated groups (Tables:21,22,23) and the Silymarin group, were significantly 
decrease when compared to CCl4 treated group and almost near the normal 
value when compared to the negative control.  
 The changes associated with Carbon tetrachloride induced liver damage of the 
present study appeared similar to the acute viral hepatitis. In CCl4 induced 
hepatotoxicity, the administration of the toxicant CCl4 showed a distinct rise 
in the levels of serum marker enzymes namely SGOT, SGPT, ALP, Total 
Bilirubin and Direct Bilirubin and as shown in Table: 21, 22, and 23. 
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 A number of reports indicates that overdose of carbon tetrachloride can 
produce centrizonal hemorrhagic hepatic necrosis in humans and experimental 
animals.  
 Carbon tetrachloride is biotransformed by the cytochrome P-450 system to 
produce the trichloromethyl free radical, which in turn covalently binds to cell 
membranes and organelles to elicit lipid peroxidation, disturb Ca 2+ 
homeostasis and finally result in cell death.  
 The drug treatment was carried out at two dose levels 100 and 200mg/kg, both 
of which along with the standard treated group showed a significant reduction 
in the elevated enzyme levels.  
 These data suggests a dose dependent hepatoprotective activity of SPC. The 
present studies were performed to assess the hepatoprotective activity in rats 
against CCL4 as hepatotoxins to prove its claims in clinical practice against 
liver disorders. 
 Reduction in the levels of SGPT, SGOT, and ALP towards the normal value is 
an indication of regeneration process. The protective effect exhibited by SPC 
at dose level of 200 mg/kg was comparable with the standard drug. The SPC 
treatments significantly reversed the levels of ALP.  
 These findings suggested the SPC administered has significantly neutralized 
the toxic effects of Carbon tetrachloride and helped in regeneration of 
hepatocytes.  
 Estimating the activities of serum marker enzymes, like SGPT,SGOT, ALP, 
Bilirubin can make the assessment of liver function when liver cell plasma 
membrane is damaged, a variety of enzyme normally located in the cytosol are 
released into the blood stream.  
 Their estimation in the serum is a useful quantitative marker of the extent and 
type of hepato cellular damage. The tendency of these enzymes to return to 
near normally in SPC administered group is a clear manifestation of anti 
hepatotoxic effects. Reduction in the levels of SGOT, SGPT and ALP towards 
the normal value is an indication of regeneration process.  
 Reduction in ALP levels with concurrent depletion of raised bilirubin levels 
suggests the stability of the biliary function during injury with Carbon 
tetrachloride.   
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 Therefore the reduction in the activity of these enzymes may result in a 
number of deleterious effects Administration of SPC increased the activities 
against CCL4-induced liver damage in rats to prevent the accumulation of 
excessive fats and protected the liver
 [121]
.  
 This was further confirmed by histopathological injuries in Fig 9 
PARACETAMOL INDUCED HEPATOTOXICITY 
Table: 24. Serum Enzymes Value (AST, ALT and ALP) 
 
Group Treatment AST(U/ml) ALT(U/ml) ALP (mg/dl) 
A Positive Control 
39.29 ±0.72 35.45 ±1.16 32.2 ± 0.86 
B 
Negative Control 
(Paracetamol) 
141.48 ±1.09 172.86 ±1.73 98 ± 0.70 
C Standard(Silymarin) 
52.37 ±1.98** 62.80 ±1.15** 35 ± 0.70** 
D SPC – 100 mg 
66.58 ±1.38* 88.75 ±1.85* 57.4 ± 1.077* 
E SPC – 200 mg 
52.29 ±1.39* 58.27 ± 3.97 48.8 ± 0.86* 
Values are expressed as mean  S.E.M; N=5; *P<0.05, **P<0.01, ***P<0.001 vs control.  
 
Chart: 4. Serum Enzymes Value (AST, ALT and ALP) 
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Table: 25. Effect of SPC on Total Cholesterol 
 
 
Group Treatment Total Cholesterol (mg/dl) 
A Positive Control 
150.4 ±6.62 
B 
Toxicant Control (Paracetamol 
-1.25 ml/kg) 
338.8 ±10.04 
C 
Standard(Silymarin -100 
mg/kg) 
167 ±4.82** 
D SPC – 100 mg 
270 ±7.38* 
E SPC – 200 mg 
203.6 ±5.38* 
Values are expressed as mean  S.E.M; N=5; *P<0.05, **P<0.01, ***P<0.001 vs control. 
 
 
Chart: 5. Effect of SPC on Total Cholesterol 
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Table: 26. Effect of SPC on Triglycerides 
 
Group Treatment Triglycerides (mg/dl) 
A Positive Control 
0.65 ±0.046 
B 
Toxicant Control (Paracetamol -1.25 
ml/kg) 
2.564 ±0.076 
C Standard(Silymarin -100 mg/kg) 
0.848 ±0.044* 
D SPC – 100 mg 
1.99 ±0.035** 
E SPC – 200 mg 
0.664 ±0.241* 
Values are expressed as mean  S.E.M; N=5; *P<0.05, **P<0.01, ***P<0.001 vs control.  
 
                                                         
Chart: 6. Effect of SPC on Triglycerides 
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Table: 27. Effect of SPC on Liver volume and weight 
 
Group Treatment 
Liver volume 
(ml) 
Liver weight  (g) 
A Positive Control 
2.748 ±0.067 4.58 ±0.61 
B 
Negative Control 
(Paracetamol -1.25 ml/kg) 
4.744 ±0.094 5.76 ±0.56 
C 
Standard 
(Silymarin-100mg/kg) 
3.244 ±0.129 3.96 ±0.60 
D SPC – 100 mg 
3.826 ±0.085* 3.91 ±0.52* 
E SPC – 200 mg 
3.8 ±0.230* 4.2 ±0.36 
Values are expressed as mean  S.E.M; N=5; *P<0.05, **P<0.01, ***P<0.001 vs control.  
 
 
Chart: 7. Effect of SPC on Liver volume and weight 
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Table: 28. Effect of SPC on duration of sleep and onset of time 
 
Group Treatment 
Duration of 
sleep(sec) 
Onset of 
time(min) 
A Positive Control 
96 ±0.707 175.4 ±1.88 
B 
Negative Control 
(Paracetamol -1.25 ml/kg) 
225.8 ±1.88 59.8 ±0.86 
C 
Standard 
(Silymarin-100mg/kg) 
120 ±1.14** 153 ±1.30 
D SPC – 100 mg 
173.4 ±1.72* 98 ±1.224 
E SPC – 200 mg 
125.2 ±0.86* 129.4 ±1.08 
Values are expressed as mean  S.E.M; N=5; *P<0.05, **P<0.01, ***P<0.001 vs control.  
 
 
Chart: 8. Effect of SPC on duration of sleep and onset of time 
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Table: 29. Effect of SPC on Total Protein and Bilirubin 
 
Group Treatment 
Total Protein 
(g/dl) 
Bilirubin (mg/dl) 
A Positive Control 
6.07 ±0.27 0.238 ±0.008 
B 
Toxicant Control 
(Paracetamol – 1.25 
ml/kg) 
3.49 ±0.29 2.202 ±0.02 
C 
Standard(Silymarin-100 
mg/kg) 
6.16 ±0.32** 0.408 ±0.012** 
D SPC – 100 mg 
6.21 ±0.19 1.488 ±0.01 
E SPC – 200 mg 
6.96 ±0.25* 0.634 ±0.017* 
Values are expressed as mean  S.E.M; N=5; *P<0.05, **P<0.01, ***P<0.001 vs control.  
 
 
 
Chart: 9. Effects of SPC on Total Protein and Bilirubin 
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Interpretation 
Effects of Siringipaerathi Chooranam on ALT, AST, and ALP, Total Protein, 
Bilirubin, Total Cholesterol, Triglycerides levels 
Paracetamol induced hepatotoxicity is the generally used screening method for 
testing the hepatoprotective nature of drugs. The hepatic damage increases the level of 
serum marker enzymes like AST, ALT, ALP and Bilirubin. This indicates the cellular 
damage as well as loss of the functional integrity of cell membrane in liver. 
In paracetamol treated rats the levels of serum marker enzymes (AST, ALT, 
ALP and Bilirubin) elevated significantly. Moreover, the increased levels of the 
serum enzymes were significantly decreased Total Cholesterol, Triglycerides 
significantly decreased and liver volume and liver weight significantly increased. 
Duration of sleep significantly increased and onset of time siginificantly decreased by 
the treatment with Siringipaerathi Chooranam at 100 mg/kg p.o and 200 mg/kg p.o, 
implying that the drug prohibited the liver damage. 
 The Siringipaerathi Chooranam treatment confirmed dose dependent 
activity, Siringipaerathi Chooranam at 200 mg/kg p.o revealed good result than 
100mg/kg p.o
 [122]
. This was further confirmed by histopathological injuries in Fig 10. 
ANTI-OXIDANT ACTIVITY 
 RESULT AND DISCUSSION 
Table: 30 DPPH Assay of Siringipaerathi Chooranam 
 
Sample 
concentration 
(µg/ml) 
Absorbance 
 
Percentage of Inhibition 
Drug Standard Drug Standard 
Control 0.5271 0.312 
 
- - 
1.25 0.4262 0.278 19.14248 40.89 
2.50 0.3704 0.202 29.7287 51.25 
5 0.2277 0.084 56.80137 74.07 
10 0.1835 0.052 65.18687 83.33 
20 0.1375 0.034 73.91387 89.62 
 
*µg/ml: microgram per milliliter. Drug:   SPC (1.25-20µg/µl). Standard: Ascorbic acid (10mg/ml DMSO) 
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Chart: 10. DPPH Assay of Siringipaerathi Chooranam 
 
DPPH stable free radical method is an easy, rapid and sensitive way to survey 
the antioxidant activity of SPC extract.  The  antioxidant  molecules  can  quench  
DPPH  free  radicals  by providing  hydrogen  atom or  by electron  donation  
and  a  colorless  stable  molecule  1,  1 diphenyl-2- picrylhydrazil is formed and 
as a result of which the absorbance at 517nm of the solution is decreased. In the 
present study, the SPC extract was analyzed was able to decolorize DPPH and the 
free radical scavenging activity was expressed as the percentage decrease in 
absorbance. 
In the present study, the extract of SPC was found to possess concentration 
dependent scavenging activity on DPPH radicals. The values of DPPH free radical 
scavenging activity of the SPC extract was given in (Table: 29). The extract of SPC 
showed the highest DPPH scavenging activity (81.71%) at 20µg/ml and the lowest 
percentage of inhibition (28.11%) at 1.25µg/ml.  Ascorbic acid (Standard) showed 
highest percentage of inhibition (89.62%) at 20µg/ml and the lowest percentage of 
inhibition (40.89%) at 1.25µg/ml.  
This indicated that % of inhibition increased with increase in concentration of 
both the standard and SPC extract. The SPC extract has more or less equal DPPH 
scavenging
 [123]
. 
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6. CONCLUSION 
 
         Liver diseases are the most common health problem in the world. The Liver is 
quantitatively the most important site of drug metabolism. However many drugs are 
known to cause hepatic injury. Conventional and synthetic drugs used in the treatment 
of liver diseases are sometimes inadequate and can have serious adverse effect. 
In the absence of a reliable liver protective drug in modern medicine there are 
a number of medicinal preparations from Siddha system of medicine recommended 
for the treatment of liver disorders. 
 The main obstacle in Siddha system of medicine in modern medical practice 
is the lack of scientific and clinical data and a better understanding of the efficacy and 
safety of herbal, metal and mineral drugs.  
In order to overcome this difficulty a novel attempt has been made to 
standardize the Siddha drug Siringipaerathi Chooranam for its hepatoprotective 
properties by using analytical, preclinical studies. 
               The drug Siringipaerathi Chooranam was selected from the Siddha 
literature SARABENDRA VAIDHYA MURAIGAL to validate the safety and its 
efficacy of CCL4 and Paracetamol induced hepatotoxicity and Anti-oxidant activity. 
The ingredients of the test drug was identified and authenticated by Siddha 
experts. The drug was prepared as per the procedure and subjected to various studies 
to reveal its potency and effectiveness against the disease. 
Various analysis such as physicochemical, phytochemical, biochemical 
analysis, instrumental analysis was made from the above analysis we came to know 
the presence of active ingredients responsible for its activity. 
Physico-chemical analysis 
 The pH of Siringipaerathi Chooranam was 6.4. This is weak acidic in nature, 
easily absorbed in upper part of stomach. Hence, the drug should not produce any 
harmful effect to the mucus membrane of the GI tract.  
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Phytochemical analysis 
Phytochemical analysis showed the presence of flavonoids, phenols, 
Carbohydrates, Phytosterols, Triterpenes, Proteins, Amino acids   and alkaloids. 
Biochemical analysis showed the presence of zinc, magnesium, potassium, calcium 
and sulphate. Thus from these results we come to know the effectiveness of the drug 
is due to the presence of these constituents and it has a synergistic effect in acting 
against the disease.                           
Phytochemicals are natural bioactive compound, found in plants and fibres, 
which act as a defense system against diseases and more accurately to protect against 
diseases 
Instrumental analysis: 
Based on the results, Siringipaerathi Chooranam is preferably non-toxic to 
human in its therapeutic dose. The standardization of the drug was evaluated by 
chemical characterization with heavy metal analysis, functional group analysis, 
elemental analysis and determination of particle size by ICP-OES, FTIR, and SEM 
respectively.  
             ICP-OES reveals the  physiologically important of  minerals like Na, K, Fe ,P, 
Ca. In Siringipaerathi Chooranam, the heavy metals like As, Cd, Pb and trace 
element like Ni were below detectable level. This reveals the safety of the drug 
The FTIR results showed the presence of O-H Stretching and bend, OH group 
has higher potential towards inhibitory activity against microorganisms. Phenols 
possess highly Anti-Oxidant property which enhances the drug effect against the 
disease 
 The SEM picture shown the presence of nanoparticle of size 100-1000 nm in 
the drug Siringipaerathi Chooranam. Further, the study shows that Siringipaerathi 
Chooranam is a kind of nanomedicine which favours the advantages of bio 
availability, better absorption and non toxic with minimal dose level. 
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Pharmacokinetic aspect:  
 The acid medicines were absorbed in acid medium. That is the Siringipaerathi 
Chooranam may be absorbed in the upper part of GIT.   
Toxicity studies: 
From the acute toxicity study as per OECD guideline 423, it was concluded 
that the test drug Siringipaerathi Chooranam is a safest drug. No mortality was 
obtained. 
Toxicological study of both acute and sub-acute toxicity study were carried 
out in animal model Wistar albino rat according to the OECD guidelines. The test 
drug showed no acute toxicity as there was no mortality seen. The sub-acute toxicity 
after the repeated dose of 28 days was done. The mortality, functional observations, 
haematological and biochemical investigations were made. There was no significant 
change seen in the normal values. Thus the toxicological study of the test drug greatly 
establishes the safety and gives the justification for long time administration. 
In Conclusion, no toxic effect was observed up to 200mg/kg of Siringipaerathi 
Chooranam treated over a period of 28 days (OECD 407). So, it can be concluded 
that the Siringipaerathi Chooranam can be prescribed for therapeutic use in human 
with the dosage recommendations of up to 100mg/kg body weight p.o. 
Antimicrobial activity: 
The Siringipaerathi Chooranam showed a broad-spectrum antimicrobial 
activity contrary to all the microorganisms. In the study reveals that the presence of 
bacterial and fungal load in the trial drug (SPC).They present within the normal 
limits. 
The pharmacological study was carried out in the animal model Wistar albino 
rats. Three activities were seen in the drug Siringipaerathi Chooranam. The Activities 
were, 
 CCL4  induced Hepato toxicity 
 Paracetamol induced Hepato toxicity 
 Anti-Oxidant Activity 
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Hepatoprotective activity against CCl4, Paracetamol: 
The present study showed that Siringipaerathi Chooranam produce protective 
against the hepatotoxicity induced by CCl4, Paracetamol.  
The hepatoprotective role of Siringipaerathi Chooranam might be due to its 
chemical constituent.  Hence Siringipaerathi Chooranam may be act as prophylactic 
as well as curative drug in treating hepato toxic conditions. Further studies needs to 
isolate the active constituents and mechanism of action. Thus the author validates 
Siringipaerathi Chooranam as a new hepato-protective drug which is cost effective 
and without any side effect.  
Anti-oxidant 
In the present study, the extract of SPC was found to possess concentration 
dependent scavenging activity on DPPH radicals .The SPC extract has more or less 
equal DPPH scavenging, when compared to standard (Ascorbic acid), it was 
concluded that the SPC extract has a marked anti-oxidant activity at higher 
concentration. 
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                                                7. FUTURE SCOPE 
 The trial drug Siringipaerathi Chooranam has its own potency of 
hepatoprotective activity in animal model which has been established in this study. 
However, the mechanism of action by which Siringipaerathi Chooranam produced its 
effect on hepatoprotective activity in experimental animals need to be validated in a 
scientific manner using specific experimental animal models and also multi-center 
clinical trials are required to understand the exact molecular mechanisms of action. So 
it could be used worldwide for hepatoprotective action. 
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8. SUMMARY 
            The Siddha Medical System is a renowned medical system belonging 
to Tamil speaking regions. Although our Indigenous systems of Medicine utilize raw 
materials from plant is unique to Siddha Medical system.  
 The test drug Siringipaerathi Chooranam was selected from the Siddha 
literature SARABENDRA VAIDHYA MURAIGAL for its hepatoprotective 
activity. The dissertation started with an introduction explaining about the 
Siddha concept, prevalence of jaundice and role of the test drug in treating 
hepatic diseases. 
 The review of literature strengthened the positive facts of possessing the 
hepatoprotective activity by each of the single drug included in the 
formulation. The pharmacological review possessed all the information 
regarding the exertion of action of the drugs, available drugs in the market, 
their adverse effects 
 The test drug was prepared properly by the given procedure. All the 
ingredients were identified and authenticated by the experts. 
 Review of literature in various categories was carried out. Siddha aspect, 
botanical aspect and pharmaceutical review disclosed about the drug and the 
disease. Pharmacological review was done to establish the methodologies. 
 The drug was subjected to analysis such as physicochemical, phytochemical, 
biochemical and also instrumental analysis which provided the key ingredients 
present in the drug thus it accounts the efficacy of the drug 
 Toxicological study was made according to OECD guidelines comprising both 
acute and sub-acute toxicity study. It showed the safety of the drug which 
attributes its utility in long time administration. 
 Pharmacological study was done. It revealed the hepatoprotective and anti-
oxidant activity of Siringipaerathi Chooranam in animal model Wistar albino 
rats and In-vitro studies. 
 Results and discussion gives the necessary justifications to prove the potency 
of the drug. 
 Conclusion gives a compiled form of the study and explains the synergistic 
effect of all the key ingredients and activities that supports the study.  
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 This current analysis authenticates that Siringipaaerathi Chooranam has 
impressive Hepatoprotective activity, which exemplifies the intelligence of the 
Siddha literature to reach globally for the welfare of mankind. 
 Thus the herbal formulation Siringipaerathi Chooranam is validated for its 
safety and efficacy for treating jaundice and it would be a great drug of choice. 
The final discussion and conclusion chapters analyzed the dissertation. The 
conclusion chapter also provides a discussion of the verification and validity of the 
research results carried out. The most vital part of some experience of the findings in 
the dissertation is also discussed and thereafter invites the reader to further studies and 
future research possibilities. 
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